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1. General introduction to Tuberculosis  
1.1 Tuberculosis remains a global health threat  
Tuberculosis (TB) has affected humans since ancient times and remains a dangerous infectious 
disease today. It usually affects the lungs, although it can also invade other organs of the body, 
such as the brain, the intestine, the kidneys, or the spine 1. Mycobacterium tuberculosis (Mtb) is 
the causative agent of TB. There are two general types of TB infection based on the clinical 
symptoms: latent and active TB. TB spreads when people who have active TB cough, spit, speak, 
or sneeze in the vicinity of uninfected individuals, who then inhale the aerosols containing the 
bacteria 2. Patients with latent TB do not manifest visible clinical symptoms, as bacteria can 
maintain a dormant state inside the host for a long period of time. However, latent TB can 
progress to clinically active TB because of various factors that can compromise the immune 
system of the host, such as malnutrition, diabetes, smoking, alcohol addiction, or reinfection. 
Overall, there is a chance of around 10% that latent TB becomes active 3. The clinical signs of 
active TB include chronic coughing, pain in the chest, weakness or fatigue, weight loss, fever, and 
night-sweats. Evidence of TB infections in Europe can be tracked centuries back. Based on 
historic records, around 25% of the population died due to a TB epidemic in the 19th century, 
frequently referred to as ‘consumption’ due to the associated weight loss 1. In modern times, TB 
remains a leading cause of morbidity and mortality in worldwide, with 10.4 million new cases 
and 1.7 million deaths in 2015 4. Moreover, TB infection often coincides with human 
immunodeficiency virus (HIV) infection, or immunocompromising chronic diseases such as 
diabetes mellitus. The resulting comorbidity and the increased occurrence of drug resistant Mtb 
strains have contributed to an increase in TB manifestations and associated mortality 5, 6. 
According to the World Health Organisation (WHO), TB is a pandemic disease that represents a 
significant health burden for developing Countries. WHO estimated that more than one-third of 
the world’s population is currently infected with Mtb and about 10-15% of this large number of 
carriers will progress to active TB. Furthermore, drug-resistant TB is a serious health threat for 
both developing and developed countries, as these strains are (becoming) resistant to the most 
frequently used first- and second-line anti-TB drugs 4. 
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1.2. Pathogenesis of tuberculosis  
Mtb is a bacterial pathogen that can parasitize host immune cells. It was first described in 1882 
by Robert Koch. In most cases, TB patients are infected by Mtb, but other strains of the Mtb 
complex can also cause TB, such as M. bovis, M. africanum, M. canetti, and M. microti. However, 
cases of TB caused by these other mycobacterial species have not been documented worldwide 
and are generally limited to regions with poor public health 7.    
TB infections start when the mycobacteria-enclosed aerosols reach the pulmonary alveoli. 
Invading mycobacteria can be recognized by alveolar macrophages through several pattern 
recognition receptors (PRRs), including toll-like receptor (TLR) 1, TLR2, TLR4, and TLR9 8-10. 
Macrophages attempt to eliminate the bacteria from the infected tissue through phagocytosis 
11. During this process, Mtb is engulfed (phagocytosed) and temporarily resides in a membrane-
bound vesicle, called a phagosome. Bacteria-containing phagosomes normally fuse with 
lysosomes to form phagolysosomes. Phagolysosome fusion presents a major anti-bacterial 
strategy by exposing engulfed bacteria to lysosomal acidic hydrolases 3. The critical survival 
strategy of Mtb inside macrophages is to prevent the fusion between phagosomes and 
lysosomes. Furthermore, Mtb can also resist the acidic environment of lysosomes 12, 13 and 
initiate various countermeasures to protect itself against other host defense mechanisms, such 
as generation of reactive oxygen species (ROS) and nitrogen species (RNS) 14. Thus, Mtb is able 
to survive and replicate inside macrophages and will eventually overgrow and kill the immune 
cells 12, 15. To achieve this, Mtb not only resists the phagolysosomal pathway, but can also escape 
from phagosomes into the cytosol. Once inside the cytosol, the bacteria have access to sufficient 
nutrients, which improves its replication rate inside of macrophages 16. This process requires the 
type VII secretion system ESX-1 (6-kDa early secretory antigenic target (ESAT-6) secretion system 
1) 17. This secretion system allows Mtb to resist host immune responses by exporting several 
effector proteins 18, 19. A recent study showed that the ESX-1 secretion system directly affects the 
acidification of Mtb-containing phagosomes 20. Furthermore, the ESX-1 secretion system has 
multiple other functions that contribute to the ability of Mtb to survive and replicate inside 
macrophages and to promote its cell-to-cell spreading 21.  
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Mtb infected macrophages produce inflammatory cytokines and chemokines to recruit other 
immune cells to form a compact and organized structure called a granuloma – the clinical 
hallmark of TB 22. The recruitment of macrophages in the early stage of infection depends on the 
local production of ligands (CCL2/MCP-1, CCL12, and CCL13) that bind to the chemokine 
receptor CCR2 23. Adaptive immune cells, like T cells and B cells, are also recruited to the forming 
granuloma during later stages of the infection. Maintaining the structure of the granuloma 
requires the production of TNF-α by infected macrophages and T cells 24.  
The granuloma is situated at the core of TB pathogenesis. This inflammatory structure functions 
to restrict mycobacteria in a limited area and provides a local environment where cells of the 
immune system can interact with the bacteria 22, 23. However, recent studies have found that 
mycobacteria also utilize the granulomas to avoid killing by the host's immune response 24-26. For 
example, macrophages in the granulomas have been shown to undergo an epithelioid transition 
that is characterized by downregulation of immune-related genes and upregulation of epithelial 
markers, a process which is induced by bacterial virulence factors 22, 24, 25, 27. Formation of tight 
junctions between neighboring epithelioid macrophages further limits access to the granuloma 
core by newly recruited immune cells and prevents bacterial clearance 22, 24, 28. Thus, 
macrophages and dendritic cells (DCs) inside of the granulomas are unable to delivery antigens 
to lymphocytes, effectively repressing the adaptive immune response 29, 30. Mtb inside the 
granuloma can become metabolically dormant and persist for decades before reactivation 
occurs 22.  
1.3. Prevention and control of tuberculosis 
The “End TB strategy” was launched in 2014 by the WHO and achieved much progress in 
reducing new TB cases by improving treatment regimens and public health awareness 31. TB 
prevention principally depends on the immunization of infants. Currently, Bacillus Calmette-
Guérin (BCG) is the only TB vaccine used worldwide 32. The BCG vaccine was generated as an 
attenuated live vaccine derived from a virulent strain of the M. bovis species by more than 200 
times of consecutive passage 33. The BCG vaccine effectively prevents forms of TB during 
childhood. However, BCG vaccination provides a highly variable level of protection against TB in 
5 
 
different populations and regions 34.  
Both latent and active TB can be diagnosed and cured. Diagnostic tools for latent and active TB 
are readily available. Latent TB is efficiently detected by the Mantoux tuberculin skin test (TST) 
and the Interferon-gamma release assay (IGRA). The Mantoux test is based on a subcutaneous 
injection of tuberculin purified protein derivative (PPD), followed by a measurement of the 
resulting induration (palpable, raised, hardened area or swelling) as a read out of the level of 
immune recognition of tuberculin peptides. The interferon-gamma release assay is based on the 
quantification of Interferon-gamma production in response to the presence of TB antigens in the 
whole blood 35. For active TB, chest radiography and bacterial cultures are efficient and rapid 
diagnostic methods 36. 
Preventive therapy is necessary to lower the risk of disease progression from latent to active TB. 
The standard treatment of latent TB recommended by the WHO is an oral antibiotic regimen 
(e.g. isoniazid and/or rifampicin) for 6 to 9 months 35, 37. However, the use of a single antibiotic 
frequently leads to development of drug resistance in active TB cases. Thus, treatment of active 
TB usually consists of a combination of antibiotics to kill the bacteria and lower the chance of 
Mtb developing drug resistance. Eradication of Mtb from the body by drug treatment is hard 
and time consuming, due to the special structure and chemical composition of the 
mycobacterial cell wall, which strongly inhibits the penetration of drugs and makes many 
antibiotics ineffective 38. If TB patients do not receive sufficient treatment, it leads to a growing 
incidence of drug resistant strains: Multidrug-resistant (MDR), Extensively drug-resistant (XDR) 
and Totally drug-resistant (TDR) strains. This further reduces the treatment options and 
increases the incidence of death 39, 40. In summary, there is a large variability in levels of 
protection provided by the current vaccine and Mtb is becoming increasingly resistant to many 





1.4. Zebrafish as a model to study mycobacterial pathogenesis 
Researchers have frequently used – and are still using – in vitro Mtb cultures or Mtb infected 
macrophages to investigate the mechanisms of Mtb infection. However, results obtained from in 
vitro studies may be difficult to translate into human therapies, as two-dimensional cell cultures 
lack the TB granuloma characteristic of this disease 41. Recently, successful attempts have been 
made to culture granulomas in three dimensions, using media that resemble the extracellular 
environment found in tissues 42. In addition, reliable animal models are essential to improve our 
understanding of the mechanisms of TB pathogenesis. Artificially infected animal models are an 
indispensable approach to investigate the host and bacterial factors involved in TB pathology, 
and to select new candidates for drugs and vaccines 43. 
Currently, several animal species are being used to study Mtb infections, which include mice, 
guinea pigs, rabbits and non-human primates. In murine infection models, it has been difficult to 
replicate human TB pathologies as the commonly used mouse strains do not develop the highly 
organized granuloma structures observed in humans and in non-human primates 22. However, 
alternative mouse strain, such as C3HeB/FeJ, DBA/2 and CBA/J, can develop necrotic granulomas 
in the lungs following infection with Mtb 44-46. These models were generated by selecting for 
mouse strains with increased susceptibility to Mtb, which resulted in the identification of 
genetic loci that prevent the formation of necrotic granulomas 46, 47. These new TB models have 
been used to screen for anti-TB drugs and to test new vaccine candidates 45, 48. Other 
mammalian models (such as guinea pigs and rabbits) have been developed that mimic human 
TB pathology, including the formation of necrotic granulomas 43. However, both the guinea pig 
and rabbit models lack of immunological reagents available for mice and are difficult in genetic 
manipulation 49. The primate infection models present similar clinical signs as human TB and 
form classical TB granuloma structures. However, the costs and ethical considerations arising 
from the use of these models imply that they can only be used sparsely. Thus, additional animal 
models are necessary to study TB pathogenesis.  
During the last 10 years, the zebrafish has become a widely used alternative animal model to 
study mycobacterial pathogenesis 50-52. Adult zebrafish have fully functional innate and adaptive 
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immunity, which is highly similar to the mammalian immune system 53. Furthermore, zebrafish 
are naturally susceptible to Mycobacterium marinum (Mm), the causative agent of TB in 
ectotherms. As a close relative of Mtb, Mm shares many of its virulence factors 54, 55. The 
zebrafish-Mm model presents additional advantages that are distinct from those of other TB 
models 56. Zebrafish embryos and larvae are transparent, which allows intravital imaging of host-
pathogen interactions following microinjection of Mm 57. At 1 day post fertilization or at later 
stages, zebrafish larvae can form organized and compact Mm granulomas, which have high 
similarity to the early stages of granulomas generated by Mtb in primates 58. Zebrafish 
transgenesis methods have been well established, and the recent breakthroughs in gene editing 
with CRISPR/Cas9 have facilitated the generation of knock-out and knock-in zebrafish 59. On the 
bacterial side, Mm presents advantages over working with Mtb, including lower biosafety 
restrictions (BSL2 instead of BSL3) and a considerably shorter replication time 58. In recent years, 
the insights from the Mm-zebrafish embryo infection model have contributed significantly to our 
understanding of TB pathogenesis 27, 59-62.  
2. Autophagy: an important immune defense mechanism against Mtb 
2.1 The basic function of autophagy 
Autophagy is an evolutionary conserved lysosomal degradation pathway in eukaryotic cells that 
can degrade cytoplasmic materials and organelles. By removing unwanted cellular contents, 
autophagy functions in maintaining cellular homeostasis. This physiological phenomenon was 
first discovered by Christian De Duve around 55 years ago 63. The process is genetically well-
defined and many of the factors involved are conserved in eukaryotes from yeast to humans 64. 
Autophagy is recognized as a survival mechanism in response to different types of stress, 
including nutrient deficiency, growth factor deficiency, and hypoxia 65. The autophagic 
degradation of cytoplasmic material recycles amino acids and other nutrients, e.g. to fuel 
metabolic pathways in nutrient-deficient conditions. Autophagy can also be stimulated by other 
stress factors that include diseases and infections 66. Activation of autophagy in these contexts 
generally follows upon an increased transcriptional activation and/or post translational protein 
modification of autophagy-related factors and regulators by the host cells 67. 
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Three main categories of autophagy are identified in mammalian cells, based on the 
mechanisms used to capture cytosolic cargo. These include macroautophagy, microautophagy, 
and chaperone-mediated autophagy. All of them rely on proteolytic degradation of cytosolic 
materials in lysosomes 68. Macroautophagy is characterized by capturing cargo in a double 
membrane-bound structure. During this process, the isolation membrane (or autophagophore) 
undergoes expansion and elongation to form a double membrane vesicle, known as an 
autophagosome, which eventually fuses with a lysosome to generate an autophagolysosome 69 . 
The term “autophagic flux” is used to describe the whole process from autophagosome 
formation to the degradation of the cytoplasmic cargo by hydrolases 70. Microautophagy is a 
non-selective degradation process during which cytosolic components are directly engulfed by 
lysosomes 71. Finally, chaperone-mediated autophagy (CMA) was identified in 1981 and is quite 
different from macro- and microautophagy in terms of its selectivity and mechanism of cargo 
degradation 72. CMA only eliminates targeted proteins and delivers them to the lysosomes via a 
process assisted by chaperone proteins/heat shock cognate proteins, such as Hsc-70. Hsc-70 can 
be recognized by the lysosomal membrane receptor lysosomal-associated membrane protein 2A 
(LAMP-2A), which leads to degradation of the Hsc-70 protein complex 73. Of the three types of 
autophagy, macroautophagy is the most abundant process and is therefore also the most 
extensively studied form of autophagy.  
Macroautophagy (hereafter referred to solely as autophagy) is historically regarded as a non-
specific pathway. However, it has become clear that this process can also be used to selectively 
remove material from the cytoplasm. In that case, so called selective autophagy receptors (SLRs) 
identify and capture targets for autophagosomal degradation based on a molecular tag, such as 
ubiquitin 74. Ubiquitination is a highly regulated process that is conserved in all eukaryotes. 
Ubiquitination can delivery covalently tagged substrates to (1) the proteasome, (2) the lysosome 
or, (3) the autophagosome 75. The crosstalk between ubiquitination and autophagy relies on 
SLRs, which act like a bridge by simultaneously binding to ubiquitinated cargos and the forming 
autophagophore 76. The selective autophagic degradation of misfolded proteins is called 
aggrephagy, that of mitochondria is called mitophagy, while the selective elimination of invading 
microbes is called xenophagy 77.  
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Xenophagy (also known as bacterial or anti-microbial autophagy) is considered a cell-
autonomous defense mechanism against invading pathogens 77. Deficiency of intracellular 
nutrients due to competition from invading pathogens is one of the signals sensed by eukaryotic 
cells to identify microbial invading and to diminish invading pathogens via autophagy 66. Anti-
microbial autophagy was first described in response to Streptococcus pyogenes (group A 
Streptococcus) infection 78. The bacteria are sequestered into autophagosomes and fuse with 
lysosomes to form autophagolysosomes. This process results in elimination of most of the 
bacteria 78. Around the same time, another study confirmed that stimulating autophagy can 
inhibit Mtb survival in infected macrophages 79. This study has shown that either physiological or 
pharmacological induction of autophagy decreased the viability of Mtb, while induction of 
autophagy was beneficial for the maturation of Mtb-containing phagosomes 79. Until now, 
autophagy has been shown to be able to directly target a diverse spectrum of pathogens, 
including various bacteria, viruses, and intracellular parasites 80. 
2.2 The components of the autophagy machinery  
Autophagy is a dynamic process which requires a series of distinct steps to complete. Autophagy 
is activated with the formation of a structure called the isolation membrane, also known as a 
phagophore. This lipid bilayer is thought to originate from the endoplasmic reticulum (ER) 
and/or the trans-Golgi network and endosomes 81. The phagophore then elongates and expands 
around the cargo, sequestering the cytoplasmic material into a double membrane structure. This 
double membrane structure defines the autophagosome. The autophagosome eventually 
matures and undergoes fusion with lysosomes, which promotes the degradation of the 
autophagosomal contents by lysosomal acid proteases 68 (Fig1). This process is driven by 
autophagy-related proteins, which are controlled by a number of signaling pathways in response 
to cellular stress factors, such as the mammalian target of rapamycin (mTOR) signaling pathway 
for nutrient sensing and pattern recognition receptor (PRR)-signaling for invading microbes 66, 82. 
The importance of autophagy is well established in mammals and other vertebrates, but the 
underlying molecular mechanisms have been uncovered using genetic analysis of yeast. 
Currently, more than 41 different ATGs have been revealed and identified in yeast by genetic 
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screening, followed by identification of homologs in higher eukaryotes 83. 
Starvation, a classical inducer of autophagy, can result in low nutrient and amino acid levels, 
which induces autophagy by inhibiting the function of mTOR 84. In turn, mTOR then relieves its 
inhibition of unc-51-like kinases 1/2 (ULK1 and ULK2) 84, 85, which are recruited to the 
phagophore to bind with the autophagy related gene 13 (ATG13) and FAK family kinase-
interacting protein of 200kDa (FIP200) 85. ULK1 and ULK2 have significant homology both in the 
C terminal and N-terminal regions. The C-terminal regions of ULK1 and ULK2 are required for 
interactions with ATG13 and FIP200, and for the translocation of ULK1 to nascent phagophores 
84. Assembly of this complex is essential for autophagy, because it allows the attraction of other 
ATG proteins to the phagophore assembly site (PAS) and activates several downstream targets 
through phosphorylation 67, 86. The activation of the ULK1/2 complex results in binding with 
Beclin1 (ATG6 in yeast) and ATG14L, which attracts additional proteins to the PAS for initiation of 
phagophore formation 68. This process requires the class III phosphatidylinositol-3 kinase 
(PI3KC3), resulting in the generation of phosphatidylinositol 3-phosphate (PI3P) by vesicular 
protein sorting 34 (Vps34) and recruitment of other effectors of the autophagy pathway 87. PI3P 
is strictly required for elongation of phagophore and attracts other ATG proteins to the 
phagophore 88, 89.  
The subsequent elongation and closure of the phagophore requires the recruitment of two 
ubiquitin-like proteins, ATG8/LC3 and ATG12 90. ATG8/LC3 (Microtubule-associated protein 1 
light chain 3; hereafter referred to as LC3) can occur in two forms: LC3-I, which resides freely in 
the cytoplasm; and LC3-II, which is the membrane bound form of LC3. LC3-II is formed when 
LC3-I is conjugated to the lipid phosphatidylethanolamine (PE). Upon activation of autophagy, 
ATG12 is conjugated to the crucial autophagy factor ATG5. The ATG12-ATG5 conjugate forms a 
complex with ATG16L1, which lipidates LC3 to direct its localization in the membrane of the 
forming autophagosome. To date, at least 6 selective autophagy receptors (SLRs) have been 
identified, namely Sequestosome 1 (SQSTM1/p62), Neighbor of BRCA1 gene1 (NBR1), Nuclear 
dot protein 52 kDa (NDP52), Optineurin (OPTN), BCL2-interacting protein 3 like (BNIP3L), and 
NDP52-like receptor TAX1-binding protein (TAX1BP1) 76, 91, 92. The common feature of these 
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receptors is that they contain an LC3 interaction region (LIR) motif and a ubiquitin binding 
domain (UBD). The LIR enables the targeting of selective receptors to LC3 (or other homologs of 
the LC3 family) attached to the membrane of a forming autophagosome 93. The UBDs (diverse 
ubiquitin binding domains in each receptor) can recognize and bind ubiquitin 94. UBDs ensure 
that selective receptors bind to ubiquitinated cargos to target them for autophagy 95.  
Eventually, during the maturation of autophagosomes into autophagolysosomes, the tail-
anchored SNARE syntaxin 17 recruited to the membrane of autophagosome allows fusion with 
lysosomes 96. This process also requires lysosomal membrane proteins LAMP1 and LAMP2 97. 




Figure 1: Schematic representation of the autophagy pathway  
The basal level of autophagy activity is low under healthy conditions. To maintain homeostasis, autophagy is 
activated upon sensing cellular stress signals, such as nutrient deprivation or intracellular infections. Autophagy is 
induced through the activation of the ULK1/ULK2 complex which also contains ATG13 and FIP200. This complex 
subsequently interacts with the VPS34-Beclin1-Atg14L complex, contributing to the initiation of the isolation 
membranes (phagophores) from endomembrane sources such as endoplasmic reticulum (ER), Golgi apparatus, the 
mitochondria and the plasma membrane-derived endocytic organelles. Phagophores can sequester cargo via 
selective or autonomous recognition. The elongation and expansion of phagophores containing cargo requires the 
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involvement of the ATG5-ATG12-ATG16 and ATG8-LC3 ubiquitin-like conjugation complexes to form double-
membraned autophagosomes. The maturation of autophagosomes involves fusion with lysosomes to form 
autophagolysosomes. This event requires the lysosomal membrane proteins LAMP1/2. After fusion, the 
sequestered cargo is degraded into amino acids and other small molecules by lysosomal and acidic hydrolases. The 
degraded material can be recycled and utilized as a source of energy for maintenance of cellular functions under 
the various stresses. LC3 is widely used as a general marker for autophagic activity and is involved in the entire 
process of autophagy. 
2.3 Role of autophagy in immunity  
Recent studies have demonstrated that defects in autophagy are associated with many diseases, 
including neuro-degenerative diseases, diabetes, cancer, and infectious diseases 98. In this thesis, 
we focus on the function of autophagy in immunity, and in particular on its role in defense 
against the intracellular mycobacterial pathogens that cause TB. The main functions of 
autophagy in innate and adaptive immunity can be classified as follows: elimination of invading 
pathogens; control of pro-inflammatory signaling; antigen presentation to activate the adaptive 
immune system; and secretion of immune mediators 66.  
Autophagy is a prominent innate immune mechanism by which an infected cell eliminates 
intracellular pathogens 66. Invading microbes are recognized by pattern recognition receptors 
(PRRs), such as toll like receptors (TLRs) and NOD like receptor (NLRs). These receptors can 
recognize pathogen-associated molecular patterns (PAMPs), which are derived from microbes. 
PAMPs consist, for instance, of nucleic acids (e.g. bacterial DNA, double and single stranded 
RNA), or other molecules that are specific for invading pathogens (e.g. flagellin) 99. For instance, 
recognition of lipopolysaccharide (LPS) – the outer membrane constituent of Gram-negative 
bacteria – by TLR4 leads to activation of autophagy 100. Furthermore, LPS-induced autophagy 
enhanced the colocalization between mycobacteria and autophagosomes in cultured 
macrophages 100. The function of autophagy in host defense against infection is well established 
for a number of invading microbes, including Mtb, Salmonella Typhimurium, Shigella flexneri, 
Listeria monocytogenes and Streptococcus pyogenes 101.   
There is also increasing evidence that the process of autophagy participates in reduction and 
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modulation of inflammatory responses 102. For instance, single nucleotide polymorphisms (SNPs) 
in genes central to the autophagy machinery significantly increase the susceptibility for Crohn’s 
disease, which is characterized by uncontrolled inflammation in the gastrointestinal tract 103. 
These results implicate that autophagy can affect the outcome of inflammatory disorders like 
Crohn’s disease. One explanation for this is derived from the fact that autophagy controls the 
homeostasis and development of immune cells, such as macrophages, neutrophils and 
lymphocytes. These cells are all necessary for host immune and inflammatory responses and 
secrete cytokines and chemokines. Thus, defects in autophagy could indirectly result in poorly 
controlled inflammatory responses 66, 104.  
However, a direct effect of autophagy on inflammatory processes has also been uncovered. 
Saitoh et al. (2008) first described that the loss of a central component in the autophagy 
machinery (ATG16L1) increased the production of pro-inflammatory cytokines when 
macrophages were stimulated with the endotoxin LPS. Their results demonstrated that 
autophagy directly controls the activity of the inflammasome, a multiprotein structure that 
promotes the maturation of interleukin 1 beta (IL1b) and interleukin 18 (IL18) and pyroptosis, an 
inflammation-associated type of programmed cell death 102. Other studies expanded on these 
important findings, and it is now clear that autophagy controls the activity of inflammatory 
cytokines at the transcriptional level 105; at the inflammasome-dependent processing step 102; 
and during the excretion of mature cytokines 106. This immune function of autophagy is highly 
relevant to TB pathogenesis, since nonresolving inflammation during mycobacterial infection 
fuels the generation of TB granulomas 107.  
Several studies have demonstrated that autophagy is also involved in adaptive immune 
responses, including the regulation of antigen processing and presentation 66. Inside antigen-
presenting cells (APCs), autophagy can deliver cytoplasmic and nuclear antigens to lysosomes, 
which can then be presented to cells of the adaptive immune system (CD4+ T cells) through the 
major histocompatibility complex class II (MHC-II) molecules 108. This function of autophagy is 
also relevant to TB prevention, as it has been shown that stimulating autophagy-mediated 
antigen presentation increases the efficacy of BCG vaccination 109. 
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2.4 Autophagy as defense mechanism against Mtb infections 
Susceptibility to active TB is partially genetically determined and variations in genes involved in 
the autophagic pathway have been identified that might disturb the host response to Mtb 
infection. A genome-wide association study has revealed a link between certain polymorphisms 
in ATGs and predispositions to TB in human patients. Three autophagy-related genes were 
identified from this screen, namely ATG16L1, IRGM, and VDR 110. Multiple other studies have 
experimentally demonstrated the involvement of autophagy factors in controlling Mtb infections 
in cultured cells 79, 111, 112, including the demonstration of an important role for IRGM in the 
elimination of intracellular mycobacteria 113.  
During Mtb infection, bacteria prevent phagosome maturation and are able to permeabilize the 
phagosomal membrane using region of difference 1 (RD1)-dependent virulence factors, which 
are secreted through the bacterial ESX-1 system 114. This enables the pathogen to escape into 
the cytoplasm, which activates selective autophagy following recognition of the bacteria by 
PRRs. Even when Mtb remains inside a permeabilized and immature phagosome, its 
extracellular bacterial DNA can still leak from the phagosome and be recognized by the cytosolic 
DNA sensor STING (stimulator of interferon genes) 115. Recognition by STING results in the 
labeling of bacteria with ubiquitin, which requires the ubiquitin ligases PARK2 (Parkin) and 
SMURF1 116, 117. This subsequently targets Mtb, or Mtb-containing immature phagosomes, for 
autophagolysosomal degradation via the ubiquitin-binding selective autophagy receptors p62 
and NDP52 115 (Fig2).   
Besides directly targeting intracellular bacteria for xenophagy, p62 also contributes to defense 
against mycobacteria by delivering ubiquitinated cytosolic proteins to autophagolysosomes, 
where they are proteolytically converted into products capable of eliminating Mtb 118. Thus, 
selective autophagy via the ubiquitin-binding receptor p62 presents an effective defense 
mechanism against intracellular mycobacterial infections via at least two mechanisms of action. 
Despite the strong evidence – mostly from in vitro studies – demonstrating a role for autophagy 
in host defense against mycobacteria, the in vivo relevance of these mechanisms has recently 
15 
 
been questioned 119. In a seminal study, Watson et al. (2012) previously found that mice with a 
monocyte/macrophage-specific deficiency in ATG5 were highly sensitive to Mtb infection and 
displayed elevated lung tissue damage. ATG5 is required for the early stage of autophagosome 
formation and ATG5 deficiency therefore affects the basal levels of autophagy 120, 121. The study 
by Kimmey et al. (2015) recently showed that macrophage-specific ATG5 depletion indeed 
resulted in increased Mtb infection, but this was mostly due to an overstimulated inflammatory 
response, rather than to impaired autophagy. Furthermore, macrophage-specific depletion of 
other autophagy factors – including ULK1, ULK2, ATG4B, and p62 – did not affect the outcome of 
Mtb infection in mice. Instead, the authors of this paper suggest that autophagy-associated 
proteins may function independent of xenophagy to influence bacterial pathogenesis 119.   
The discrepancies between in vitro and in vivo studies illustrate the need for further 
investigations into the role of autophagic defense against mycobacteria in animal models for TB. 
In this light, work using the zebrafish TB model can help to bridge the gap between mechanistic 
findings in cell culture models and their implications for disease outcome 52, 54, 58. For instance, a 
study from our laboratory that combined in vitro and in vivo experiments, demonstrated the 
relevance of a novel signaling pathway controlling autophagic defense against mycobacterial 
infections 62. In this study, analysis in Mtb infected human macrophages and the zebrafish model 
for TB revealed that the DNA damage-regulated autophagy modulator 1 (DRAM1) is activated 
downstream of pathogen recognition by TLRs. Signaling via the TLR-MYD88-NFκB innate 
immune sensing pathway activated DRAM1 and promoted selective autophagy against the 
bacteria. Transient knockdown of dram1 in the zebrafish TB model leads to increased 
mycobacterial infection, whereas transient overexpression of Dram1 reduces infection by 
activation of autophagy. Finally, DRAM1-mediated selective autophagic defenses required the 








Figure 2: Schematic diagram of elimination of Mtb infection via the phagocytosis and autophagy pathways 
The activation of autophagy via diverse signaling pathways plays an important function in the clearance of 
intracellular Mtb. Maturation of Mtb containing phagosomes partially attributes to killing of Mtb. However, Mtb 
inhibits phagosome maturation via multiple virulence mechanisms. For instance, Mtb utilizes its ESX-1 secretion 
system to escape from phagosomes into the cytosol. Cytoplasmic bacterial DNA can be recognized by the DNA 
sensor STING and promotes ubiquitination of Mtb. In this process, the ubiquitin ligases PARKIN and SMURF support 
the recruitment of ubiquitin to Mtb. Ubiquitin receptors, such as p62 and NDP52, recognize ubiquitinated Mtb and 
recruit LC3, contributing to the activation of autophagy to degrade Mtb. Finally, multiple factors stimulate 
autophagic clearance of Mtb. Mtb infection induces DRAM1 as well as cytokine genes via a TLR-MYD88-NFκB 




3. The DRAM family of proteins  
3.1 DRAM family proteins are regulators of autophagy  
As described above, autophagy is orchestrated by several core proteins that are involved in all 
autophagic responses. In addition, autophagy regulators have been identified that are not 
critical components of the core autophagy machinery, but that play roles in regulating 
autophagy in specific situations or in response to specific stimuli. These autophagy regulators 
include the members of the DNA damage-regulated autophagy modulator (DRAM) family of 
proteins. DRAM1 was identified by Crighton et al. around one decade ago 122. Until now, four 
other family members were identified and characterized as DRAM2/TMEM77, 
DRAM3/TMEM150B, DRAM4/TMEM150C and DRAM5/TMEM150A (Table 1). Currently, six Dram 
family members have been identified in zebrafish: Dram1, Dram2a, Dram2b, Dram3/Tmem150b, 
Dram4/Tmem150c and Dram5/Tmem150a. The DRAM family is conserved from humans to 
teleost fish, including zebrafish, with the exception that a DRAM1 homolog has not been 
identified in Coelacanth (L. chalumnae) yet (Fig3).      
 














Figure 3: Phylogenetic comparison of DRAM family protein sequences from different species. Species include 
zebrafish (Danio rerio), spotted gar (Lepisosteus oculatus), coelacanth (Latimeria chalumnae), frog (Xenopus), 
mouse (Mus musculus) and human (Homo sapiens). The protein sequences of DRAM1 (ENST00000258534.12), 
DRAM2 (ENST00000286692.8), DRAM3/TMEM150B (ENST00000326652.8), DRAM4/TMEM150C 
(ENST00000449862.6) and DRAM5/TMEM150A (ENST00000306353.7) were obtained from Ensembl. The 
phylogenetic tree was constructed with 4 independent MarKov chain Monte Carlo runs in MrByers 3.2.1 and each 
run consisted of 1,000,000 iterations sampled once every 200 iterations. 
The human DRAM1 gene encodes a protein that consists of 236 amino acids 122. Protein domain 
analysis suggests that DRAM1 contains an endoplasmic reticulum (ER) targeting signal and six 
hydrophobic transmembrane regions (Table 1). DRAM1 is predominately found on lysosomes 122. 
However, its presence in other compartments has also been described, including endosomes, 
peroxisomes, autophagolysosomes, the endoplasmic reticulum, and the Golgi apparatus 123. 
Expression of DRAM1 can be regulated by the tumor suppressing transcription factors p53 122, 
p73 124, and E2F1 125, as well as the immunity-related transcription factor NF-κB 62. It has been 
reported that DRAM1 is involved in the regulation of various cellular processes, including 
autophagy, apoptosis, immunity, and cellular differentiation 126. For instance, DRAM1 is required 
to initiate autophagy and cell death downstream of p53-activation 122, 124. Nonetheless, DRAM1 
protein interactions remain poorly characterized. A direct interaction between DRAM1 and the 
apoptosis regulator BAX has been demonstrated 127, but the evidence for interactions with, for 
instance, p62 remains circumstantial 62, 128. Given the many cellular functions DRAM1 is involved 
in, it is not surprising that this autophagy and cell death regulator has been implicated in several 
human diseases, including cancer 122, 124, 128-130, HIV131 and tuberculosis 62.   
DNA damage regulated autophagy modulator 2 (DRAM2) is closely related to DRAM1. Both 
DRAM1 and DRAM2 consist of six putative transmembrane domains and localize primarily to 
lysosomes 132, 133. As is the case for DRAM1, overexpression of DRAM2 induces autophagic 
structures 134. Moreover, silencing DRAM2 interferes with starvation-induced autophagy 134, 
which also implicates DRAM2 in regulation of autophagy. Like DRAM1, DRAM2 is also required 
for p53-dependent cell death, and overexpression of both DRAM1 and DRAM2 together was 
found to be sufficient to induce apoptosis 133. DRAM2 was shown to interact with BECN1 and 
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UVRAG, essential components of the autophagy machinery, leading to the displacement of 
RUBCN from the BECN1-complex and promoting the activity of the class III phosphatidylinositol 
3 kinase (PtdIns3K) 135. DRAM2 also interacts with LAMP1 and LAMP2 to facilitate 
autophagosome maturation 135. Although the transcriptional regulation of DRAM2 remains to be 
determined, DRAM2 mRNA levels have been identified as direct targets of down regulation by 
micro RNA (miRNA) 125b and miRNA144* 135, 136. Downregulation of DRAM2 is linked to human 
disease, as its expression was found to be reduced in ovarian cancers 133, and downregulation of 
DRAM2 by miRNA125b promoted retino blastoma growth136. DRAM2 has also been implicated 
in tuberculosis, as further discussed below. 
DRAM3 has an amino acid sequence overlap of 30% and a sequence similarity of 43% with 
DRAM1 126, 137. Like DRAM1, DRAM3 contains a signal peptide and several transmembrane 
domains. DRAM3 has been detected in a range of normal tissues and tumor cells, but unlike 
DRAM1, its expression is not induced by p53 137. Similar to DRAM1, DRAM3 localizes to 
(auto)lysosomes and endosomes. However, it also localizes to the plasma membrane, which 
DRAM1 does not. The initial characterization of DRAM3 function revealed that it regulates 
autophagic flux and cell survival in response to starvation, but its effect on cell survival occurred 
independent of autophagy 137   
To date, DRAM4/TMEM150C and DRAM5/TMEM150A have been identified in silico as DRAM-
family members but remain poorly characterized. DRAM5/TMEM150A was reported as the 
functional homologue of yeast Sfk1 138. DRAM5 forms a complex with PI 4-kinase type IIIα 
(PI4KIIIα) at the plasma membrane to regulate the generation of phosphatidylinositol 4,5-
biphosphate PI(4,5)P2 
138. DRAM4 could also be detected at the plasma membrane but is 
primarily localized to lysosomes 138. Clearly, the two remaining DRAM-family members are 





Table 1: Interactions and functions of DRAM-family proteins in relation to human diseases 
 
3.2 DRAM1 and DRAM2 play an important role in restricting mycobacterial infection 
DRAM1 was first reported as a factor involved in host-pathogen interactions by Laforge et al. in 
2013, who implicated DRAM1 in host defense against HIV infection via regulation of lysosome 
membrane permeabilization and subsequent cell death. This function of DRAM1 is dependent 
on activation of the p53 pathway and silencing of DRAM1 is shown to increase HIV infection131. 
Shortly thereafter, our group discovered that zebrafish Dram1 functions independently of p53 in 
host defense against intracellular mycobacteria 62. As described before, we could demonstrate 
that mycobacterial infection induces zebrafish dram1 and human DRAM1 via a TLR-MYD88-NFκB 
signaling pathway. The autophagic defense against mycobacterial infection inferred by activation 
of zebrafish Dram1 also required Sting and the selective autophagy receptor p62 62. 
Furthermore, Dram1 promoted the fusion between bacteria-containing compartments and 
DRAM-family 
proteins 















































































































lysosomes. Since expression of zebrafish dram1 can also be induced by injection of the 
endotoxin LPS, we proposed that DRAM1 functions in defense against a spectrum of bacterial 
pathogens. This hypothesis was later confirmed by Masud et al. 141, who demonstrated that 
Dram1 also provides protection against infection by Salmonella typhimurium. A recent study 
using Mtb infected human macrophages revealed that DRAM2 also functions in defense against 
mycobacterial infections 135. In this study, it was demonstrated that DRAM2 is required for 
acidification of Mtb-containing phagosomes. DRAM2 was shown to physically interact with a 
complex of autophagy regulators, including BECN1 and UVRAG, to remove the autophagy-
inhibiting protein RUBICON from this complex and activate autophagy.  
Concluding, both DRAM1 and DRAM2 have been demonstrated to participate in the immune 
response to mycobacterial infections, either in vivo using the zebrafish infection model (Dram1), 
or in vitro using human cell culture studies (both DRAM1 and DRAM2) 62, 135. Interestingly, 
expression of human and zebrafish DRAM1/dram1 is induced upon Mtb or Mm infection, while 
induction of miRNA144* reduces expression of DRAM2 in response to Mtb infection 135. The 
latter observation suggests that Mtb has evolved mechanisms to counteract the host’s 
autophagy defenses. The interplay between the two DRAM-family members in defense against 
bacterial pathogens remains to be investigated.   
4. Prospects of DRAM1 as a target for host-directed therapy against 
tuberculosis  
4.1 Host-directed therapies as adjuvant for TB treatment 
The rapid emergence of drug-resistant Mtb strains and co-morbidity caused by, for instance, HIV 
co-infections makes it difficult to treat TB patients 5. Thus, the development of new and effective 
treatment regimens for TB is urgently needed. Currently, host-directed therapy (HDT) has gained 
interest as a complementary approach to antibiotic treatment. HDTs could transform traditional 




HDTs do not act like traditional antibiotics that directly target the pathogens and thereby put 
selective pressure on them. Therefore, application of these strategies might also reduce the 
development of drug resistance 5. HDTs can increase host cellular responses to pathogens, 
counteract the cellular effects of disease-causing virulence factors, and activate immune 
responses (i.e. activation of autophagy, production of anti-microbial peptides, reactive oxygen 
species or cytokines), or reduce the pathological consequences of excessive inflammation 38, 142. 
A range of candidate host-directed TB therapies have been developed aiming either at reducing 
the abundant inflammation and lung tissue damage typical of TB pathology, or at augmenting 
the specific innate and adaptive immune processes which directly target Mtb 38. On the latter 
front, the most promising strategies for development of HDTs include 1) targeting the 
mechanisms of granuloma formation, 2) the induction of phagolysosomal fusion and autophagy, 
and 3) the modulation of cell-mediated immune responses 5, 38, 143. 
Various pro-inflammatory cytokines are produced in response to Mtb infection, including TNF-α, 
IL1-b, IL-12, IL-17 and interferon gamma (IFN-γ) 144. Inflammation functions as a double-edged 
sword during TB infection, and the levels of pro- and anti-inflammatory cytokine production can 
strongly affect the outcome of Mtb infections 14. The balance of host inflammatory responses is 
also controlled by the production of lipoxin A4 (LXA4) and leukotriene B4 (LTB4): increased LXA4 
levels are beneficial for a balanced inflammatory response and control of TB, while increased 
LTB4 levels produce the opposite effect with hyperinflammation and exacerbated infection 145, 
146. The inflammation induced by Mtb infection starts from the very early stages, and continues 
during the progression to active TB, until complete eradication 146. This is at the basis of the 
current concept of modulating the inflammatory response as an HDT to reduce the lung tissue 
damage and adjust the host immune response 147. For instance, a clinical trial has revealed that 
an IFN-γ adjuvant therapy can improve the outcome of TB treatment, resulting in significantly 
reduced respiratory symptoms and lung tissue damage, as well as reduced mortality compared 
to chemotherapy regimens without IFN-γ supplement. However, IFN-γ adjuvant therapy has also 
resulted in side effects, such as fever and headaches 148, 149.  
The granuloma plays a central role in Mtb pathogenesis, encapsulating the bacteria to avoid Mtb 
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spreading into deeper tissue. As a side effect, granulomas also limit the effectiveness of anti-TB 
treatment due to poor penetration of antibiotics. TNF-α is known to be essential for granuloma 
maintenance and host defense against TB 150-152. Hence, patients undergoing anti-TNF treatment 
for inflammatory diseases are at risk of activation of latent TB151. Nevertheless, neutralizing TNF-
α during TB treatment with antibiotics could be promising strategy, as this was found to disrupt 
the architecture of granulomas and improve drug efficacy against Mtb 153. However, the role of 
the granuloma in TB pathogenesis is not completely understood yet, which still restricts the use 
of this HDT in the clinic 26.   
Given that autophagy is a critical immune defense mechanism against Mtb infection, this 
process is also a promising therapeutic target for TB treatment 154. In fact, autophagy inducers 
were identified as hits in several drug screens for HDTs using Mtb infected human cells 155-157. 
Furthermore, it was demonstrated that autophagy is required for effective anti-mycobacterial 
drug action of the first line drugs, such as isoniazid and pyrazinamide 156. Both isoniazid and 
pyrazinamide treatment clearly induced autophagosome formation and co-localization of Lc3 
with Mt.b in primary murine bone marrow-derived macrophages (BMDMs) 156. However, it is a 
risk to induce canonical autophagy by non-selective drugs, due to the involvement of autophagy 
in diverse cellular functions. Rapamycin is a general autophagy-inducing drug which acts by 
inhibiting mTOR. Strikingly, treatment of zebrafish larvae with this drug increased susceptibility 
to mycobacterial infection, rather than decreasing it 62. This could potentially be explained by 
the fact that Rapamycin is also known for its immunosuppressive effects on the host 158. Thus, 
targeting autophagy to combat infectious diseases requires the development of specific 
modulators of autophagy. 
4.2. Prospects of Dram-family members as host directed therapy against TB 
Killing Mtb in infected macrophages in the early stages of infection is a key approach to avoid 
progression of TB disease. Two out of five DRAM family members (DRAM1 and DRAM2) have 
been implicated in anti-mycobacterial defense by enhancing autophagy and the microbicidal 
function of lysosomes either in vitro or in vivo 62, 135. Thus, these DRAM family members are 
potential targets for HDTs that stimulate killing of Mtb by host-autonomous mechanisms.  
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Activation of zebrafish Dram1 leads to a significantly improved disease outcome following 
mycobacterial infection. The current bottleneck is to dissect how to pharmacologically stimulate 
DRAM1 in animal models or human patients. Based on our previous study, LPS injection is a 
strong inducer of dram1 expression in vivo 62. However, this approach carries severe risks in a 
clinical situation, as LPS injections can result in hyperactivation of inflammatory processes, or 
even toxic shock.  
Another approach would be to directly inject DRAM1 recombinant protein into TB patients to 
elevate DRAM1 protein levels. DRAM1 protein could directly participate in defense against Mtb. 
However, it will be difficult to ensure that DRAM1 ends up at the appropriate location in infected 
cells to carry out its function. Thus, the more valid approach is to continue our study into the in 
vivo working mechanisms of DRAM1 (and other members of the DRAM family), to identify 
endogenous modulators that can serve as drug targets to stimulate DRAM1 activity. Identifying 
those might help to bring this research closer to clinical applications.  
5. Outline of the thesis 
The aim of the work described in this thesis was to exploit the benefits of the embryonic and 
larval zebrafish TB model to further study the function of selective autophagy in defense against 
mycobacterial infections. To this end we created null mutants for zebrafish Dram1, and the 
selective autophagy receptors p62 and Optineurin. The generated mutant lines were then used 
to study the role of these proteins in autophagic defense, as well as their potential effect on 
bacterial pathogenesis outside of autophagy.    
This introductory Chapter 1 provides background information about TB and autophagy and 
highlights that the DRAM family of proteins could be promising targets for host-directed therapy 
to modulate autophagy and eliminate mycobacterial infection.     
Chapter 2 describes how mutation of the dram1 gene leads to increased susceptibility to 
mycobacterial infection and highlights that the absence of Dram1 induces Caspase-1 dependent 
cell death of infected macrophages. 
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Chapter 3 reports on a transcriptome analysis of dram1 mutants in the absence and presence of 
infection. This study revealed that deficiency in Dram1 has major effects on the expression of 
genes in pathways involved in metabolism, lytic cell death, and Toll-like receptor signaling.  
Chapter 4 describes that mutation of the genes for the selective autophagy receptors 
Optineurin and p62 results in increased susceptibility to mycobacterial infection. These proteins 
mediate an autophagic defense response against mycobacterial infection by sequestering 
ubiquitin-labeled bacteria into autophagosomes.  
Chapter 5 summarizes and discusses the findings presented in this thesis in relation to the latest 















1. Smith I. Mycobacterium tuberculosis Pathogenesis and Molecular Determinants of 
Virulence. Clinical Microbiology Reviews 2003; 16:463-96. 
2. Al-Humadi HW, Al-Saigh RJ, Al-Humadi AW. Addressing the Challenges of Tuberculosis: A 
Brief Historical Account. Front Pharmacol 2017; 8:689. 
3. Flynn JL, Chan J. Tuberculosis: latency and reactivation. Infect Immun 2001; 69:4195-201. 
4. WHO. Global tuberculosis report 2017 (WHO/HTM/TB/2017.23).  2017. 
5. Kolloli A, Subbian S. Host-Directed Therapeutic Strategies for Tuberculosis. Front Med 
(Lausanne) 2017; 4:171. 
6. Matteelli A, Roggi A, Carvalho AC. Extensively drug-resistant tuberculosis: epidemiology 
and management. Clin Epidemiol 2014; 6:111-8. 
7. Grange JM, Yates MD, de Kantor IN. Guidelines for speciation within the Mycobacterium 
tuberculosis complex. World Health Organization, Emerging and other Communicable Diseases, 
Surveillance and Control 1996. 
8. Sanchez D, Rojas M, Hernandez I, Radzioch D, Garcia LF, Barrera LF. Role of TLR2- and 
TLR4-mediated signaling in Mycobacterium tuberculosis-induced macrophage death. Cell 
Immunol 2010; 260:128-36. 
9. Chelsea E. Stamm ACC, Michael U. Shiloh. Sensing of Mycobacterium tuberculosis 
and consequences to both host 
and bacillus. Immunological Reviews 2015; 264:204-19. 
10. Mortaz E, Adcock IM, Tabarsi P, Masjedi MR, Mansouri D, Velayati AA, et al. Interaction of 
Pattern Recognition Receptors with Mycobacterium Tuberculosis. J Clin Immunol 2015; 35:1-10. 
11. Kaufmann SHE. HOW CAN IMMUNOLOGY CONTRIBUTE TO THE CONTROL OF 
TUBERCULOSIS ? Nat Rev Immunol 2001; 1:20-30. 
12. Vandal OH, Nathan CF, Ehrt S. Acid resistance in Mycobacterium tuberculosis. J Bacteriol 
2009; 191:4714-21. 
13. Sundaramurthy V, Korf H, Singla A, Scherr N, Nguyen L, Ferrari G, et al. Survival of 
Mycobacterium tuberculosis and Mycobacterium bovis BCG in lysosomes in vivo. Microbes 
Infect 2017; 19:515-26. 
27 
 
14. Sasindran SJ, Torrelles JB. Mycobacterium Tuberculosis Infection and Inflammation: what 
is Beneficial for the Host and for the Bacterium? Front Microbiol 2011; 2:2. 
15. Mahamed D, Boulle M, Ganga Y, Mc Arthur C, Skroch S, Oom L, et al. Intracellular growth 
of Mycobacterium tuberculosis after macrophage cell death leads to serial killing of host cells. 
Elife 2017; 6. 
16. Flannagan RS, Cosio G, Grinstein S. Antimicrobial mechanisms of phagocytes and 
bacterial evasion strategies. Nat Rev Microbiol 2009; 7:355-66. 
17. Smith J, Manoranjan J, Pan M, Bohsali A, Xu J, Liu J, et al. Evidence for pore formation in 
host cell membranes by ESX-1-secreted ESAT-6 and its role in Mycobacterium marinum escape 
from the vacuole. Infect Immun 2008; 76:5478-87. 
18. Ligon LS, Hayden JD, Braunstein M. The ins and outs of Mycobacterium tuberculosis 
protein export. Tuberculosis (Edinb) 2012; 92:121-32. 
19. Majlessi L, Prados-Rosales R, Casadevall A, Brosch1 R. Release of mycobacterial antigens. 
Immunological Reviews 2015; 264:25-45. 
20. Queval CJ, Song OR, Carralot JP, Saliou JM, Bongiovanni A, Deloison G, et al. 
Mycobacterium tuberculosis Controls Phagosomal Acidification by Targeting CISH-Mediated 
Signaling. Cell Rep 2017; 20:3188-98. 
21. Houben D, Demangel C, van Ingen J, Perez J, Baldeon L, Abdallah AM, et al. ESX-1-
mediated translocation to the cytosol controls virulence of mycobacteria. Cell Microbiol 2012; 
14:1287-98. 
22. Guirado E, Schlesinger LS. Modeling the Mycobacterium tuberculosis Granuloma - the 
Critical Battlefield in Host Immunity and Disease. Front Immunol 2013; 4:98. 
23. Silva Miranda M, Breiman A, Allain S, Deknuydt F, Altare F. The tuberculous granuloma: 
an unsuccessful host defence mechanism providing a safety shelter for the bacteria? Clin Dev 
Immunol 2012; 2012:139127. 
24. Ramakrishnan L. Revisiting the role of the granuloma in tuberculosis. Nat Rev Immunol 
2012; 12:352-66. 
25. Volkman HE, Pozos TC, Zheng J, Davis JM, Rawls JF, Ramakrishnan L. Tuberculous 




26. Kiran D, Podell BK, Chambers M, Basaraba RJ. Host-directed therapy targeting the 
Mycobacterium tuberculosis granuloma: a review. Semin Immunopathol 2016; 38:167-83. 
27. Cronan MR, Beerman RW, Rosenberg AF, Saelens JW, Johnson MG, Oehlers SH, et al. 
Macrophage Epithelial Reprogramming Underlies Mycobacterial Granuloma Formation and 
Promotes Infection. Immunity 2016; 45:861-76. 
28. Pieters J. Mycobacterium tuberculosis and the macrophage: maintaining a balance. Cell 
Host Microbe 2008; 3:399-407. 
29. Schreiber HA, Sandor M. The role of dendritic cells in mycobacterium-induced 
granulomas. Immunol Lett 2010; 130:26-31. 
30. Bozzano F, Marras F, De Maria A. Immunology of tuberculosis. Mediterr J Hematol Infect 
Dis 2014; 6:e2014027. 
31. Matteelli A, Sulis G, Capone S, D'Ambrosio L, Migliori GB, Getahun H. Tuberculosis 
elimination and the challenge of latent tuberculosis. Presse Med 2017; 46:e13-e21. 
32. Roy A, Eisenhut M, Harris RJ, Rodrigues LC, Sridhar S, Habermann S, et al. Effect of BCG 
vaccination against Mycobacterium tuberculosis infection in children: systematic review and 
meta-analysis. BMJ 2014; 349:g4643. 
33. Kaufmann SHE, Hussey G, Lambert P-H. New vaccines for tuberculosis. The Lancet 2010; 
375:2110-9. 
34. Andersen P, Doherty TM. The success and failure of BCG —implications for a novel 
tuberculosis vaccine. Nature 2005; 3:656-62. 
35. Fox GJ, Dobler CC, Marais BJ, Denholm JT. Preventive therapy for latent tuberculosis 
infection-the promise and the challenges. Int J Infect Dis 2017; 56:68-76. 
36. Ryu YJ. Diagnosis of pulmonary tuberculosis: recent advances and diagnostic algorithms. 
Tuberc Respir Dis (Seoul) 2015; 78:64-71. 
37. WHO. Guidelines on the management of latent tuberculosis infection 
(WHO/HTM/TB/2015.01).  2014. 
38. Zumla A, Rao M, Parida SK, Keshavjee S, Cassell G, Wallis R, et al. Inflammation and 
tuberculosis: host-directed therapies. J Intern Med 2015; 277:373-87. 
29 
 
39. Horsburgh CR, Jr., Barry CE, 3rd, Lange C. Treatment of Tuberculosis. N Engl J Med 2015; 
373:2149-60. 
40. Ormerod LP. Multidrug-resistant tuberculosis (MDR-TB): epidemiology, prevention and 
treatment. Br Med Bull 2005; 73-74:17-24. 
41. Kapoor N, Pawar S, Sirakova TD, Deb C, Warren WL, Kolattukudy PE. Human granuloma in 
vitro model, for TB dormancy and resuscitation. PLoS One 2013; 8:e53657. 
42. Bielecka MK, Tezera LB, Zmijan R, Drobniewski F, Zhang X, Jayasinghe S, et al. A 
Bioengineered Three-Dimensional Cell Culture Platform Integrated with Microfluidics To Address 
Antimicrobial Resistance in Tuberculosis. MBio 2017; 8. 
43. Gupta UD, Katoch VM. Animal models of tuberculosis. Tuberculosis (Edinb) 2005; 85:277-
93. 
44. Driver ER, Ryan GJ, Hoff DR, Irwin SM, Basaraba RJ, Kramnik I, et al. Evaluation of a 
mouse model of necrotic granuloma formation using C3HeB/FeJ mice for testing of drugs against 
Mycobacterium tuberculosis. Antimicrob Agents Chemother 2012; 56:3181-95. 
45. Kramnik I, Beamer G. Mouse models of human TB pathology: roles in the analysis of 
necrosis and the development of host-directed therapies. Semin Immunopathol 2016; 38:221-
37. 
46. Apt A, Kramnik I. Man and mouse TB: contradictions and solutions. Tuberculosis (Edinb) 
2009; 89:195-8. 
47. Pietrantonio TD, Schurr E. Mouse models for the genetic study of tuberculosis 
susceptibility. BRIEFINGS IN FUNCTIONAL GENOMICS AND PROTEOMICS 2005; 4:277-92. 
48. Harper J, Skerry C, Davis SL, Tasneen R, Weir M, Kramnik I, et al. Mouse model of necrotic 
tuberculosis granulomas develops hypoxic lesions. J Infect Dis 2012; 205:595-602. 
49. Myllymaki H, Niskanen M, Oksanen KE, Ramet M. Animal models in tuberculosis research 
- where is the beef? Expert Opin Drug Discov 2015; 10:871-83. 
50. Swaim LE, Connolly LE, Volkman HE, Humbert O, Born DE, Ramakrishnan L. 
Mycobacterium marinum infection of adult zebrafish causes caseating granulomatous 
tuberculosis and is moderated by adaptive immunity. Infect Immun 2006; 74:6108-17. 
51. Tobin DM, May RC, Wheeler RT. Zebrafish: a see-through host and a fluorescent toolbox 
30 
 
to probe host-pathogen interaction. PLoS Pathog 2012; 8:e1002349. 
52. Meijer AH. Protection and pathology in TB: learning from the zebrafish model. Semin 
Immunopathol 2016; 38:261-73. 
53. van der Vaart M, Spaink HP, Meijer AH. Pathogen recognition and activation of the innate 
immune response in zebrafish. Adv Hematol 2012; 2012:159807. 
54. Ramakrishnan L. The zebrafish guide to tuberculosis immunity and treatment. Cold 
Spring Harb Symp Quant Biol 2013; 78:179-92. 
55. Tønjum T, Welty DB, Jantzen E, Small PL. Differentiation of Mycobacterium ulcerans, M. 
marinum, and M. haemophilum: Mapping of Their Relationships to M. tuberculosis by Fatty Acid 
Profile Analysis, DNA-DNA Hybridization, and 16S rRNA Gene Sequence Analysis. J Clin Microbiol 
1998; 36:918-25. 
56. Cronan MR, Tobin DM. Fit for consumption: zebrafish as a model for tuberculosis. Dis 
Model Mech 2014; 7:777-84. 
57. Torraca V, Masud S, Spaink HP, Meijer AH. Macrophage-pathogen interactions in 
infectious diseases: new therapeutic insights from the zebrafish host model. Dis Model Mech 
2014; 7:785-97. 
58. Tobin DM, Ramakrishnan L. Comparative pathogenesis of Mycobacterium marinum and 
Mycobacterium tuberculosis. Cell Microbiol 2008; 10:1027-39. 
59. Torraca V, Mostowy S. Zebrafish Infection: From Pathogenesis to Cell Biology. Trends Cell 
Biol 2018; 28:143-56. 
60. Tobin DM, Vary JC, Jr., Ray JP, Walsh GS, Dunstan SJ, Bang ND, et al. The lta4h locus 
modulates susceptibility to mycobacterial infection in zebrafish and humans. Cell 2010; 140:717-
30. 
61. Davis JM, Ramakrishnan L. The role of the granuloma in expansion and dissemination of 
early tuberculous infection. Cell 2009; 136:37-49. 
62. van der Vaart M, Korbee CJ, Lamers GE, Tengeler AC, Hosseini R, Haks MC, et al. The DNA 
damage-regulated autophagy modulator DRAM1 links mycobacterial recognition via TLR-MYD88 
to autophagic defense [corrected]. Cell Host Microbe 2014; 15:753-67. 
63. Uchiyama Y, Shibata M, Koike M, Yoshimura K, Sasaki M. Autophagy-physiology and 
31 
 
pathophysiology. Histochem Cell Biol 2008; 129:407-20. 
64. Reggiori F, Klionsky DJ. Autophagy in the Eukaryotic Cell. Eukaryotic Cell 2002; 1:11-21. 
65. Levine B, Kroemer G. Autophagy in the pathogenesis of disease. Cell 2008; 132:27-42. 
66. Deretic V, Saitoh T, Akira S. Autophagy in infection, inflammation and immunity. Nat Rev 
Immunol 2013; 13:722-37. 
67. He C, Klionsky DJ. Regulation mechanisms and signaling pathways of autophagy. Annu 
Rev Genet 2009; 43:67-93. 
68. Glick D, Barth S, Macleod KF. Autophagy: cellular and molecular mechanisms. J Pathol 
2010; 221:3-12. 
69. Klionsky BLaDJ. Development by Self-Digestion: 
Molecular Mechanisms 
and Biological Functions of Autophagy. Developmental Cell 2004; 6: 463–77. 
70. Solvik T, Debnath J. At the crossroads of autophagy and infection: Noncanonical roles for 
ATG proteins in viral replication. J Cell Biol 2016; 214:503-5. 
71. Li M, Hou Y, Wang J, Chen X, Shao ZM, Yin XM. Kinetics comparisons of mammalian Atg4 
homologues indicate selective preferences toward diverse Atg8 substrates. J Biol Chem 2011; 
286:7327-38. 
72. Neff NT, Bourret L, Miao P, Dice FJ. Degradation of Proteins Microinjected into IMR-90  
human diploid fibroblast THE JOURNAL OF CELL BIOLOGY 1981; 91:184-94. 
73. Cuervo AM, Wong E. Chaperone-mediated autophagy: roles in disease and aging. Cell 
Res 2014; 24:92-104. 
74. Kraft C, Peter M, Hofmann K. Selective autophagy: ubiquitin-mediated recognition and 
beyond. Nat Cell Biol 2010; 12:836-41. 
75. Popovic D, Vucic D, Dikic I. Ubiquitination in disease pathogenesis and treatment. Nat 
Med 2014; 20:1242-53. 
76. Kim B-W, Kwon DH, Song HK. Structure biology of selective autophagy receptors. BMB 
Reports 2016; 49:73-80. 
77. Levine B. Eating oneself and uninvited guests: autophagy-related pathways in cellular 
defense. Cell 2005; 120:159-62. 
32 
 
78. Ichiro Nakagawa AA, Noboru Mizushima,, Akitsugu Yamamoto HY, Takahiro Kamimoto,, 
Atsuki Nara JF, Masanobu Nakata, Kayoko Tsuda,, Shigeyuki Hamada TY. Autophagy Defends Cells 
Against Invading Group A Streptococcus. Science 2004; 306 1037-40. 
79. Gutierrez MG, Master SS, Singh SB, Taylor GA, Colombo MI, Deretic V. Autophagy is a 
defense mechanism inhibiting BCG and Mycobacterium tuberculosis survival in infected 
macrophages. Cell 2004; 119:753-66. 
80. Sumpter R, Jr., Levine B. Autophagy and innate immunity: triggering, targeting and 
tuning. Semin Cell Dev Biol 2010; 21:699-711. 
81. Yorimitsu T, Klionsky DJ. Eating the endoplasmic reticulum: quality control by autophagy. 
Trends Cell Biol 2007; 17:279-85. 
82. Mizushima N, Komatsu M. Autophagy: renovation of cells and tissues. Cell 2011; 
147:728-41. 
83. Harnett MM, Pineda MA, Latre de Late P, Eason RJ, Besteiro S, Harnett W, et al. From 
Christian de Duve to Yoshinori Ohsumi: More to autophagy than just dining at home. Biomed J 
2017; 40:9-22. 
84. Wong PM, Puente C, Ganley IG, Jiang X. The ULK1 complex: sensing nutrient signals for 
autophagy activation. Autophagy 2013; 9:124-37. 
85. Alers S, Löffler AS, Paasch F, Dieterle AM, Keppeler H, Lauber K, et al. Atg13 and FIP200 
act independently of Ulk1 and Ulk2 in autophagy induction. Autophagy 2014; 7:1424-33. 
86. Yin Z, Pascual C, Klionsky DJ. Autophagy: machinery and regulation. Microb Cell 2016; 
3:588-96. 
87. Klionsky DJ. Autophagy: from phenomenology to molecular understanding in less than a 
decade molecular cell biology 2007; 8:931-7. 
88. Proikas-Cezanne T, Takacs Z, Donnes P, Kohlbacher O. WIPI proteins: essential PtdIns3P 
effectors at the nascent autophagosome. J Cell Sci 2015; 128:207-17. 
89. Burman C, Ktistakis NT. Regulation of autophagy by phosphatidylinositol 3-phosphate. 
FEBS Lett 2010; 584:1302-12. 
90. Geng J, Klionsky DJ. The Atg8 and Atg12 ubiquitin-like conjugation systems in 




91. Ney PA. Mitochondrial autophagy: Origins, significance, and role of BNIP3 and NIX. 
Biochim Biophys Acta 2015; 1853:2775-83. 
92. Whang MI, Tavares RM, Benjamin DI, Kattah MG, Advincula R, Nomura DK, et al. The 
Ubiquitin Binding Protein TAX1BP1 Mediates Autophagasome Induction and the Metabolic 
Transition of Activated T Cells. Immunity 2017; 46:405-20. 
93. Birgisdottir AB, Lamark T, Johansen T. The LIR motif - crucial for selective autophagy. J Cell 
Sci 2013; 126:3237-47. 
94. Hurley JH, Lee S, Prag G. Ubiquitin-binding domains. Biochem J 2006; 399:361-72. 
95. Shaid S, Brandts CH, Serve H, Dikic I. Ubiquitination and selective autophagy. Cell Death 
Differ 2013; 20:21-30. 
96. Itakura E, Kishi-Itakura C, Mizushima N. The hairpin-type tail-anchored SNARE syntaxin 17 
targets to autophagosomes for fusion with endosomes/lysosomes. Cell 2012; 151:1256-69. 
97. Eskelinen EL. Roles of LAMP-1 and LAMP-2 in lysosome biogenesis and autophagy. Mol 
Aspects Med 2006; 27:495-502. 
98. Levine B, Kroemer G. Autophagy in aging, disease and death: the true identity of a cell 
death impostor. Cell Death Differ 2009; 16:1-2. 
99. Tang D, Kang R, Coyne CB, Zeh HJ, Lotze MT. PAMPs and DAMPs: signal 0s that spur 
autophagy and immunity. Immunol Rev 2012; 249:158-75. 
100. Xu Y, Jagannath C, Liu XD, Sharafkhaneh A, Kolodziejska KE, Eissa NT. Toll-like receptor 4 is 
a sensor for autophagy associated with innate immunity. Immunity 2007; 27:135-44. 
101. Mostowy S, Cossart P. Bacterial autophagy: restriction or promotion of bacterial 
replication? Trends Cell Biol 2012; 22:283-91. 
102. Saitoh T, Fujita N, Jang MH, Uematsu S, Yang BG, Satoh T, et al. Loss of the autophagy 
protein Atg16L1 enhances endotoxin-induced IL-1beta production. Nature 2008; 456:264-8. 
103. Hampe J, Franke A, Rosenstiel P, Till A, Teuber M, Huse K, et al. A genome-wide 
association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in 
ATG16L1. Nat Genet 2007; 39:207-11. 
104. Qian M, Fang X, Wang X. Autophagy and inflammation. Clin Transl Med 2017; 6:24. 
34 
 
105. Crisan TO, Plantinga TS, van de Veerdonk FL, Farcas MF, Stoffels M, Kullberg BJ, et al. 
Inflammasome-independent modulation of cytokine response by autophagy in human cells. 
PLoS One 2011; 6:e18666. 
106. Harris J, Hartman M, Roche C, Zeng SG, O'Shea A, Sharp FA, et al. Autophagy controls IL-
1beta secretion by targeting pro-IL-1beta for degradation. J Biol Chem 2011; 286:9587-97. 
107. Kaufmann SH. Tuberculosis vaccines: time to think about the next generation. Semin 
Immunol 2013; 25:172-81. 
108. Crotzer VL, Blum JS. Autophagy and its role in MHC-mediated antigen presentation. J 
Immunol 2009; 182:3335-41. 
109. Jagannath C, Lindsey DR, Dhandayuthapani S, Xu Y, Hunter RL, Jr., Eissa NT. Autophagy 
enhances the efficacy of BCG vaccine by increasing peptide presentation in mouse dendritic 
cells. Nat Med 2009; 15:267-76. 
110. Wellcome Trust Case Control C, Australo-Anglo-American Spondylitis C, Burton PR, 
Clayton DG, Cardon LR, Craddock N, et al. Association scan of 14,500 nonsynonymous SNPs in 
four diseases identifies autoimmunity variants. Nat Genet 2007; 39:1329-37. 
111. Biswas D, Qureshi OS, Lee WY, Croudace JE, Mura M, Lammas DA. ATP-induced 
autophagy is associated with rapid killing of intracellular mycobacteria within human 
monocytes/macrophages. BMC Immunol 2008; 9:35. 
112. Alonso S, Pethe K, Russell DG, Purdy GE. Lysosomal killing of Mycobacterium mediated by 
ubiquitin-derived peptides is enhanced by autophagy PNAS 2007; 104:6031-6. 
113. Sudha B. Singh ASD, Gregory A. Taylor, Vojo Deretic. Human IRGM induces autophagy to 
eliminate intracellular mycobacteria SCIENCE 2006; 313:1438-41. 
114. Conrad WH, Osman MM, Shanahan JK, Chu F, Takaki KK, Cameron J, et al. Mycobacterial 
ESX-1 secretion system mediates bacteri host cell lysis throughum contact-dependent gross 
membrane disruptions. Proc Natl Acad Sci U S A 2017; 114:1371-6. 
115. Watson RO, Manzanillo PS, Cox JS. Extracellular M. tuberculosis DNA targets bacteria for 
autophagy by activating the host DNA-sensing pathway. Cell 2012; 150:803-15. 
116. Manzanillo PS, Ayres JS, Watson RO, Collins AC, Souza G, Rae CS, et al. The ubiquitin 
ligase parkin mediates resistance to intracellular pathogens. Nature 2013; 501:512-6. 
35 
 
117. Franco LH, Nair VR, Scharn CR, Xavier RJ, Torrealba JR, Shiloh MU, et al. The Ubiquitin 
Ligase Smurf1 Functions in Selective Autophagy of Mycobacterium tuberculosis and Anti-
tuberculous Host Defense. Cell Host Microbe 2017; 21:59-72. 
118. Ponpuak M, Davis AS, Roberts EA, Delgado MA, Dinkins C, Zhao Z, et al. Delivery of 
cytosolic components by autophagic adaptor protein p62 endows autophagosomes with unique 
antimicrobial properties. Immunity 2010; 32:329-41. 
119. Kimmey JM, Stallings CL. Bacterial Pathogens versus Autophagy: Implications for 
Therapeutic Interventions. Trends Mol Med 2016; 22:1060-76. 
120. Codogno P MA. Atg5: more than an autophagy factor. NATURE CELL BIOLOGY 2006; 
8:1045-7. 
121. Hara T, Nakamura K, Matsui M, Yamamoto A, Nakahara Y, Suzuki-Migishima R, et al. 
Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice. 
Nature 2006; 441:885-9. 
122. Crighton D, Wilkinson S, O'Prey J, Syed N, Smith P, Harrison PR, et al. DRAM, a p53-
induced modulator of autophagy, is critical for apoptosis. Cell 2006; 126:121-34. 
123. Mah LY, O'Prey J, Baudot AD, Hoekstra A, Ryan KM. DRAM-1 encodes multiple isoforms 
that regulate autophagy. Autophagy 2012; 8:18-28. 
124. Crighton D, O'Prey J, Bell HS, Ryan KM. p73 regulates DRAM-independent autophagy that 
does not contribute to programmed cell death. Cell Death Differ 2007; 14:1071-9. 
125. Polager S, Ofir M, Ginsberg D. E2F1 regulates autophagy and the transcription of 
autophagy genes. Oncogene 2008; 27:4860-4. 
126. Mrschtik M, Ryan KM. Another DRAM involved in autophagy and cell death. Autophagy 
2016; 12:603-5. 
127. Guan JJ, Zhang XD, Sun W, Qi L, Wu JC, Qin ZH. DRAM1 regulates apoptosis through 
increasing protein levels and lysosomal localization of BAX. Cell Death Dis 2015; 6:e1624. 
128. Galavotti S, Bartesaghi S, Faccenda D, Shaked-Rabi M, Sanzone S, McEvoy A, et al. The 
autophagy-associated factors DRAM1 and p62 regulate cell migration and invasion in 
glioblastoma stem cells. Oncogene 2013; 32:699-712. 
129. Humbert M, Mueller C, Fey MF, Tschan MP. Inhibition of damage-regulated autophagy 
36 
 
modulator-1 (DRAM-1) impairs neutrophil differentiation of NB4 APL cells. Leuk Res 2012; 
36:1552-6. 
130. Lorin S, Borges A, Ribeiro Dos Santos L, Souquere S, Pierron G, Ryan KM, et al. c-Jun NH2-
terminal kinase activation is essential for DRAM-dependent induction of autophagy and 
apoptosis in 2-methoxyestradiol-treated Ewing sarcoma cells. Cancer Res 2009; 69:6924-31. 
131. Laforge M, Limou S, Harper F, Casartelli N, Rodrigues V, Silvestre R, et al. DRAM triggers 
lysosomal membrane permeabilization and cell death in CD4(+) T cells infected with HIV. PLoS 
Pathog 2013; 9:e1003328. 
132. O'Prey J, Skommer J, Wilkinson S, Ryan KM. Analysis of DRAM-related proteins reveals 
evolutionarily conserved and divergent roles in the control of autophagy. Cell Cycle 2009; 
8:2260-5. 
133. Park SM, Kim K, Lee EJ, Kim BK, Lee TJ, Seo T, et al. Reduced expression of 
DRAM2/TMEM77 in tumor cells interferes with cell death. Biochem Biophys Res Commun 2009; 
390:1340-4. 
134. Yoon JH, Her S, Kim M, Jang IS, Park J. The expression of damage-regulated autophagy 
modulator 2 (DRAM2) contributes to autophagy induction. Mol Biol Rep 2012; 39:1087-93. 
135. Kim JK, Lee HM, Park KS, Shin DM, Kim TS, Kim YS, et al. MIR144* inhibits antimicrobial 
responses against Mycobacterium tuberculosis in human monocytes and macrophages by 
targeting the autophagy protein DRAM2. Autophagy 2017; 13:423-41. 
136. Bai S, Tian B, Li A, Yao Q, Zhang G, Li F. MicroRNA-125b promotes tumor growth and 
suppresses apoptosis by targeting DRAM2 in retinoblastoma. Eye (Lond) 2016; 30:1630-8. 
137. Mrschtik M, O'Prey J, Lao LY, Long JS, Beaumatin F, Strachan D, et al. DRAM-3 modulates 
autophagy and promotes cell survival in the absence of glucose. Cell Death Differ 2015; 22:1714-
26. 
138. Chung J, Nakatsu F, Baskin JM, De Camilli P. Plasticity of PI4KIIIalpha interactions at the 
plasma membrane. EMBO Rep 2015; 16:312-20. 
139. Zhang XD, Qi L, Wu JC, Qin ZH. DRAM1 regulates autophagy flux through lysosomes. PLoS 
One 2013; 8:e63245. 
140. Meng C, Liu Y, Shen Y, Liu S, Wang Z, Ye Q, et al. MicroRNA-26b suppresses autophagy in 
37 
 
breast cancer cells by targeting DRAM1 mRNA, and is downregulated by irradiation. Oncol Lett 
2018; 15:1435-40. 
141. Masud S. Autophagy and Lc3-associated phagocytosis in host defense against 
Salmonella. Leiden University, 2017:233. 
142. Wallis RS, Hafner R. Advancing host-directed therapy for tuberculosis. Nat Rev Immunol 
2015; 15:255-63. 
143. Encinales L, Zuniga J, Granados-Montiel J, Yunis M, Granados J, Almeciga I, et al. Humoral 
immunity in tuberculin skin test anergy and its role in high-risk persons exposed to active 
tuberculosis. Mol Immunol 2010; 47:1066-73. 
144. Majeed S. Dual Role of Inflammation in Prognosis and Prevention of Tuberculosis. Journal 
of Clinical & Cellular Immunology 2015; 06. 
145. Tobin DM, Roca FJ, Oh SF, McFarland R, Vickery TW, Ray JP, et al. Host genotype-specific 
therapies can optimize the inflammatory response to mycobacterial infections. Cell 2012; 
148:434-46. 
146. Tobin DM, Roca FJ, Ray JP, Ko DC, Ramakrishnan L. An enzyme that inactivates the 
inflammatory mediator leukotriene b4 restricts mycobacterial infection. PLoS One 2013; 
8:e67828. 
147. Coussens AK, Wilkinson RJ, Hanifa Y, Nikolayevskyy V, Elkington PT, Islam K, et al. Vitamin 
D accelerates resolution of inflammatory responses during tuberculosis treatment. Proc Natl 
Acad Sci U S A 2012; 109:15449-54. 
148. Park SK, Cho S, Lee IH, Jeon DS, Hong SH, Smego RA, Jr., et al. Subcutaneously 
administered interferon-gamma for the treatment of multidrug-resistant pulmonary 
tuberculosis. Int J Infect Dis 2007; 11:434-40. 
149. Milanes-Virelles MT, Garcia-Garcia I, Santos-Herrera Y, Valdes-Quintana M, Valenzuela-
Silva CM, Jimenez-Madrigal G, et al. Adjuvant interferon gamma in patients with pulmonary 
atypical Mycobacteriosis: a randomized, double-blind, placebo-controlled study. BMC Infect Dis 
2008; 8:17. 
150. Clay H, Volkman HE, Ramakrishnan L. Tumor necrosis factor signaling mediates resistance 




151. Lin PL, Myers A, Smith L, Bigbee C, Bigbee M, Fuhrman C, et al. Tumor necrosis factor 
neutralization results in disseminated disease in acute and latent Mycobacterium tuberculosis 
infection with normal granuloma structure in a cynomolgus macaque model. Arthritis Rheum 
2010; 62:340-50. 
152. Algood HM LP, Flynn JL. Tumor Necrosis Factor and Chemokine Interactions 
in the Formation and Maintenance of Granulomas 
in Tuberculosis. Clinical Infectious Diseases 2005; 41:S189–93. 
153. Bourigault ML, Segueni N, Rose S, Court N, Vacher R, Vasseur V, et al. Relative 
contribution of IL-1alpha, IL-1beta and TNF to the host response to Mycobacterium tuberculosis 
and attenuated M. bovis BCG. Immun Inflamm Dis 2013; 1:47-62. 
154. Hawn TR, Matheson AI, Maley SN, Vandal O. Host-directed therapeutics for tuberculosis: 
can we harness the host? Microbiol Mol Biol Rev 2013; 77:608-27. 
155. Levine B, Packer M, Codogno P. Development of autophagy inducers in clinical medicine. 
J Clin Invest 2015; 125:14-24. 
156. Kim JJ, Lee HM, Shin DM, Kim W, Yuk JM, Jin HS, et al. Host cell autophagy activated by 
antibiotics is required for their effective antimycobacterial drug action. Cell Host Microbe 2012; 
11:457-68. 
157. Kumar D, Nath L, Kamal MA, Varshney A, Jain A, Singh S, et al. Genome-wide analysis of 
the host intracellular network that regulates survival of Mycobacterium tuberculosis. Cell 2010; 
140:731-43. 
















Chapter 2  
 
 
Dram1 deficiency leads to increased susceptibility of zebrafish 
to mycobacterial infection due to activation of pyroptotic cell 
death in infected macrophages 
Rui Zhang, Monica Varela, Vincenzo Torraca, Michiel van der Vaart and Annemarie H. Meijer 












Mycobacterium tuberculosis (Mtb) and Mycobacterium marinum (Mm) are infectious bacterial 
pathogens and the causative agents of tuberculosis (TB) in humans and fish, respectively. These 
mycobacteria can survive and proliferate inside host macrophages. In response, infected 
macrophages elicit diverse mechanisms in an attempt to eliminate the intracellular pathogens 
and prevent further dissemination. There are many factors – both host and bacteria derived – 
that together determine the fate of a mycobacterium-infected macrophage: will it kill the 
pathogen, or succumb to the infection? The autophagy and cell death mediator DRAM1 was 
previously linked to autophagic host defense against mycobacterial infection. In this study, we 
found that CRISPR/Cas9-mediated mutation of zebrafish Dram1 does not reduce basal levels of 
autophagy under non-infected conditions. However, in the zebrafish larval model of TB, Dram1 
deficiency reduces autophagic targeting of Mm and results in increased susceptibility to 
infection. Moreover, we demonstrate that Dram1, which is predominantly localized to lysosomal 
membranes, is required for acidification of Mm-containing vesicles. By in vivo imaging of the 
infection process, we observed that Dram1-deficient macrophages fail to restrict Mm during 
early stages of the infection. Knockdown of the zebrafish functional homolog of Caspase 1 could 
rescue the increased infection levels of Dram1 mutants. Therefore, extending the previously 
described function of Dram1 in maturation of mycobacteria-containing vesicles, we now 
propose that the presence of functional Dram1 limits pyroptotic cell death of mycobacteria-
infected macrophages and thereby contributes to host resistance to mycobacterial infection.  
 
Introduction 
Tuberculosis (TB), caused by Mycobacterium tuberculosis (Mtb), remains a severe infectious 
disease and global health threat. The increase in drug-resistant Mtb strains and the occurrence 
of comorbidities, like co-infection with HIV, lower the effectiveness of current TB treatments 1, 2. 
Thus, it is essential to fully understand the mechanisms of Mtb pathogenesis and develop novel 
approaches to improve the outcome of TB treatment. Autophagy is a conserved process that 
maintains cellular homeostasis by degrading unwanted cytoplasmic contents 3. Various studies 
have demonstrated that autophagy also acts as an innate immune defense mechanism to 
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control mycobacterial infection 4-8. Therefore, enhancing autophagic defenses forms a promising 
target for host-directed TB treatment 9, 10.  
Many autophagy factors involved in defense against mycobacterial infection have been 
identified. DNA Damage Regulated Autophagy Modulator 1 (DRAM1) is a more recently 
discovered regulator of autophagy and cell death 11, 12. Besides being involved in cancer and HIV 
infection 11, 13, a role for DRAM1 has been identified in defense against mycobacterial infections 
7. Transient knockdown of zebrafish dram1 leads to decreased autophagic targeting of 
mycobacteria and increased susceptibility to mycobacterial infection. Conversely, transient 
overexpression of dram1 promotes autophagic sequestration of mycobacteria and decreases 
mycobacterial infection 7. In addition, human DRAM1 colocalizes with Mtb in infected 
macrophages 7. Therefore, DRAM1 is a potential target for host directed therapy to restrict TB 
infection.  
Macrophages commonly serve as the first innate immune cells to engulf mycobacteria and play 
a central role in TB pathogenesis 14, 15. Nevertheless, mycobacteria can utilize macrophages as a 
niche in which they are able to survive and replicate via activation of diverse virulence 
mechanisms. For example, mycobacteria have evolved versatile mechanisms to alter the host 
environment, which prevents the delivery of mycobacteria to microbicidal lysosomes16. Arrested 
phagosome maturation or mycobacterial escape from phagosomes results in activation of 
autophagic defenses by infected macrophages 4, 17. The role of autophagy in defense against 
mycobacterial infections has been studied well, both in vitro and in vivo 4, 7, 18. The sequestering 
of an invading microbe by autophagy is called xenophagy 19. In this process, selective autophagy 
receptors like p62, NDP52 and NBR1 serve as adaptor proteins to directly connect ubiquitin-
tagged mycobacteria to forming autophagosomes 4, 20, 21. Apart from directly capturing 
cytoplasmic mycobacteria by xenophagy, p62 also contributes to defense against mycobacteria 
by delivering ubiquitinated cytosolic proteins to autophagolysosomes, where they are 
proteolytically converted into neo-antimicrobial peptides 22. Previously, our laboratory found 
that Dram1-mediated autophagic defense against mycobacterial infection requires the selective 
autophagy receptor p62 7. 
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Intracellular proliferation of mycobacteria ultimately leads to the death of the macrophage that 
has phagocytosed them. The remains of this dead macrophage and the now extracellular 
bacteria will be engulfed by newly recruited macrophages, which themselves become infected 
and disseminate the infection 23. However, the newly recruited macrophages phagocytose a 
large number of mycobacteria from the deceased macrophage, which means that newly infected 
macrophages will also die rapidly 24. In general, once overproliferation of mycobacteria initiates 
death of individual macrophages, this will result in a cascade of infection and killing of newly 
recruited macrophages 25, 26. Eventually, this leads to large scale dissemination of the infection 
and the formation of inflammatory infection foci, called granulomas 27, 28. The granuloma is a 
compact and organized structure that is a typical pathological feature of TB disease 28, 29. It is 
formed by mycobacteria-infected macrophages that attract other immune cells, like neutrophils, 
T cells, and B cells. On the one hand, granulomas function as host-protective structures to 
restrict mycobacteria locally 30. However, these structures also provide a safe shelter for 
mycobacteria to persist inside the host for long periods and they are poorly penetrated by anti-
mycobacterial drugs 31, 32. Furthermore, recent studies have demonstrated that the process of 
granuloma formation facilitates the spreading of mycobacteria between macrophages and 
thereby promotes the dissemination of infection 23, 29, 33, 34. Therefore, the fate of individual 
infected macrophages is a major determinant for the outcome of mycobacterial infection. 
Mycobacteria-infected macrophages can undergo at least three general types of cell death: 
apoptosis, necrosis and pyroptosis35. Apoptosis is an energy-dependent form of programmed 
cell death that does not induce an inflammatory response upon execution 36, 37. There are cell-
extrinsic and -intrinsic pathways activating apoptosis, governed by the involvement of different 
initiator and effector cysteine-dependent aspartate-directed proteases (Caspases). The 
similarity between these two types of activation pathways is that both require the participation 
of Caspase 3 38 The role of apoptotic macrophages in controlling mycobacterial infection has 
been well-established by in vitro studies 39, 40. In contrast, recent in vivo studies have shown that 
mycobacteria-induced apoptosis tends to promote the spreading of the infection during early 
stages of granuloma formation in zebrafish 23, 41, although necrotic cell death of infected 
macrophages promotes the spreading of infection to an even greater extent 42. Necrosis is 
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accompanied by swelling of organelles and damaging of the plasma membrane. This is generally 
considered a passive type of cell death but can also occur as a form of programmed cell death 
(necroptosis) 42, 43. Eventually, released cytoplasmic material enters the extracellular space 37, 44. 
Necrotic cell death of mycobacteria-infected macrophages facilitates dissemination of the 
infection and promotes granuloma formation both in zebrafish and mouse models 23, 45. 
Pyroptotic cell death activates the inflammatory response during a process that requires the 
involvement of Caspase 1 37, 38. It is conceivable that pyroptosis, similar to other lytic types of 
cell death (necrosis, necroptosis), is beneficial to bacterial spreading and proliferation 46. In 
summary, the fate of mycobacteria-infected macrophages plays an important role in TB 
pathogenesis. While a role for DRAM1 in autophagic defense against mycobacterial infections 
has been demonstrated 7, its potential function as a modulator of cell death during TB 
pathogenesis has not been explored.  
In this study, we used zebrafish embryos and larvae infected with Mycobacterium marinum 
(Mm) as a model for TB pathogenesis to study the role of Dram1 in controlling mycobacterial 
infection. We have generated two zebrafish dram1 mutant alleles using CRISPR/Cas9-mediated 
mutagenesis. Using these mutants, we have demonstrated that Dram1 deficiency has no 
apparent effect on development and does not reduce basal levels of autophagy in zebrafish 
larvae under non-infected conditions. Confirming and extending our previous knockdown 
studies, we present evidence that Dram1 is required for autophagic targeting and host defense 
against Mm. Specifically, analysis of the mutant fish showed that Dram1 is required for 
maturation of Mm-containing vesicles and for macrophages to restrict Mm infection. Without 
functional Dram1, Mm-infected macrophages initiate programmed cell death via a Caspase 1-
dependent mechanism, indicative of pyroptosis. Collectively, our data advocate that Dram1 
protects against mycobacterial infection by modulating autophagic targeting and maturation of 
Mm-containing vesicles. In the absence of Dram1, infected macrophages rapidly become 
overburdened by the bacteria and initiate pyroptotic cell death, resulting in increased 




Generation of Dram1 null mutants by CRISPR/Cas9 method  
In a previous study, we have shown that the autophagy modulator Dram1 protects against 
mycobacterial infection via stimulation of autophagic defenses and maturation of bacteria-
containing vesicles 7. Here, we generated a zebrafish dram1 mutant line using CRISPR/Cas9 
technology to validate and expand on our previous findings. We designed a single guide RNA 
(sgRNA) that targets the CRISPR/Cas9 endonuclease complex to the first coding exon of the 
dram1 gene (Fig1 A). We predicted that random insertions or deletions around the target site 
due to non-homologous end joining would introduce a frame shift and/or premature stop 
codon, ensuring that the Dram1 protein will not be translated (Fig1 A). We injected the sgRNA 
and Cas9 mRNA into the yolk of one cell stage embryos and analyzed the resulting mutations by 
Sanger sequencing to identify F0 founders (FigS1 A). Dram1 is known as a modulator of 
autophagy 11. Thus, F0 founders carrying two independent mutations in exon1 of dram1 were 
outcrossed with Tg(CMV:EGFP-map1lc3b) fish (hereafter referred to a GFP-Lc3) to allow 
visualization of autophagic processes 47. Upon adulthood, F1 heterozygous carriers of the 
mutated dram1 alleles (dram1+/-) were incrossed to obtain F2 homozygous mutants (dram1-/-) 
and wild type siblings (dram1+/+) with or without GFP-Lc3 in the background. We performed 
Sanger sequencing on genomic DNA (F2) obtained from fin tissue to characterize the two 
independent mutant alleles: 1) a 21 nucleotides deletion combined with a 2 nucleotides 
insertion at the target site, named dram1∆19n/∆19n (Fig1 B); and 2) a 5 nucleotides insertion at the 
target site, named dram15n/5n (FigS1 B). In this study, we focused primarily on the dram1∆19n/∆19n 
allele, and confirmed crucial observations with the dram15n/5n allele. Using an N-terminal 
antibody capable of detecting zebrafish Dram1 by western blot, we could not detect Dram1 
protein in the dram1∆19n/∆19n line, supporting that this represents a null allele (Fig1 C).  
Apart from its important role in autophagy, Dram1 has also been found to modulate other 
cellular processes, including apoptosis and neutrophil differentiation11, 48. We therefore first 
asked whether Dram1 deficiency results in developmental defects. We compared body size 
measurements, but found no apparent difference in development between dram1∆19n/∆19n and 
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wild type siblings (dram1+/+) (Fig1 E). Furthermore, dram1∆19n/∆19n larvae or adult fish (up to 18 
months) did not exhibit observable differences in behavior, survival, or fertility compared to 
dram1+/+ (data not shown). Finally, we used a Chi-square test to determine that the offspring 
from incrossed heterozygous dram1∆19N (hereafter referred to as dram1∆19n/+) strictly followed 
Mendelian inheritance (Fig1 D). The same was true for incrossed dram15n/+ parents (FigS1 C). We 
also performed Tunel staining to detect if Dram1 deficiency affect the basal cell death, the result 
showed that dram1+/+ and dram1∆19n/∆19n display similar numbers of Tunel+ cells (Fig1 F and G). 
Collectively, we have used CRISPR/Cas9 targeted mutagenesis to generate two dram1 null 
mutants, both of which display no apparent phenotypes during development and can be used to 
study the function of Dram1 in autophagy and immune defense against infection.  
Figure 1: Generation of Dram1 mutant lines (Figure on next page) 
A. Schematic representation of the zebrafish dram1/Dram1(ENSDARG00000045561/ENSDARP0 0000066996.3) 
genetic and protein domain architecture and CRISPR/Cas9 target site. Dram1 (240 amino acids) contains six 
transmembrane domains, which are indicated with grey boxes and labels (T1-T6) with amino acid numbers above. 
The gene is depicted with coding exons as grey boxes and introns as solid black lines (introns not drawn to scale). 
The position of the CRISPR/Cas9 target site at the beginning of the first coding exon is indicated and the predicted 
truncated protein in the dram1
∆19n/∆19n 
mutant line is drawn above. The dram1
5n/5n
 allele was generated at the same 
target site, leading to a similarly truncated protein (FigS1). 




from F2 offspring. Red lines indicate CRISPR/Cas9 target sites. 
The genomic DNA was isolated from fin tissue (>3 months old fish). The dram1
∆19n/∆19n 
mutant allele has 21 
nucleotides deleted and 2 nucleotides inserted. 
C. Confirmation of truncation of the Dram1 protein by western blotting analysis. Protein samples were extracted 




larvae (>10 larvae/sample). The blots were probed with antibodies against 
Dram1 and Actin as a loading control.  
D. Segregation from dram1
∆19n/+
 F1 heterozygous incross. Genotypes of adult fish (>3 months old) were combined 
from at least three independent breedings and confirmed by PCR and Sanger sequencing. Data were analyzed by 
Chi Square test. ns, non-significant,*p<0.05,**p<0.01,***p<0.001.  






were imaged by 
stereo microscopy at 3dpf and body lengths were measured as indicated by the red dotted lines. 




larvae in the tail region. Tunel staining was 



























dram1 null mutants display increased susceptibility to mycobacterial infection  
Since transient knockdown of zebrafish dram1 by antisense morpholino oligonucleotide 
knockdown resulted in increased Mm infection and extracellular growth of bacteria 7, we sought 
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to confirm this phenotype in our dram1 mutants. Therefore, we infected dram1∆19n/∆19n, 
dram1+/+, and unrelated wild types (AB/TL) with Mm at 1 dpf via blood island injection and 
found that dram1∆19n/∆19n had a significantly increased susceptibility to infection (Fig2 A and B). 
Furthermore, Dram1-deficient larvae randomly displayed accumulation of bacteria inside 
intersegmental blood vessels at 3 days post infection (dpi), which is indicative of extracellular 
growth of bacteria (Fig2 A). We detected no differences in bacterial burden between dram+/+ and 
unrelated wild types, indicating that the genetic background in which the mutation was made 
did not affect its susceptibility to mycobacterial infection (Fig2 B). Mycobacterial infection in 
dram1∆19n/∆19n resulted in a clearly increased infection burden of around 290% compared to their 
WT siblings (Fig2 B). We next tested the infection susceptibility of larvae homozygous for the 
other dram1 mutant allele, dram15n/5n, and found that it roughly exhibited the same increase 
(around 250%) compared to their wild type siblings (FigS2 B and FigS2 C). As expected, these 
experiments demonstrated that both dram1 mutant alleles (19n indel and 5n indel) were more 
susceptible to mycobacterial infection. Since there are no clear differences between the two 
mutant alleles in susceptibility to Mm infection, we decided to use the dram1∆19n/∆19n allele for 
further study into Dram1 function.  
Next, we asked if transient overexpression of dram1 mRNA can compensate for Dram1-
deficiency in dram1∆19n/∆19n. For this purpose, we injected dram1 mRNA into one cell 
dram1∆19n/∆19n and dram+/+ embryos to overexpress dram1. As a negative control, we also 
injected dram1 mutant mRNA, which was generated from cDNA obtained from dram1∆19n/∆19n. 
The results showed that transient overexpression of dram1 mRNA rescued Dram1 deficiency 
during mycobacterial infection, while overexpression of mutant dram1 mRNA did not affect Mm 
infection burden (Fig2 C). Collectively, our analysis of two zebrafish dram1 mutant alleles 





















Figure 2: Dram1 deficiency leads to increased susceptibility to Mm infection 




larvae at 3 dpi. 
B. Bacterial burdens were determined at 3dpi. The data is accumulated from two independent infection 
experiments. Each dot represents an individual larva. The arrowhead indicates the accumulation of bacteria in 
intersegmental veins. ns, non-significant, *p<0.05,**p<0.01,***p<0.001 . 
C. Embryos were injected at the one cell stage with 50 ng of dram1 or dram1
∆19n 
mRNA, or non injected. Data is 
accumulated from two independent infection experiments. Each dot represents an individual larva. ns, non-
significant, *p<0.05,**p<0.01,***p<0.001. 
Analyzing autophagic processes in dram1 null mutants suggests defects in 
autophagosome maturation 
Human DRAM1 is a modulator of autophagy and DRAM1 deficiency results in impaired 
autophagy induction in vitro11. Furthermore, a role for DRAM1 in maturation of 
autophagosomes has been described 49. Therefore, we assessed the effect of zebrafish dram1 
mutation on autophagy in developing embryos (Fig3 A). Increased GFP-Lc3 puncta and LC3-II 
protein levels can indicate enhanced autophagosome formation 50. However, increased GFP-Lc3 
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puncta or Lc3-II protein levels can also indicate a block in degradation of autophagosomes 
(reduced autophagic flux). First, we used the GFP-Lc3 reporter to analyze whether differences in 
basal autophagy could be detected due to Dram1 deficiency. We imaged GFP-Lc3 puncta in the 
tail fin tissue of dram1∆19n/∆19n and dram1+/+. Although the average number of autophagy-related 
structures was slightly higher in dram1∆19n/∆19n, the difference between the two groups under 
basal conditions was not significant (Fig3 B). However, there might be differences that are 
obscured by ongoing autophagic flux, or that only become apparent under certain conditions. 
Therefore, we examined GFP-Lc3 accumulation following treatment with the vacuolar H+ ATPase 
(V-ATPase) inhibitor Bafilomycin A1 (BafA1). Treatment with BafA1 prevents maturation of 
autophagic vacuoles by inhibiting fusion between autophagosomes and lysosomes 51, 52. While 
BafA1 treatment resulted in accumulation of GFP-Lc3 puncta in both dram1∆19n/∆19n and 
dram1+/+, the dram1 mutants accumulated more GFP-Lc3 puncta than their wild type siblings 
(Fig3 C). To independently confirm these results, we next detected endogenous Lc3 protein 
levels by western blot. In agreement with the GFP-Lc3 puncta analysis, Lc3-II protein levels were 
not detectably different between dram1∆19n/∆19n and dram1+/+ larvae under basal conditions, but 
Dram1 deficiency significantly increased Lc3-II protein levels when autophagic flux is blocked by 
BafA1 treatment (Fig3 D and E). Finally, we assessed the protein levels of p62 and Optineurin, 
since these ubiquitin-binding receptors are depleted during selective autophagy 53-55. Therefore, 
protein levels of p62, as well as Optineurin, can be used as an inverse indicator of autophagy 
activity 56. The results showed that Optineurin and p62 protein levels were similar in 
dram1∆19n/∆19n and dram1+/+ under basal conditions but were elevated in dram1∆19n/∆19n larvae 
when autophagic flux is blocked in the presence of BafA1 (FigS3 A). This accumulation of 
Optineurin and p62 could be due either to increased production or to reduced degradation of 
these selective autophagy receptors. Taken together, Dram1 deficiency did not cause detectable 
differences in autophagic processes under basal conditions. However, blocking autophagic flux 
revealed alterations in the autophagy pathway that could be explained by an increase in 































Figure 3: Dram1 mutation leads to impairment in autophagic flux  
A. Workflow representing the experimental design followed in panels B-D. 3.5 dpf larvae were treated with BafA1 




 larvae in GFP-Lc3 background were used for 
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larvae not carrying GFP-Lc3 
were used for assaying autophagy activity by western blot (WB). 
B-C. Representative confocal micrographs of GFP-Lc3 puncta present in the tail fin, and quantification of the 
number of GFP-Lc3 puncta in dram1
∆19n/∆19n 
and dram1
+/+   
larvae in an unstimulated situation (basal autophagy, B) 
and following BafA1 treatment (C). Each larva was imaged at a pre-defined region of the tail fin (as indicated by the 
red boxed area in Fig3 A)  (≥6 larvae/group). Results are representative of two independent experiments. Scale bars, 
10 μm.  




larvae in absence or presence of BafA1. Protein 




larvae (>10 larvae/sample). The WB were probed 
with antibodies against Lc3 and Actin as a loading control. WB were repeated three times with protein extracts 
derived from independent experiments.  




larvae in absence or presence of 
BafA1. WB band intensities were quantified by Lab Image (Bio-Rad). The data were combined from three 
independent experiments. 
Dram1 deficiency leads to reduced GFP-Lc3 targeting of mycobacteria, but 
accumulated Lc3-II protein levels 
We previously found that Dram1 mediates autophagic defense against Mm and that dram1 
knockdown decreased targeting of autophagic vesicles to Mm 7. Thus, we infected dram1∆19n/∆19n 
and dram1+/+ in a GFP-Lc3 background with Mm to determine whether dram1 knockout 
confirms our previous observations. We used confocal laser scanning microscopy to image the 
entire caudal hematopoietic tissue (CHT) at 2 dpi, since the majority of immune cells that have 
phagocytosed Mm are present in the CHT at this time point (Fig4 A). We quantified the 
colocalization between GFP-Lc3 and Mm and found that dram1∆19n/∆19n larvae displayed 
significantly less GFP-Lc3-positive Mm clusters compared to their wild type siblings (Fig4 B). 
Approximately 9% of the Mm clusters were positive for GFP-Lc3 in wild type siblings, opposed to 
only around 3% in dram1∆19n/∆19n (Fig4 C). Since Dram1 deficiency reduced autophagic targeting 
of Mm, we expected to detect lower Lc3-II protein levels by western blot at 3 dpi. The results 
showed that Mm infection increased Lc3-II levels in dram1∆19n/∆19n and dram1+/+ (Fig4 D), 
consistent with the observed autophagic targeting of Mm (Fig4 B). However, the results also 
showed that Dram1-deficient larvae accumulated more Lc3-II than their wild type siblings during 
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Mm infection (Fig4 D), which was opposite to our expectation. Since ubiquitination of 
cytoplasmic cargo plays an important role in selective autophagy against mycobacteria 20, we 
performed western blot detection of ubiquitinated proteins on non-infected and infected 
dram1∆19n/∆19n and dram1+/+. The results showed that Dram1 deficiency led to accumulation of 
ubiquitinated proteins during the infection (FigS4 A). In conclusion, Mm infection results in 
increased accumulation of Lc3-II and ubiquitinated proteins. While these proteins accumulate at 
even higher levels in Dram1-deficient larvae, we clearly observed reduced autophagic targeting 
























Figure 4: Dram1 is required for GFP-Lc3 targeting to Mm clusters 
A. Workflow representing the experimental design followed in B. 2 dpi fixed larvae were used for confocal imaging. 
The entire caudal hematopoietic tissue (CHT) was imaged, as indicated by the black box. 





larvae. The top image shows the entire CHT region. the bottom images show GFP-Lc3 colocalization of  




larvae. The arrowheads indicate the overlap between GFP-Lc3 and Mm 
clusters. Scale bars, 10 μm. 
C. Quantification of the percentage of Mm clusters positive for GFP-Lc3 vesicles. The data is accumulated from two 
independent experiments, each dot represents an individual larva (≥15 larvae/group). 
D. Lc3 protein levels were determined by WB in infected and uninfected larvae. Protein samples were extracted 
from 4 dpf larvae (>10 larvae/sample). The blots were probed with antibodies against Lc3 and Actin as a loading 
control. WBs were repeated two times with independent extracts.  
Dram1-deficiency does not affect phagocytosis of Mm 
Macrophages play an important role in defense against mycobacterial infections. Thus, we were 
interested to know whether Dram1 deficiency affects the immune functions of macrophages. 
Therefore, the dram1∆19n/∆19n line was outcrossed with the macrophage marker line 
Tg(mpeg1:mCherry-F)umsF001 57 and subsequently incrossed to obtain dram1+/+, dram1∆19n/+, and 
dram1∆19n/∆19n with  an mpeg1-driven and membrane-localizing mCherry-F  in the background 
(FigS1 A and D). Since human DRAM1 is involved in cellular differentiation of immune cells 48, we 
first asked whether Dram1-deficiency affected the development of immune cells in zebrafish. 
For this purpose, we performed TSA-staining to count the number of neutrophils and utilized the 
mpeg1:mCherry-F reporter to count the number of macrophages. The results revealed that 
Dram1 deficiency did not alter the number of macrophages and neutrophils (Fig5 A and Fig5 B). 
Since the first stages of TB pathogenesis take place inside macrophages, we asked whether 
increased mycobacterial burden caused by Dram1 deficiency was due to defects in phagocytosis 
by macrophages. We infected dram1∆19n/∆19n and dram1+/+ with Mm and assessed the phagocytic 
activity of leukocytes at 1 hour post infection (hpi). The results showed that Mm were 
phagocytosed by macrophages both in dram1∆19n/∆19n and their wild type siblings, and there was 
no significant difference in the percentage of Mm clusters that reside inside macrophages at 1 
hpi (Fig5 C and Fig5 D). Next, we determined at which time point during the infection we were 
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first able to detect a difference in bacterial burden between dram1∆19n/∆19n and dram1+/+. We 
found that there was no detectable difference in Mm infection burden at 1 dpi, but Dram1 
deficiency significantly increased Mm infection burden at 2 dpi (Fig5 E and Fig5 F). In conclusion, 
Mm are phagocytosed at a similar rate by dram1∆19n/∆19n and dram1+/+, and the 



























Figure 5: Dram1 deficiency does not affect the capability of macrophages to phagocytose Mm  




larvae following an 
immunohistochemical peroxidase activity detection protocol. The number of neutrophils in this region was 
quantified per individual larva (≥10 larvae/group). Each data point represents an individual larva. The results are 
representative for two individual repeats.  
B. Representative stereo micrographs of macrophages in the whole tail region and quantification of the number of 




/ mpeg1:mCherry-F larvae were obtained from 
incrossed dram1
∆19n/+ 
animals and the number of macrophages for each larva were counted before knowing the 
genotype. Genotyping was performed by PCR and Sanger sequencing (≥7 larvae/ group). The results are 
representative for two individual repeats. 





mpeg1:mCherry-F background at 1 hour post infection (hpi). Scale bars, 10 μm.  




 embryos in 
mpeg1:mCherry-F background
  
were infected Mm at 30 hpf and fixed at 1 hpi. Each dot represents the percentage 
of macrophages that have phagocytosed Mm clusters in an individual larva (≥8 larvae/ group). The results are 
representative for two individual repeats. 




. Each dot 
represents an individual infected larva. ns, non-significant, *p<0.05,**p<0.01,***p<0.001 ..  




 embryos at 1 and 2 dpi.  
Dram1 is required for macrophages to restrict Mm infection  
Since Dram1 is a lysosomal membrane protein 11, we asked whether Dram1-deficiency affected 
the maturation of Mm-containing vesicles. We used LysoTracker to determine the extent of 
colocalization between Mm and acidic vesicles in the CHT at 1 dpi, a time point at which we did 
not observe a difference in bacterial burden between dram1∆19n/∆19n and dram1+/+ yet (Fig5 E). In 
wild type siblings, we observed that roughly 60% of the bacterial clusters were LysoTracker-
positive, while in Dram1-deficient larvae only roughly 20% of the bacterial clusters were positive 
for LysoTracker staining (Fig6 B). This implicates that Dram1 is indeed required for maturation of 
Mm-containing vesicles. Next, we asked whether the reduced maturation of Mm-containing 
vesicles limits the ability of macrophages in dram1∆19n/∆19n hosts to combat the infection. The 
results showed that at 1 dpi the majority of Mm clusters were restricted inside macrophages 
both in dram1∆19n/∆19n and dram1+/+ (63% and 75%, respectively; Fig6 C and Fig6 D). However, at 
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2 dpi, we observed that the majority of Mm remained inside of macrophages in dram1+/+ (65%), 
while in dram1∆19n/∆19n larvae we found that most Mm had escaped from macrophages and only 
31% remained intracellular (Fig6 E and F). Furthermore, we frequently observed evidence of 
macrophage cell death in the proximity of bacterial clusters in dram1∆19n/∆19n (Fig6 E). Together, 
these data demonstrated that Dram1 is necessary for macrophages to restrict mycobacterial 











Figure 6: Macrophages fail to restrict Mm infection in Dram1-deficient larvae (Figure on next page) 






embryos at 1 
dpi. The arrowheads indicate the colocalization between Mm and LysoTracker staining. Scale bars, 10 μm. 




was determined in infected 
embryos (≥10 embryos/group) at 1 dpi. Each dot represents the percentage of Mm clusters that are LysoTracker
+ 
in 
an individual infected larva. Data is representative of two independent experiments. ns, non-
significant,*p<0.05,**p<0.01,***p<0.001. 




 embryos/larvae in mpeg1:mCherry-F 
background, infected as described in Fig6 A, at 1 and 2 dpi. The entire CHT region of fixed embryos or larvae was 
imaged. The arrowheads indicate extracellular Mm clusters and stars(*) indicate dead macrophages. Scale bars, 10 
μm. 
E and F: The percentage of Mm clusters restricted inside macrophages was determined at 1 and 2 dpi (≥5 
embryos/group). Each dot represents the percentage of intracellular Mm clusters in an individual embryos. Data is 






Dram1 deficiency results in increased Caspase-1 dependent programmed cell death 
Since we observed many dead macrophages around Mm in dram1∆19n/∆19n at 2 and 3 dpi (Fig6 E 
and data not shown), we aimed to decipher the mechanism responsible for this cell death. Thus, 
we performed Terminal deoxynucleotidyl transferase dUTP nick end labeling (Tunel) on infected 
embryos and imaged the entire CHT region of dram1∆19n/∆19n and dram1+/+. This staining can 
detect damaged DNA present both in apoptotic and pyroptotic cells 58, 59. We could observe 
Tunel-positive cells around Mm clusters both in dram1∆19n/∆19n and dram1+/+ (Fig7 A). The results 
showed that the percentage of Tunel-positive Mm clusters was around 2.1 times higher in 
dram1∆19n/∆19n when compared to dram1+/+ (Fig7 B). Human DRAM1 has previously been 
reported as a regulator of apoptosis 12. Thus, we determined whether Dram1-deficiency affected 
apoptosis in response to infection. Caspase 3 serves as a main executioner and indicator of 
apoptotic cell death 38, 60. We therefore utilized an antibody against full length and active 
Caspase 3 to monitor apoptosis activity by western blot in dram1∆19n/∆19n and dram1+/+. The 
results showed that Caspase 3 was activated (cleaved) in response to Mm infection in 
dram1∆19n/∆19n and dram1+/+. However, we did not detect any difference in the levels of Caspase 
3 activation between dram1∆19n/∆19n and dram1+/+ (Fig7 C). This indicated that cells undergo 
apoptosis in dram1∆19n/∆19n and dram1+/+ during Mm infection but did not provide evidence that 
the increased cell death observed in dram1∆19n/∆19n was due to increased apoptosis. Next, we 
asked if these macrophages died via pyroptotic cell death. Pyroptosis is a Caspase 1-dependent 
form of cell death 37. Thus, we detected Caspase 1 activity in the absence and presence of Mm 
infection in dram1∆19n/∆19n and dram1+/+ at 2dpf, the time point at which we observed increased 
cell death in dram1∆19n/∆19n. The results showed that Caspase 1 activity was increased in 
dram1∆19n/∆19n infected with Mm, but not in dram1+/+ (Fig7 D). Next, we asked if the increased 
bacterial burden in Dram1-deficient larvae is dependent on Caspase 1 activity. Thus, we injected 
caspase a (a functional homologue of caspase 1) morpholino into the one cell stage of dram1+/+ 
and dram1∆19/∆19 embryos and infected with Mm at 1 dpf. In agreement with previous results 
(Fig 2), the infection burden of dram1∆19n/∆19 embryos was higher that of dram1+/+ (Fig7 E and F). 
Morpholino knockdown of caspase a knockdown in decreased infection burden in dram1+/+ by 
48% and in dram1∆19/∆19 by 63%, bringing the infection burden of both groups to a similar low 
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level (Fig7 E and F). Collectively, these data suggest that mycobacterial infection in zebrafish 
embryos is promoted by pyroptosis of infected macrophages and that the lack of functional 





























Figure 7: Dram1 deficiency results in increased Caspase 1-dependent programmed cell death 




larvae at 2  dpi. The entire CHT 






was imaged. The arrowheads indicate the cells positive for 
Tunel staining (Tunel
+ 
). Scale bars, 10 μm. 





+/+   
larvae. Each dot 
represents the percentage of Mm clusters Tunel
+
 in the CHT region of an individual infected larva. ns, non-
significant,*p<0.05,**p<0.01,***p<0.001. 












The western blots were probed with antibodies against Caspase 3 and Actin as a loading control. The experiments 
were repeated two times. 




/GFP-Lc3 embryos. Protein samples were obtained 




 embryos (>30 embryos/sample). The data is 
accumulated from two independent experiments. ns, non-significant,*p<0.05,**p<0.01,***p<0.001 




embryos. The data is accumulated from two independent experiments. ns, non-
significant,*p<0.05,**p<0.01,***p<0.001 




larvae at 2 dpi with and without caspase a 
MO injection. 
Discussion  
The lysosomal protein DRAM1 regulates autophagy and cell survival/death decisions under 
multiple stress conditions, including diseases like cancer and infection. Its mechanism of action 
remains largely unknown. In this study, we have demonstrated that mutation of dram1 in 
zebrafish impairs resistance to mycobacterial infection. Importantly, we show that Dram1 
deficiency reduces the acidification of Mm-containing vesicles, ultimately resulting in Caspase 1-
dependent cell death of infected macrophages and increased extracellular growth of 
mycobacteria during early stages of the infection.   
In this study we generated two independent dram1 mutant lines using CRISPR/Cas9 technology 
to confirm and build upon results obtained with transient knockdown studies 7. The combined 
use of knockdown (transient silencing) and knockout (stable loss of function) technologies is 
important, considering that targeting the same gene with these two approaches can result in 
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different phenotypes due to several reasons 61. First, knockdown approaches can generate off-
target effects and thereby induce phenotypes that are quite different from corresponding 
mutants. On the other hand, higher eukaryotic organisms can adapt to genetic variation (e.g. 
loss of function) by altering the activity of other genes, a mechanism which is called genetic 
compensation 62, 63. This genetic compensation cannot be activated during transient knockdown 
of a gene and might therefore account for discrepancies between phenotypes resulting from 
knockout or knockdown approaches 62, 63. Embryos and larvae homozygous for the two dram1 
CRISPR/Cas9 mutant alleles were viable and displayed no apparent phenotypes. Furthermore, 
we used the stable mutant lines to demonstrate that Dram1 deficiency does not affect 
development into adulthood or fertility. These observations are similar to DRAM1 mutation in 
mouse models, which resulted in viable, fertile, and apparently normal individuals compared to 
their wild-type siblings (Mah thesis 2012) 86. While DRAM1 deficiency was previously shown to 
affect the differentiation of neutrophils in acute promyelocytic leukaemia (APL) 48, the absence 
of functional Dram1 in zebrafish did not affect the total numbers of neutrophils or macrophages. 
In agreement with previous morpholino knockdown studies 7, both dram1 mutant alleles 
showed increased susceptibility to mycobacterial infection in the zebrafish larval model of TB. 
The observation of a similar infection phenotype by two methods for disrupting dram1 gene 
activity provides strong evidence that Dram1 is an important factor for host resistance against 
pathogenic mycobacteria. Furthermore, dram1 mutants display decreased survival during 
Salmonella Typhimurium infection (Masud thesis) 87, indicating that Dram1 plays a role in 
immune defense against a broad range of intracellular bacterial pathogens.  
The function of DRAM1 as a modulator of autophagy has been studied well in vitro 11. We 
therefore tested whether zebrafish dram1 mutants display defects in autophagic processes. 
Autophagy is a host response to diverse stress factors, including starvation. Wild type zebrafish 
larvae until 5 dpf can rely on their yolk proteins for nutrients 64, and we therefore assumed that 
their autophagic processes are not activated above a level normal for their developmental stage, 
unless autophagy is triggered by a stressor such as infection. In agreement, we did not detect 
any differences when comparing the basal levels of autophagy activity in uninfected dram1 
mutant larvae of 4 dpf to those of their wild type siblings. This finding is consistent with an in 
62 
 
vitro study of the function of mouse DRAM1 65, which showed that basal autophagy was not 
altered in the absence of DRAM1 in primary mouse embryonic fibroblasts (MEFs). The five 
members of the DRAM family are conserved between human, mouse and zebrafish 7, 11, 66-68, 
and as also described in chapter 1 of this thesis. Therefore, it is conceivable that other DRAM 
family members can replace the loss of Dram1/DRAM1 under basal conditions, or that DRAM1 
is only involved in autophagic processes in response to specific stress factors. Galavotti et al. 
(2013) found that autophagy induction in response to starvation or while blocking mTOR was 
not changed in the absence of DRAM1 69. However, the lack of DRAM1 affected the activation of 
autophagy in human cells (Hela and A549) following the induction of cellular stress by treatment 
with the mitochondria inhibitor 3-nitropropionic acid (3-NP) 49. Besides infection, DNA-damage, 
and interference with impaired energy metabolism 7, 11, 13, it remains to be further investigated 
which stress factors can activate DRAM1/Dram1 in vitro and in vivo.  
Treatment of dram1 mutant larvae with BafA1, which blocks lysosomal degradation of 
autophagosomes, revealed an increase of GFP-Lc3 punctae and Lc3-II protein levels. This result 
is reminiscent of a previous study which showed that transient knockdown of human DRAM1 
significantly affected the clearance of autophagosomes in Hela cells 49. The dram1 mutants also 
accumulated higher Lc3-II protein levels than their wild type siblings under conditions of Mm 
infection. As in the case of BafA treatment, the accumulation of Lc3-II could indicate an increase 
in autophagosome production, or a defect in the degradation of autophagosomes. The latter 
possibility is supported by increased accumulation of ubiquitinated proteins in the dram1 
mutants. Collectively, we propose based on our data and the existing literature that the 
lysosomal protein Dram1/DRAM1 is important for maturation and degradation of 
autophagosomes. Furthermore, we believe that the induction of additional autophagosomes in 
response to BafA1 treatment or Mm infection – could function as a compensatory mechanism 
for the defect in degradation of cellular stress factors. Intriguingly, despite of the increased Lc3-
II levels in infected dram1 mutants, imaging in GFP-Lc3 transgenic fish revealed that 
mycobacteria are targeted by autophagic vesicles nearly 3-folds less frequently in dram1 
mutants than in wild type zebrafish larvae. This provides new evidence that Dram1 is required 
for autophagic defense against mycobacteria, as previously proposed based on morpholino 
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knockdown results 7. How autophagic targeting of intracellular pathogens is orchestrated by 
DRAM1/Dram1 remains an important question for future research.  
Previous studies have revealed that interaction occurs between autophagosomes and 
phagosomes 6, 70. Specifically, defects in autophagy led to increased phagocytosis of Mtb in 
mouse macrophages 71. Therefore, it was important to address the question whether altered 
autophagic targeting of Mm in zebrafish mutants was associated with different phagocytic 
ability of zebrafish macrophages. We found that, while Dram1 deficiency impaired autophagic 
defense against mycobacterial infection, it did not affect the capability of macrophages to 
phagocytose Mm. We did, however, find that Dram1 deficiency reduced autophagic targeting 
and acidification of Mm-containing vesicles, which ultimately resulted in the death of infected 
macrophages. These findings are in line with a recent study that revealed that DRAM1 directly 
mediates lysosomal membrane permeabilization (LMP) in HIV infected CD4+ T cells 13. Lysosome 
destabilisation triggered cell death and lowered viral replication 13. While the mechanism of cell 
death could be similar in both situations, we detected higher mycobacterial burdens following 
death of the infected immune cells, as is to be expected from extracellularly growing Mm 23.  
Apoptosis of infected cells is generally regarded as a host protective defence mechanism against 
mycobacterial infection, and virulent Mtb therefore actively inhibit apoptosis 33, 40, 72. Apoptosis 
is a non-lytic form of cell death which prevents activation of an inflammatory response. 
Therefore, any intracellular mycobacteria will be encapsulated within the apoptotic envelope 
until the remains of the dying cell have been phagocytosed by recruited macrophages 40, 46, 73. 
This is reasoned to be beneficial to the host by preventing uncontrolled extracellular growth 
of the bacteria. However, an in vivo study has demonstrated that apoptotic cell death can 
facilitate the expansion and dissemination of mycobacteria when macrophages 
phagocytosing the remains of the infected cell become infected themselves 23. Nevertheless, 
only a small proportion of infected macrophages initiates apoptosis, as the majority of 
infected macrophages undergoes mycobacteria-induced lytic cell death 46. In our study we 
observed that Caspase 3 was activated during mycobacterial infection, which is an indicator for 
apoptotic processes. DRAM1 was previously shown to mediate apoptosis by blocking the 
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degradation of the pro-apoptotic protein Bax 12. While Dram1 deficiency leads to more cell 
death during Mm infection, we did not observe any changes in apoptosis activity on a whole 
embryo level, which led us to explore the role of Dram1 in other types of programmed cell 
death.  
Strikingly, we found that Dram1 deficiency leads to more Caspase 1 activity and Caspase 1-
dependent pyroptotic cell death. Pyroptosis is a lytic form of cell death which activates an 
inflammatory response 74. Thus, the mechanisms, characteristics, and consequences of 
pyroptotic cell death are different from apoptosis 37, 75. Previous studies revealed that 
pyroptosis can be induced by diverse pathogens and forms a critical mechanism to restrict 
microbial infection 75, 76. In line with this, there is also evidence that mycobacteria inhibit 
pyroptosis of infected macrophages via diverse mechanisms 77. However, recent studies found 
that lytic cell death (e.g. pyroptosis and necrosis) helps mycobacteria to evade host immunity 
and dissminate the infection 24, 46. Indeed, in this present study we found that Caspase 1-
dependent pyroptotic cell death promoted the expansion of bacteria. Moreover, genetic 
inhibition of Caspase 1 could rescue the exacerbated bacterial growth in dram1 mutants. Taken 
together, the death of infected macrophages is intricately related to TB pathogenesis and can 
result either in increased dissemination or restriction of the infection. The sometimes 
contradicting evidence concerning the beneficial or detrimental effects of the different modes 
of cell death suggests that the context of cell death (e.g. location, timing during TB pathogenesis, 
and the immune status of the host) plays a crucial role in determining the outcome.        
In conclusion, restriction of mycobacteria in infected macrophages during the early stages of 
infection requires functional Dram1. In this work, we have shown that Dram1 is involved in 
several processes important to defense against intracellular pathogens, potentially providing an 
intersection between modulation of autophagy, lysosomal function, and programmed cell death. 
Future studies are required to precisely elucidate the role of the lysosomal protein 
Dram1/DRAM1 in this network. Facing the complexity of the current TB situation, there is an 
urgent need to improve treatment strategies to control TB progression. Host-directed therapies 
(HDT) have emerged as a promising alternative to counter TB. HDTs can assist the host in 
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responding appropriately to Mtb infection, thereby promoting the effectiveness of drug 
treatments and reducing the time required for treatment 9. Using an in vivo model for the early 
stages of TB disease we have demonstrated the importance of Dram1 for the elimination of 
intracellular mycobacteria and the cell fate of infected macrophages.  This makes 
Dram1/DRAM1 – and its interaction partners that remain to be identified –promising targets for 
HDT development to improve the outcome of TB disease.  
Materials and methods 
Zebrafish culture and lines  
Zebrafish lines in this study (TableS1) were maintained and used in compliance with local animal 
welfare regulations as overseen by the Leiden University (registration number: 10612). Embryos 
were kept in egg water, in a 28.5°C-30°C incubator, and treated with 0.02% Ethyl 3-
aminobenzoate methanesulfonate (Tricaine, SIGMA-ALDRICH) in egg water for anesthesia 
before bacterial injections, imaging and fixation. 
CRISPR/Cas9 mediated mutagenesis of zebrafish dram1 
Single guide RNAs (sgRNAs) targeting the first coding exon of zebrafish dram1 
(ENSDARG00000045561) were designed using the chop-chop website 78. To make sgRNAs, the 
template single strand DNA (ssDNA) (122 bases) was obtained by PCR complementation and 
amplification of full length ssDNA oligonucleotides. Oligonucleotides up to 81 nucleotides were 
purchased from Sigma-Aldrich using standard synthesis procedures (25 nmol concentration, 
purification with desalting method) (TableS2). The pairs of semi-complimentary oligos were 
annealed together by a short PCR program (50 µL reaction, 200uM dTNPs, 1 unit of Dream Taq 
polymerase (EP0703, ThermoFisher); PCR program: initial denaturation 95°C/3 minute (min), 5 
amplification cycles 95°C/30 Second (s), 55°C/60 s, 72°C/30 s, final extension step 72°C/15 min) 
and subsequently the products were amplified using the primers in TableS2 with a standard PCR 
program (initial denaturation 95°C/3 min, 35 amplification cycles 95°C/30 s,55°C/60 s, 72°C/30 s, 
final extension step 72°C/15 min). The final PCR products were purified with Quick gel extraction 
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and PCR purification combo kit (00505495, ThermoFisher). The purified PCR products were 
confirmed by gel electrophoresis or Sanger sequencing (Base Clear, Netherlands). For in vitro 
transcription of sgRNAs, 0.2 µg template DNA was used to generate sgRNAs using the MEGA 
short script ®T7 kit (AM1354, ThermoFisher) and purified by RNeasy Mini Elute Clean up kit 
(74204, QIAGEN Benelux B.V., Venlo, Netherlands). The Cas9 mRNA was transcribed using 
mMACHINE® SP6 Transcription Kit (AM1340, ThermoFisher) from a Cas9 plasmid (39312, 
Addgene) (Hrucha et al 2013) and purified with RNeasy Mini Elute Clean up kit (74204,QIAGEN 
Benelux B.V., Venlo, Netherlands). A mixture of sgRNA and Cas9 mRNA was injected into one cell 
stage AB/TL embryos (sgRNA 150 pg/embryo and Cas9 mRNA 300 pg/embryo). The effect of 
CRISPR injection was confirmed by PCR and Sanger sequencing. 
Genomic DNA isolation and genotyping  
Genomic DNA was isolated from an individual embryo (2 dpf) or small pieces of the tail fin tissue 
of adults (>3 months) by fin clipping. Embryos or tissue samples were incubated in 200 µL 100% 
Methanol at -20°C overnight (O/N), then methanol was removed, and remaining methanol was 
evaporated at 70°C for 20 min. Next, samples were incubated in 25 µL of TE buffer containing 1.7 
µg/µL proteinase K at 55°C for more than 5 h. Proteinase K was heat inactivated at 80°C for 30 
min, after which samples were diluted with 100 µL of Milli-Q water. Genotyping was performed 
by PCR-amplification of the region of interest using the following primers: Forward: 
AGTGAACGTCCGTGTCTTTCTT, Reverse: ACATCTTGTCGATACAAAGCGA; followed by Sanger 
sequencing to identify mutations (Base Clear, Netherlands). 
Western blot analysis  
Embryos (4dpf/3dpi) were anaesthetised with Tricaine (Lot#MKBG4400V, SIGMA-ALDRICH) and 
homogenised with a Bullet-blender (Next-Advance) in RIPA buffer (#9806, Cell Signalling) 
containing a protein inhibitor cocktail (000000011836153001, cOmplete, Roche). The extracts 
were then spun down at 4°C for 10 min at 12000 rpm/min and the supernatants were frozen for 
storage at −80°C. Western blotting was performed using Mini-PROTEAN-TGX (456-9036, Bio-Rad) 
or 18% Tris-Hcl 18% polyacrylamide gels, and protein transfer to commercial PVDF membranes 
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(Trans-Blot Turbo-Transfer pack, 1704156, Bio-Rad). Membranes were blocked with 5% dry milk 
(ELK, Campina) in Tris buffered saline (TBS) solution with Tween 20 (TBST,1XTBS contains 0.1% 
Tween 20) buffer and incubated with primary and secondary antibodies. Digital images were 
acquired using Bio-Rad Universal Hood II imaging system (720BR/01565 UAS). Band intensities 
were quantified by densitometric analysis using Image Lab Software (Bio-Rad, USA) and values 
were normalised to actin as a loading control. Antibodies used were as follows: polyclonal rabbit 
anti DRAM1 (N-terminal) (ARP47432- P050, Aviva systems biology), polyclonal rabbit anti-
Optineurin (C-terminal) (1:200, lot#100000; Cayman Chemical), polyclonal rabbit anti-p62 (C-
terminal) (PM045, lot#019, MBL), polyclonal rabbit anti Lc3 (1:1000, NB100-2331, lot#AB-3, 
Novus Biologicals), monoclonal Caspase 3 antibody (1:1000, #9662, Lot#12, Cell Signaling), Anti 
mono-and polyubiquitinated conjugates mouse monoclonal antibody (1:200; BML-PW8810-
0100, lot#01031445, Enzo life Sciences), Polyclonal actin antibody (1:1000, 4968S, lot#3, Cell 
Signaling), Anti-rabbit IgG, HRP-Linked Antibody (1:1000, 7074S, Lot#0026, Cell Signaling), Anti-
mouse IgG, HRP-linked Antibody (1:3000, 7076S, Lot#029, Cell Signaling).  
Infection conditions and bacterial burden quantification 
Mycobacterium marinum strain M or Mycobacterium marinum strain 20 fluorescently labeled 
with Wasabi or mCherry, respectively 79, 80, were microinjected into the blood island of embryos 
at 28 hpf as previously described 81. The injection dose was 200 CFU for all experiments, except 
for the phagocytosis assay (500 CFU). Embryos were manually dechorionated by tweezers and 
treated with tricaine to keep anesthesia before the injection. Infected embryos were imaged 
using a Leica MZ16FA stereo fluorescence microscope equipped with a DFC420C colour camera, 
and the bacterial pixels per infected fish data were obtained from the individual embryo stereo 
fluorescence images using previously described software 82.  
Confocal laser scanning microscopy and image quantification 
Fixed or live embryos were mounted with 1.5% low melting agarose (140727, SERVA) and 
imaged using a Leica TCS SPE confocal microscopy. For quantification of numbers of GFP-Lc3 
positive vesicles, the fixed 4dpf larvae were imaged by confocal microscopy with a 63x water 
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immersion objective (NA 1.2) in the pre-defined tail fin region to detect the number of GFP-LC3-
positive vesicles (Fig3 B and C). The numbers of GFP-Lc3 vesicles were measured by Fiji/ImageJ 
software (Fig3 B and C) 83. For quantification of the autophagic response targeted to Mm clusters 
(Fig4 B and C), the fixed 2 dpi infected larvae were imaged by confocal microscopy with a 40X 
water immersion objective (NA 1.0) at over the whole caudal hematopoietic tissue (CHT) region. 
The percentage of Mm clusters that were positive for GFP-Lc3 per embryo was determined in 
this study. The same approach was used to quantify Mm acidification in the CHT region (Fig6 A 
and B). To investigate the intramacrophage or extracellular localization of bacteria, fixed 2 dpi 
larvae were again imaged over the CHT as described above, and  first the number of Mm clusters 
was counted in this region and then the number of Mm clusters that were inside of 
macrophages were counted. To assay cell death, images from fixed 2 dpi larvae were acquired as 
above, and the number of Tunel staining+ cells in the CHT region was counted manually. 
mRNA preparation and injection 
dram1 or dram1∆19N (negative control) RNA was isolated from wild type or dram1∆19n/∆19n 
embryos using QIAzol lysis reagent (79306, QIAGEN) and purified with the RNeasy MinElute 
Cleanup kit (74204, QIAGEN). cDNA synthesis was performed using the iScript cDNA synthesis kit 
(1708891, BIO-RAD). Full-length dram1 cDNA and dram1∆19N cDNA was obtained by PCR 
amplification using Phusion High-Fidelity DNA Polymerase (M0530S, New England Biolabs). The 
following primers were used: Forward: CTG CGG CGA GAT GTT TTG GTT; Reverse: CAA AAA CAG 
TGG GAC ATA CAG TGA A. dram1 or dram1∆19N PCR products were ligated into a ZERO BLUNT 
TOPO vector (450245, ThermoFisher) and the insert was confirmed by Sanger sequencing (Base 
Clear, Netherlands). dram1 and dram1∆19N mRNA was generated using the SP6 mMessage 
mMachine kit (AM1340, Thermo Fisher) and Poly(A) Tailing Kit (AM1350, ThermoFisher);purified 
using the RNeasy Min Elute Cleanup kit (74204, QIAGEN) and 50pg mRNA was microinjected into 
one cell stage embryos. 
TUNEL assay 
Cell death was examined by Terminal deoxynucleotidyl transferase dUTP nick end labelling 
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(TUNEL staining) with the In Situ Cell Death Detection Kit (000000011684795910, SIGMA-
ALDRICH) in 2dpi fixed embryos. The assay was performed as follows: embryos were re-hydrated 
with 75% Methanol (MeOH)/5min, 50% MeOH/10 min, 25% MeOH/5 min, Wash 3× 5 min in 
PBS-TX. Then, embryos were permeabilized in 10 μg/mL Proteinase K for 40 min at 37 °C 
followed by a quick rinse in PBST. 50μl of reagents mixture was added per sample, incubated 
O/N at 37°C while protected from light. Samples were washed 3X with PBST for 15 min each 
time and stored in PBST. Samples were examined with confocal microscopy as described above. 
LysoTracker staining and Myeloperoxidase (Mpx) activity assay 
Infected embryos were immersed in egg water with 10 μM LysoTracker Red DND-99 (L7528, 
ThermoFisher) for 1h. Embryos were washed 3 times with egg water before imaging. 
Myeloperoxidase (Mpx) activity assay was performed with the Leukocyte detection Kit (390A, 
SIGMA-ALDRICH) for detection of neutrophils as previously described 82.  
Drug treatment 
Embryos were bath treated with Bafilomycin A1 (BafA1) (B1793-10UG, SIGMA-ALDRICH) diluted 
into egg water at the working concentration of 100 nM for 12h.  
Caspase 1 activity assay 
Caspase-1 activity was assayed with the fluorometric substrate Z-YVAD 7-Amido-4-
trifluoromethylcoumarin (Z-YVAD-AFC, Caspase-1 Substrate IV, Colorimetric, sc-311283, Santa 
Cruz) as described previously 84 20 embryos/group were lysed in hypotonic cell lysis buffer 
(25 mM 4-(2-hydroxyethyl) piperazine-1-ethanesulfonic acid, 5 mM ethylene glycol-bis (2-
aminoethyl ether)-N,N,N′,N′-tetraacetic acid, 5 mM dithiothreitol, 1:20 protease inhibitor 
cocktail (000000011836153001, cOmplete, Roche), pH 7.5) on ice for 10 min. For each reaction, 
10 μg protein was incubated for 90 min at 28°C with 50 μM YVAD-AFC in 50 μl of reaction buffer 
(0.2% 3-[(3-cholamidopropyl) dimethylammonio]-1-propanesulfonate (CHAPS), 0.2 M 4-(2-
hydroxyethyl) piperazine-1-ethanesulfonic acid, 20% sucrose, 29 mM dithiothreitol, pH 7.5). 
After the incubation, the fluorescence of the AFC released from the Z-YVAD-AFC substrate was 
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measured with a Microplate Readers (Tecan M1000) at an excitation wavelength of 400 and 
emission wavelength of 505 nm. 
Morpholino Injection condition  
caspase a morpholino (MO) in this study was previously used and validated 85 and purchased 
from Gene tools (Gene Tools, USA). MO oligonucleotide sequence: 5’GCCAT 
GTTTAGCTCAGGGCGCTGAC-3’ 85. MO was diluted in Milli-Q water with 0.05% phenol red and 
1nL of 0.6 mM MO was microinjected into the yolk of one cell stage embryos as previously 
described. 
Statistical analyses 
Statistical analyses were performed using GraphPad Prism software (Version 5.01; GraphPad). All 
experimental data (mean ± SEM) was analyzed using unpaired, two-tailed t-tests for 
comparisons between two groups and one-way ANOVA with Tukey’s multiple comparison 
methods as a posthoc test for comparisons between more than two groups. (ns, no significant 
difference; *p < 0.05; **p < 0.01; ***p < 0.001). For segregation from F1 or F3 heterozygous, 
data were analysed with a Chi-square test (ns, no significant difference). 
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Supplementary figure 1: Dram1 deficiency does not result in apparent defects in development or survival 
A. Schematic diagram showing the workflow used for the generation of dram1 mutant lines. Target-specific sgRNA 
and Cas9 mRNA were co-injected into one cell stage embryos (AB/TL, wild type line). Founders were outcrossed to 
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Tg(CMV:EGFP-map1lc3b) or wild type fish to obtain F1. After 3-4 months, the F1 was incrossed to obtain 
homozygous mutant and wild type F2 siblings. dram1
∆19n/∆19n 
were outcrossed with the macrophage marker 
Tg(mpeg1:mCherry-F)
umsF001














 from F2 fish. The red line indicates the CRISPR/Cas9 target site. 
The genomic DNA was isolated from fin tissue of adults (>3 months old). The dram1
5n/5n
 sequence revealed 
insertion of 5 nucleotides within the target site. 
C. Segregation from dram1
5N/+
 F1 heterozygous incross. Genotypes of adult fish (>3 months old) combined from at 
least three independent breedings were confirmed by PCR and Sanger sequencing. Data were analyzed by Chi 
square test. ns, non-significant,*p<0.05,**p<0.01,***p<0.001 
D. Segregation from dram1
∆19n+
/mpeg1:mCherry-F F1 heterozygous incross. Genotypes of adult fish (>3 months old) 
combined from at least three independent breedings were confirmed by PCR and sequencing. Data were analyzed 
by Chi square test. ns, non-significant,*p<0.05,**p<0.01,***p<0.001 

























Supplementary figure 2: Dram1 is required for the host to restrict Mm infection  
A. Workflow representing the experimental design for Mm infection experiments. Bacterial pixel counts were 
examined at 3 dpi.  




 larvae at 3 dpi.  
C. Bacterial burdens were determined at 3 dpi. The data is accumulated from two independent experiments. Each 








Supplementary figure 3: Increased accumulation of p62 and Optineurin suggests that autophagic flux is 
decreased without Dram1 




larvae in absence or presence of 




larvae (>10 larvae/sample). The blots 
were probed with antibodies against p62, Optineurin, and Actin as a loading control. p62/Actin and 



































larvae (>10 larvae/sample). The blots were probed with antibodies against poly and 
mono ubiquitin; Actin was used as a loading control. Ubiquitinated protein/Actin ratios are indicated below the blot.  
Supplementary table1: The zebrafish lines used in this study 
 
Name Description Reference 
AB/TL Wild type strain 7 
Tg(CMV:EGFP-map1lc3b) 









Siblings of dram1 carrying a transgenic 
GFP-Lc3 reporter 
In this study 
dram1∆19n/∆19n/GFP-Lc3 
dram1 mutant line (∆19n indel) 
carrying a transgenic GFP-Lc3 reporter 
In this study 
dram15n/5n/GFP-Lc3 
dram1 mutant line (5n indel) carrying a 
transgenic GFP-Lc3 reporter 
In this study 
dram1+/+/mpeg1:mCherry-F 
Siblings of dram1∆19n /∆19n carrying a 
transgenic mpeg1:mCherry-F reporter 
In this study 
dram1∆19n/∆19n/mpeg1:mCherry-F 
Siblings of dram1+/+ carrying a 
transgenic mpeg1:mCherry-F reporter 
In this study 
 
      
Supplementary table2:  Primers for complementation and amplification of sgRNA 
 
 
T7 promoter: TAATACGACTCACTATAG 
 
The underlined sequence indicates the target sites for gRNAs designed to mutate dram1 
Name Forward (5’-3’) Reverse (5’-3’) 




















Deficiency of the autophagy modulator Dram1 affects the 
transcriptional regulation of metabolic and immune response 
pathways during mycobacterial infection  
Rui Zhang, Monica Varela, Gabriel Forn-Cuní, Michiel van der Vaart and Annemarie H. Meijer 











The widespread and gradually increasing number of multidrug-resistant (MDR) or extensively 
drug-resistant (XDR) Tuberculosis (TB) cases remains a major threat to global health. Currently, 
it is urgent to develop an effective treatment to combat TB. Using the zebrafish model for TB, 
we have previously demonstrated that the lysosomal protein known as DNA Damage Regulated 
Autophagy Modulator 1 (Dram1) protects against mycobacterial infections via autophagic 
defense mechanisms. Dram1 therefore presents a promosing target for host-directed therapy 
against TB. To further explore the function of Dram1 in health and during the early stages of TB 
pathogenesis, we performed whole organism transcriptome analysis on uninfected and 
Mycobacterium marinum (Mm)-infected zebrafish larvae carrying a dram1 loss-of-function 
mutation compared to wild type control groups. Under unchallenged conditions, we found that 
deficiency of Dram1 affects the network of gene regulation to a small degree, with detectable 
differences in proteinase and metabolic pathways. The transcriptome response to 
mycobacterial infection was vastly different between dram1 mutants and wild type zebrafish, 
which indicates that the immune response to mycobacterial infection is altered in the absence 
of Dram1. Furthermore, we found that the metabolic response to mycobacterial infection that 
occurs in wild type zebrafish was lacking in Dram1-deficient zebrafish, again pointing towards a 
function in metabolic pathways for Dram1. Finally, we highlight that loss-of-function mutation 
of dram1 affects cell death and Toll-like receptor (TLR) signaling pathways during mycobacterial 
infection. Our analyses suggest that Dram1 is involved in cell death processes activated during 
mycobacterial infection, while recognition of mycobacteria by TLRs appears altered in the 
absence of Dram1. Collectively, our RNAseq study reveals a role for Dram1 in metabolic 
processes under basal and pathogenic stress conditions, and emphasizes the importance of 
autophagic mechanisms in the host immune response against mycobacterial pathogens.  
Introduction 
Mycobacterium tuberculosis (Mtb) is the causative organism of Tuberculosis (TB) and remains a 
big threat to public health, resulting in nearly 2 million deaths every year 1. Around 30% of the 
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world population is latently or actively infected with Mtb and there is an increase in the 
occurrence of multidrug-resistant (MDR) and extensively drug-resistant (XDR) strains 1. The 
development of novel effective anti-TB therapies is therefore a key priority 2. However, the 
pathogenesis of TB is not completely elucidated yet, which hinders the development of new 
therapies. Recently, studies performed using the zebrafish TB model have generated new 
insights into the host-pathogen interactions underlying TB disease. An excellent example is that 
macrophages are sufficient to initiate the formation of tuberculous granulomas under 
circumstances in which only the innate immune system is functional 3. Intriguingly, it was found 
that mycobacterial virulence factors also contribute to the formation of granulomas, making 
these hallmark structures of TB a double-edged sword. Moreover, macrophages also perform 
dual roles in TB pathogenesis by both restricting the initial infection via phagocytosis of 
mycobacteria and promoting dissemination of infection via subsequent initiation of granuloma 
formation 4, 5, which eventually leads to the infection of newly attracted macrophages 3, 6.   
Infections with Mycobacterium marinum (Mm) in zebrafish embryos and larvae present a well-
described in vivo TB model that recapitulates hallmark structural features of human TB 7, 8. 
Moreover, the activation of gene transcription in response to Mm infection in the zebrafish 
model is similar to the transcriptional response elicited by Mtb infection in humans. It was 
shown that Mm-infected larvae express many genes homologous to human immune responsive 
factors to Mtb infection 9, 10. Using the zebrafish TB model, our group has previously 
demonstrated that the transcriptional response of the host during the early stages of TB 
granuloma formation follows three main stages 11. The early stage corresponds to the first few 
hours after phagocytosis of Mm by macrophages and is characterized by activation of 
transcription factors and genes of the complement system, followed by a minor induction of 
pro-inflammatory cytokines. The mid phase, ranging from 6 hours to 1-day post infection (dpi), 
is characterized by a minimal transcriptional response, which could be due to suppression of the 
host immune response by mycobacterial virulence factors. The late phase begins when 
granulomas start to develop around 2 dpi and are characterized by progressively increasing 
induction of transcription factors, complement genes, pro-inflammatory cytokines, matrix 
metalloproteases, and other defense and inflammation-related transcriptional signatures.  
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Selective autophagy plays a vital role in restricting mycobacterial infection and our group has 
previously demonstrated that DNA Damage Regulated Autophagy Modulator 1 (Dram1) 
functions in host defense against TB 12. Human DRAM1 was first identified as a p53-induced 
regulator of autophagy and cell death 13, but in response to mycobacterial infection, its 
transcription is regulated by NFκB 12. DRAM1 has been demonstrated to be involved in diverse 
cellular processes, including autophagy, apoptosis, immunity, and cellular differentiation 14. We 
have generated Dram1-deficient mutant zebrafish (dram1∆19n/∆19n) and demonstrated that the 
absence of functional Dram1 increases susceptibility to Mm infection via a decrease in the 
maturation of Mm-containing vesicles and a subsequent increase in cell death of infected 
macrophages (Chapter 2 of this thesis). 
To gain a deeper understanding of the transcriptional changes underlying these findings, we 
have now used RNA deep sequencing to analyse the transcriptomes of infected and uninfected 
dram1∆19n/∆19n larvae and their wild type siblings. With this approach, we set out to uncover 
which cellular functions of Dram1 are involved in defense against mycobacterial infection based 
on differences in the transcriptional regulation of diverse host processes. We found evidence 
that Dram1 deficiency has major effects on the expression profiles of proteinase and metabolic 
pathways. Furthermore, we were able to detect differences in gene expression of immune 
response and cell death pathways that help explain the increased susceptibility of dram1∆19n/∆19n 
larvae to mycobacterial infection.   
Results 
Principle component analysis of RNAseq data indicates transcriptional effects of 
dram1 mutation in the absence and presence of TB infection 
Previous studies in our group have shown that Dram1 deficiency leads to increased 
mycobacterial infection burdens 12 (Chapter 2 of this thesis). Thus, to further explore the 
phenotype of dram1∆19n/∆19n mutants, we performed RNA deep sequencing to identify changes 
in the transcriptome that could help explain their increased susceptibility to mycobacterial 
infection. We chose to analyze the differences in gene expression between infected and 
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uninfected dram1+/+ and dram1∆19n/∆19n larvae at 4 days post infection (dpi), corresponding to 5 
days post fertilization (dpf). Early stage granuloma-like structures have been formed at this time 
point after infection, and a previous time course infection study has shown this correlates with 
transcriptional activation of diverse defense-related processes 11. Therefore, we designed 
infection experiments in which we infected dram1+/+ with 300 CFU (colony forming units) of Mm 
via injection into the caudal vein at 28 hours post fertilization (hpf), while we infected 
dram1∆19n/∆19n with two different dosages: 150 or 300 CFU (Fig1 A). To control for any 
transcriptional response to the injection itself, the uninfected dram1+/+ and dram1∆19n/∆19n 
groups were injected with PBS. Since dram1 mutation is known to increase the susceptibility of 
zebrafish larvae to Mm infection (Chapter 2 of this thesis), mutant larvae infected with the dose 
of 300 CFU were expected to display a higher infection burden compared to their wild type 
siblings infected with the same dose, whereas infection with 150 CFU in dram1∆19n/∆19n was 
expected to develop the same level of infection compared to infection with 300 CFU in dram1+/+. 
With this setup, we would be able to identify transcriptional differences that are specifically 
caused by the absence of functional Dram1, rather than by the higher infection burden. 
Analyzing the level of infection at 4 dpi confirmed our expectation that 150 CFU infected 
dram1∆19n/∆19n larvae display the same level of infection as dram1+/+ infected with 300 CFU, 
while dram1∆19n/∆19n larvae infected with 300 CFU displayed highly increased infection burdens 
(Fig1 B). Thus, we isolated total RNA from samples of pooled larvae from three independent 
biological replicates to perform RNA deep sequencing analysis. We used Illumina sequencing 
technology and mapped the obtained reads to zebrafish genome assembly GRCz10.80 (Genome 
Reference Consortium Zebrafish Build 10.80). Quality control analysis showed that the samples 
from one independent group (dram1∆19n/∆19n family 2) did not align with the two other replicates, 
according to the principal component analysis (PCA). Therefore, we discarded all samples 
belonging to this group and performed the further analysis with samples from two independent 
experiments for the dram1 mutant fish (Fig1 C). For the remaining samples, the PCA showed 
clustering of the different samples belonging to the same experimental group, and clear 
differences in the regulation of gene expression between the infected and non-infected groups, 






Figure 1: The experimental design for investigating the effect of Dram1 deficiency on gene expression  
A. Experimental design to obtain samples for RNA deep sequencing. Mycobacterium marinum strain M (Mm) 
fluorescently labeled with mCherry was microinjected into the blood island of embryos at 28 hpf at an injection 
dosage of 300 CFU of 150 CFU. Control groups were injected with PBS. B. Bacterial burdens at 4 dpi. The data is 
accumulated from three independent experiments. Each dot represents an individual larva. ns, non-significant, 
*p<0.05,**p<0.01,***p<0.001. C. Principal component analysis of the gene expression data obtained by RNA 
sequencing. The RNA sequencing samples clustered well, as pictured by the dashed ellipses grouping the conditions. 
The data sets of one family of dram1
∆19n/∆19n
 (Mm infected and uninfected) were outliers (data points outside the 
dashed ellipses) and were discarded from the analysis 
Mycobacterial infection increases the transcriptional differences between wild type 
and Dram1-deficient zebrafish 
We performed DESeq2 analysis to detect differential gene expression between the different 
conditions. When comparing the transcriptome of uninfected dram1∆19n/∆19n larvae to that of 
uninfected dram1+/+ larvae, we found that 236 genes were differentially regulated between the 
two conditions. In total, 77 genes were expressed at a significantly higher level in dram1∆19n/∆19n, 
while 159 genes were downregulated (Fig2 A). This indicates that, while the absence of Dram1 
influences the network of gene regulation, it only does so to a relatively small extent under 
uninfected conditions. When challenged by a mycobacterial infection, wild type larvae 
differentially expressed a total of 1971 genes compared to uninfected wild type larvae, which is 
comparable with previous findings for this stage of pathogenesis in the zebrafish TB model 11. Of 
this set of genes with altered expression during infection, 1109 genes were upregulated, and 
862 genes were downregulated. In dram1∆19n/∆19n larvae infected with the same dose (300 CFU), 
we observed a total of 1269 differentially regulated genes compared to uninfected 
dram1∆19n/∆19n, 861 of which were upregulated and 408 downregulated. For dram1∆19n/∆19n 
larvae infected with 150 CFU, 1143 genes were differentially regulated compared to uninfected 
dram1∆19n/∆19n, 876 of which were upregulated and 267 downregulated.  
Both wild type larvae and dram1 mutants displayed a marked increase in gene regulation when 
comparing the transcriptome of infected larvae with that of their uninfected siblings. To analyze 
whether the same set of genes is differentially regulated in response to infection in the absence 
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of functional Dram1, we plotted four comparisons in a Venn-diagram: (1) uninfected dram1 
mutants vs uninfected wild types, (2 & 3) low and high dose infected dram1 mutants vs 
uninfected dram1 mutants, and (4) infected wild types vs uninfected wild types (Fig2 B). 
Strikingly, we found that roughly 60% of the infection-responsive genes in wild types (1170 out 
of a total of 1971) were not differentially regulated in response to infection in dram1∆19n/∆19n. 
Furthermore, while a low dose infection of dram1∆19n/∆19n (150 CFU) results in a similar bacterial 
burden as a high dose-infection in wild type larvae (300 CFU), the transcriptome response of 
highly infected dram1∆19n/∆19n larvae (300 CFU) showed more overlap with the wild type 
response to infection. This initial analysis of global changes in gene expression suggests that 
dram1∆19n/∆19n larvae display limited alterations in gene expression compared to dram1+/+ under 













Figure 2: Dram1 deficiency affects the host transcriptome response to Mm infection   
A. The general profile of differential gene expression between the different conditions. Genes upregulated are 
coloured in yellow, and downregulated in blue. The fold change level of the genes in each group is indicated by 
colour intensity. 
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dram1 mutants display transcriptional changes in metabolic and proteolytic 
pathways under non-infected conditions 
When comparing the transcriptome of uninfected dram1 mutants to that of uninfected wild 
types, we only found a total of 236 significantly differentially expressed genes (Fig2 A). This 
small difference in gene expression under basal conditions fits with the described function of 
DRAM1/Dram1 in response to cellular stress factors 13, 15. Nonetheless, analysing the top 25 
annotated genes that were differentially expressed under basal conditions provided interesting 
links to processes that were affected by dram1 deficiency, including isg15 and alox5b which are 
involved in ubiquitination and the arachidonic acid pathway, respectively (TableS1). For an 
unbiased assessment of potentially altered biological processes in dram1∆19n/∆19n larvae under 
basal conditions, we analysed gene ontology (GO) enrichment on the subsets of differentially 
up- or down-regulated genes. Only two GO terms were enriched in the absence of functional 
Dram1, both of which are related to proteinase activity (TableS1). Conversely, several GO terms 
were underrepresented in the differentially expressed genes in dram1∆19n/∆19n compared to 
dram1+/+, most of which are related to metabolic processes (TableS1).  
In a more detailed analysis, we found no significant differences between dram1 mutants and 
wild type larvae when analyzing whether specific KEGG (Kyoto Encyclopedia of Genes and 
Genomes) pathways for biological processes were enriched amongst the differentially 
expressed genes (data not shown). We therefore turned to Gene Set Enrichment Analysis (GSEA) 
to compare our dataset against curated gene sets related to specific pathways or disease states 
in the Molecular Signature Database (MSigDB). We identified several published gene sets that 
were enriched in uninfected dram1∆19n/∆19n or dram1+/+ larvae. The gene sets that were enriched 
in dram1∆19n/∆19n larvae displayed clear links to known functions of DRAM1, or processes that it 
has been implicated in, such as UV damage; cancer; apoptosis; and the mTOR and MAPK 
pathways which are involved in autophagy regulation (Fig3 A). This is also the case for the 
inhibited (or underrepresented) gene sets in dram1∆19n/∆19n larvae, which include clear links to 
the phagosome pathway; ubiquitination; apoptosis; immunity; autophagy (rapamycin-
responsive genes); and p53 signaling (Fig3 B). To identify a potential common set of genes in the 
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previous pathways, we performed a leading edge analysis of the GSEA results. With this analysis, 
we could identify four main clusters of genes whose expression was inhibited in the 
dram1∆19n/∆19n larvae in comparison to the dram1+/+ larvae that were shared by many of the 
negatively correlated pathways: proteasome, ribosome, mitochondrial, and polymerase genes. 
Taken together, our GSEA analysis shows that dram1∆19n/∆19n larvae display altered 
transcriptional profiles in pathways related to metabolic and catabolic processes, which could 
be a compensatory response to defects in autophagosomal and lysosomal processes due to the 
















Figure 3: Transcriptomic gene expression changes in dram1 mutants under non-infected conditions (Figure on 
next page). All the genes in the RNA sequencing were ranked according to their statistical significance and fold 
change level, from left (most significant upregulated, in yellow) to the right (most significant, downregulated in 
blue), and the gene sets of the curated C2 MSigDB were tested for enrichment in the ranked gene list with GSEA. 
The number of genes belonging to each gene set found in our RNA sequencing (size column), the enrichment score 
values (NES), and the significance of the enrichment before (pval) and after Benjamini-Hochberg multitest 
correction (FDR) are shown. The gene ranks depict the position of each gene from the gene set in the ranked list 
(one gene = one column). 
A. Gene sets enriched (high expression) in the dram1
∆19n/∆19n
 mutants in comparison to the dram1
+/+
  
B. Gene sets enriched (high expression) in the dram1
+/+




















Dram1 deficiency has a major impact on the metabolic pathways induced by Mm 
challenge  
Next, we analyzed the KEGG pathways to compare the immune response to Mm infection 
without functional dram1 (Fig4). As a general remark, we found that dram1∆19n/∆19n larvae 
infected with the high infection displayed more similarity to the dram1+/+ response than the low 
infection dose, with 15 pathways commonly altered by the infection in the high dose compared 
to only 8 in the low dose. The pathways commonly affected in both the dram1+/+ and 
dram1∆19n/∆19n larvae were those involved in defense against mycobacterial infections, such as 
the Nod-like receptor signaling pathway, phagosome-related processes, cytokine signaling, and 
apoptosis. As in previously published results 11, we found that the Mm infection strongly 
affected metabolic pathways, especially the ones related to energy and carbon metabolism 
(Glycolysis, TCA cycle, etc.). Strikingly, the alteration of these metabolic pathways was absent in 
the dram1∆19n/∆19n infected larvae. However, we found that the infection of dram1∆19n/∆19n with 
300 CFU influenced other metabolic processes, including the cholesterol, alanine, aspartate, and 
glutamate pathways. Thus, the data shows that mutation of Dram1 hinders the activation of 
several metabolic pathways known to be involved in defense against Mm, while modulating 




Figure 4: Venn diagram of the enriched KEGG pathways in larvae infected with Mm.  
A. The KEGG pathways enrichment comparisons  were performed on dram1
∆19n/∆19n









300 CFU versus dram1
+/+
 PBS.  
 
Dram1 deficiency alters the expression of genes involved in programmed cell death 
mechanisms 
DRAM1 has been reported to be involved in the regulation of cellular death and we found that 
Dram1 deficiency affected both the apoptosis and necroptosis KEGG pathways in our study. We 
therefore decided to investigate the modulation of these pathways in more detail by comparing 
the expression of the genes involved in these pathways between the different groups (Fig5 A). 
Regarding the apoptosis pathway, we found a pronounced activation of caspase 8 (casp8l2) and 
caspase 9 expression in dram1∆19n/∆19n larvae infected with 300 CFU, while the 150 CFU infected 
larvae slightly increased the expression of these two caspase genes but did not reach 
significance levels. In comparison, in infected wild type larvae the expression of these two genes 
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were not significantly changed. We also found a profound inhibition of granzyme 3 expression in 
infected dram1 mutant fish, while this gene was highly expressed in infected dram1+/+ larvae. 
Despite this, in general terms, the apoptosis effectors were not very differentially regulated 
between the dram1 mutants and the wild types.  
Concerning the necroptosis pathway (representing lytic forms of cell death), we found 
enhanced expression of 27 genes activated following DNA damage in dram1∆19n/∆19n larvae 
infected with 300 CFU. For example, we found a high expression level of h2afva and baxa. 
Histone H2A (encoded by h2afva) is involved in repair of a variety of DNA damage 16. The 
increased expression of h2afva in infected dram1∆19n/∆19n larvae might indicate an increase in 
DNA damage, such as chromatinolysis triggered by programmed cell death 17. The activation of 
programmed cell death mediates sequential activation of baxa expression, which translocates 
from mitochondria to the nucleus to enhance chromatinolysis. We found that gene expression 
of the necroptosis regulators ripk1 and ripk3 was activated both in infected dram1+/+ and 
dram1∆19n/∆19n larvae. However, the expression of hsp90, which regulates protein stability of 
Ripk1 and Ripk3, was suppressed in infected dram1∆19n/∆19n larvae compared with infected wild 
types. We also observed that caspase 1 expression was significantly increased in dram1∆19n/∆19n 
larvae infected with 300 CFU. In summary, while the gene expression level of apoptosis 
effectors does not appear altered between infected dram1∆19n/∆19n and wild type larvae, we did 
observe differences in gene expression that point towards an increase in lytic cell death in the 










on next page) The three data sets used for comparison are shown in the legend of the figure. The expression fold 
change of the genes is depicted by colour (yellow, upregulated, blue downregulated).  
A. Cellular death signaling.  






Dram1 deficiency alters the expression of genes involved in immune signaling  
We found that sensor pathways, like TLR and RIG-I-like signaling, were not activated in 
dram1∆19n/∆19n infected with the low dose of Mm, despite that these larvae developed similar 
bacterial burden as the wild type larvae infected with higher dose (Fig4). Since TLR signaling was 
previously found to be critical for defense of the zebrafish host against Mm 9, we set out to 
compare the gene expression of TLR components (Fig5 B). Explicitly, TLR2, TLR4 and TLR9 have 
been reported as crucial for the host to recognize the diverse molecular patterns of 
mycobacteria and activate an immune response against this pathogen 18, 19. Strikingly, we found 
that tlr2 expression was highly suppressed in dram1∆19n/∆19n larvae during infection, but highly 
activated in dram1+/+ in response to infection. We found an opposite expression pattern in the 
expression of tlr1, which was activated in dram1 mutants but not affected in the dram1+/+ 
infected larvae. The high dose infection of dram1∆19n/∆19n larvae induced a high expression of tlr3 
and tlr9. Furthermore, the expression of MyD88-dependent immune signaling genes, including 
irak1, irak4, traf6, and ikbkb were only upregulated in the dram1+/+ and dram1∆19n/∆19n larvae 
infected with a high dose of Mm. These results indicate that the presence or absence of 
functional Dram1, in combination with the level of infection, affects which TLR signaling routes 
are employed to detect the pathogen. 
Dram1 deficiency leads to suppressed expression of LTB4 
The control of the inflammatory balance is a crucial factor that affects the outcome of 
mycobacterial infection 20. The arachidonic acid metabolism pathway produces principal 
mediators of inflammation –both pro- and anti-inflammatory– and directly impacts the 
progression and outcome of the infection. Since we found that the alox5b.1 and alox5b.2 genes 
were downregulated in dram1-deficient larvae (both in absence and presence of infection) and 
that the arachidonic acid pathway was affected during mycobacterial infection, we sought to 
explore this in more detail (Fig6 and FigS1). As a read-out for the function of this pathway, we 
performed ELISAs (enzyme-linked immunosorbent assays) to detect the level of lipoxin A4 
(LXA4), which acts as an anti-inflammatory molecule, and leukotriene B4 (LTB4), whose function 
is pro-inflammatory. The synthesis of both these lipids depends on the arachidonic acid pathway. 
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We collected samples at 5 dpf from infected and non-infected larvae to measure the 
concentration of LTB4 and LXA4. The results showed that the level of LTB4 was around 2.5 times 
higher in uninfected dram1+/+ than in uninfected dram1∆19n/∆19n larvae (Fig6 B). During 
mycobacterial infection, the levels of LTB4 in dram1+/+ were decreased to similar levels as in 
dram1∆19n/∆19n larvae. For LXA4 we did not detect any differences between infected and non-
infected larvae, or between the two genotypes (Fig6 B). These data demonstrate that Dram1 
deficiency leads to impaired production of the pro-inflammatory molecule LTB4, but differences 














Figure 6: Dram1 deficiency leads to reduced LTB4 production 
A. Differential expression of the genes from the Arachidonic Acid Metabolism pathway involved in the production 
of LTB4 and LXA4. The five data sets used for comparison are shown in the legend of the figure. The expression fold 
change is depicted by colour (yellow, upregulated, blue downregulated). 
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larvae. Data shown are the averages from three replicates. ns, non-significant, *p<0.05,**p<0.01,***p<0.001. 
Discussion 
The lysosomal protein DRAM1 modulates autophagy and cell death in response to cellular stress 
factors, such as cancer, infection or nutrient depletion 12, 13. Specifically, it was shown that 
DRAM1/Dram1 is activated downstream of a TLR-MyD88-NFκB signaling pathway to modulate 
autophagic defense against mycobacterial infection in primary human macrophages and 
zebrafish larvae 12. In this study, we have demonstrated that loss-of-function mutation of dram1 
alters the expression of TLR signaling, cell death and metabolic pathway components during 
Mm infection in zebrafish. These results suggest that Dram1 contributes to host defense against 
mycobacterial pathogens by transcriptional modulation of the immune response in addition to 
its known function in anti-bacterial autophagy. 
Before analyzing the effect of Dram1 deficiency on the transcriptome response to infection, we 
asked whether a difference in gene expression could be observed between dram1∆19n/∆19n and 
wild type larvae. Despite that the known functions of Dram1 are related to stress conditions, we 
found that, even without infection challenge, a total of 236 genes displayed altered expression 
between dram1 mutant and wild type larvae. Amongst these altered genes, we identified many 
genes related to metabolic processes and the proteasome. This transcriptional response could 
be a compensatory mechanism for defects in lysosomal function due to the deficiency in Dram1. 
This hypothesis is in line with recent studies that have revealed that lysosomes function as 
central regulatory units in signal transduction 21. The differences between dram1 mutants and 
wild types in the expression of metabolic pathway genes was markedly enhanced in response to 
Mm infection. Many recent studies have shown that the metabolic status of macrophages, the 
primary cell type parasitized by mycobacteria, is critical for their innate host defense function 22. 
Therefore, it is conceivable that metabolic dysregulation in dram1 mutants is a major cause of 
the hypersusceptibility phenotype. 
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TLRs can recognize invading mycobacterial pathogens and play an essential role in resistance to 
the infection. Recognition of mycobacteria via TLR/MyD88 signaling activates NFκB to initiate 
the expression of dram1, which in turn modulates autophagic responses to control 
mycobacterial infection 12. We have demonstrated that Dram1 deficiency fails to restrict Mm 
inside lysosomal vesicles, culminating in increased death of infected macrophages (Chapter 2 of 
this thesis). Thus, without Dram1 mycobacterial infection more commonly results in 
extracellular growth of the bacteria. Both the localization of mycobacteria and the mode of cell 
death can contribute to the recognition of bacteria by pattern recognition receptors (PRRs) and 
activation of immune and inflammatory responses. PRRs can recognize mycobacteria and other 
pathogens in different locations, including TLR2 which is located on the surface of the plasma 
membrane, while TLR3, TLR7, and TLR9 are predominantly located on the lumen of endosomes 
23, 24. In our case, the expression of tlr2 was significantly reduced in infected dram1 mutant 
larvae compared to infected wild types. Moreover, the expression of tlr3 and tlr9 was increased 
dramatically in Dram1-deficient larvae during mycobacterial infection. This could reflect the 
altered localization of bacteria, which potentially results in adjustments in the expression of 
plasma membrane and endosomal TLRs. For instance, the down regulation of tlr2 in dram1 
mutants might be related to the overgrowth of extracellular mycobacteria, which are not 
effectively eliminated by the host. Therefore, we can speculate that Tlr2 molecules on the 
plasma membrane are continuously signaling, causing the cell to down regulate tlr2 as a 
negative feedback loop.  
Inflammatory responses play a vital role in eliminating mycobacterial infections. The 
inflammatory response to mycobacterial infection is balanced by the production of the pro-
inflammatory lipid leukotriene B4 (LTB4) and the anti-inflammatory lipid lipoxin A4 (LXA4) 25. 
The enzyme LTA4H catalyses the final step in the synthesis of LTB4. LTA4H polymorphisms that 
resulted in reduced production of LTB4 and increased production of LXA4 have been linked to 
host susceptibility to mycobacterial infections 26. In addition, it has been shown that 
overexpression of LTA4H, which increases LTB4 levels, causes hyperinflammation and 
exacerbated infection 27, 28. In our transcriptome analyses, the arachidonic acid pathway was 
affected due to the disrupted function of Dram1. We found that the alox5b1 and alox5b2 genes 
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were downregulated in dram1 mutants. Alox5 is a lipoxygenase that catalyses membrane lipid 
peroxidation and has been suggested to be involved in the regulation of cell death 29, 30. We 
found that the production of LTB4 was impaired due to Dram1 deficiency, while the production 
of LXA4 was not changed in the absence of Dram1. We also observed that Mm infection 
reduced LTB4 in wild type larvae to the same level as that of uninfected and infected dram1 
mutants. Based on these results, we believe that the increased susceptibility of dram1 mutants 
to mycobacterial infection is not related to the arachidonic acid pathway, since both wild type 
larvae and dram1 mutants infected with Mm display similar levels of LTB4 and LXA4. 
Cell death of infected macrophages is a crucial factor in dissemination of invading mycobacterial 
pathogens. In this study, we found that Dram1 deficiency affects the signaling pathways 
orchestrating cell death. Specifically, the apoptosis and necroptosis KEGG pathways were 
differentially regulated between infected dram1+/+ and dram1∆19n/∆19n larvae. We have 
previously demonstrated that apoptosis could be induced by mycobacterial infection both in 
dram1+/+ and dram1∆19n/∆19n, with no difference in apoptosis activity between dram1+/+ and 
dram1∆19n/∆19n (Chapter 2 of this thesis). In agreement with these results, we found only minor 
differences in caspase 8 and 9 expression, and did not detect striking differences in regulation of 
apoptosis effector genes in response to infection between infected dram1+/+ and dram1∆19n/∆19n 
larvae. The differentially regulated necroptosis KEGG pathway contains various regulators and 
effectors of different forms of lytic cell death, including those involved in pyroptosis. Looking 
specifically at necroptosis, the activation of this pathway requires the involvement of RIPK1, 
RIPK3 and MLKL 31. While zebrafish do not express a mlkl gene, ripk1 and ripk3 were activated 
by mycobacterial infection both in dram1+/+ and dram1∆19n/∆19n larvae. In contrast, the 
expression of hsp90 was suppressed in infected dram1∆19n/∆19n larvae compared with infected 
wild types. HSP90 has been reported to regulate necroptosis via maintaining the stability of 
RIPK1, RIPK3 and MLKL 31, 32. Therefore, although ripk1 and ripk3 are equally expressed in 
infected dram1+/+ and dram1∆19n/∆19n larvae, there might be differences at the protein level due 
to altered stability caused by differences in hsp90 expression. Furthermore, we also observed 
that caspase 1 expression was significantly increased in dram1∆19n/∆19n larvae infected with 300 
CFU. This suggests that Dram1 deficiency leads to pyroptotic cell death via activation of caspase 
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1. Other evidence supporting this hypothesis is that higher levels of Caspase 1 protease activity 
can be detected in infected dram1∆19n/∆19n larvae and that the hypersusceptibility phenotype of 
these mutants can be rescued by knockdown of caspase 1 gene activity (Chapter 2 of this thesis). 
Taken together, we propose that infected macrophages in dram1∆19n/∆19n larvae more frequently 
activate lytic cell death pathways compared to their wild type counterparts. While increased 
pyroptotic cell death of infected macrophages in dram1∆19n/∆19n larvae has been experimentally 
demonstrated (Chapter 2 of this thesis), a potential increase in the occurrence of necroptosis in 
the absence of Dram1 remains to be investigated.       
In conclusion, we have demonstrated that the presence of functional Dram1 is important for the 
transcriptional regulation of metabolic processes under basal and pathogenic stress conditions 
at the whole organism level. While these observations require further investigations, we 
implicate altered cell death programs and differential requirements for pattern recognition 
receptors as important factors in the hypersusceptibility of dram1 mutants to mycobacterial 
infection, adding to the previously reported effects of Dram1 deficiency on anti-bacterial 
autophagy.  
Materials and methods 
Zebrafish culture and lines  
Zebrafish lines in this study (TableS2) were maintained and used in compliance with local animal 
welfare regulations as overseen by the Leiden University (registration number: 10612). Embryos 
were kept in egg water, in a 28.5°C-30°C incubator, and treated with 0.02% Ethyl 3-
aminobenzoate methanesulfonate (Tricaine, SIGMA-ALDRICH) in egg water for anesthesia 
before bacterial injections, imaging and fixation. 
Infection conditions and bacterial burden quantification 
Approximately 300 CFU of Mycobacterium marinum strain fluorescently labelled with mCherry 
33 were microinjected into the blood island of embryos at 28 hpf as previously described 34. 
Embryos were manually dechorionated by tweezers and treated with tricaine to keep 
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anesthesia before the injection. Infected embryos were imaged using a Leica MZ16FA stereo 
fluorescence microscope equipped with a DFC420C colour camera, and the bacterial pixels per 
infected fish data were obtained from the individual embryo stereo fluorescence images using 
previously described software 35. 
RNA preparation and RNA sequencing 
Total RNA was extracted from 5 dpf infected and non infected larvae (20 larvae/sample) from 
three independent crosses using Trizol reagent (15596026, Invitrogen) according to the 
manufacturer’s instructions and extracted with RNeasy Min Elute Clean up kit (Lot:154015861, 
QIAGEN). RNAs were quantified using a 2100 Bioanalyzer (Agilent, US). At least 10 million reads 
per sample were sequenced using Illumina Single read 50 nt runs in a Hiseq2500. Sequencing, 
mapping the reads against the D. rerio GRCz10.80 reference genome and read counting were 
performed by ZF-screens (Leiden, Netherlands).  
Analysis of RNA sequencing results 
Analysis of the count libraries was performed in RStudio 1.1.383 36 running R 3.4.3 37 using in-
house scripts (available at github.com/gabrifc). An initial quality check of the samples was 
performed using the tools provided in the edgeR package v3.20.7 38. Based on a PCA analysis 
and gene expression heatmap, a biological replicate from the dram1-/- samples, including non-
infected and infected fish was discarded from subsequent analysis. Differential gene expression 
was assessed via pairwise comparisons using DESeq2 v1.18.1 39. Genes with a FDR-adjusted p-
value < 0.05 were considered statistically significant. Venn Diagrams were created using the R 
package VennDiagram v1.6.18 40.  
Gene lists were ranked using the published function “-log(adjpval)*log2FC” and compared to 
the C2 “Curated Gene Sets” collection from the Molecular Signatures Database (MSigDB) using 
GSEA v3.0 41, and visualized with fgsea v1.4.1 42. Gene ontology enrichment was analysed with 
goseq v1.3.0 43. Updated gene length and Gene Ontology data from the Zv9 assembly was 
retrieved from Ensembl with the packages ensembldb v2.2.1 44 and biomaRt v2.34.2 45, 
107 
 
respectively. When necessary, mapping between different database gene identifiers was also 
performed using biomaRt. KEGG Pathway analysis was performed with the kegga function 
provided in limma v3.34.5 46. Gene regulation data of significant pathways was visualized with 
pathview v1.18.0  47. 
Detection of LTB4 and LXA4 by ELISA   
LTB4 and LXA4 in whole larvae were detected using a previously described method 48. 5dpf 
infected and uninfected larvae (20 larvae/group) were collected and washed with PBS. All liquid 
was removed and samples were snap frozen (10s) in liquid nitrogen. For the ELISA, 375 µL PBS 
and 0.2 SSB02 stainless steel beads (Next Advance) were added to each sample. Larvae were 
homogenized using a Bullet Blender (Next Advance) for 3 minutes on speed 8. The samples were 
then centrifuged at 3500 rpm for 5 minutes. The supernatant was collected and centrifuged 
again at 5000 rpm for 5 minutes after which the supernatant was collected again. An LTB4 ELISA 
kit (ADI-900-068, Enzo Life Sciences) and an LXA4 ELISA kit (CEB452Ge, Cloud-Clone Corp) were 
used according to the manufacturer’s instructions. All samples were measured in duplicate (50 
or 100 µL used per measurement), and the data from the duplicates were averaged. Data shown 
are the averages (SEM) from 3 replicates. 
Statistical analyses 
Statistical analyses were performed using GraphPad Prism software (Version 5.01; GraphPad). 
All experimental data (mean ± SEM) was analyzed using unpaired, two-tailed t-tests for 
comparisons between two groups and one-way ANOVA with Tukey’s multiple comparison 
methods as a posthoc test between more than two groups. (ns, no significant difference; *p < 
0.05; **p < 0.01; ***p < 0.001).  
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Regulation GO ID FDR DGE Category Term 
Overrepresented 
GO:0070011 1,97E-07 16 585 peptidase activity, acting on L-amino acid peptides 
GO:0008233 3,19E-07 16 608 peptidase activity 
Underrepresented 
GO:0005623 1,34E-08 29 10118 Cell 
GO:0044464 1,34E-08 29 10118 cell part 
GO:0009987 2,07E-08 34 10941 cellular process 
GO:0043226 5,64E-08 12 6372 Organelle 
GO:0043229 1,06E-07 12 6265 intracellular organelle 
GO:0044424 4,32E-07 21 7983 intracellular part 
GO:0044260 5,24E-07 8 4969 cellular macromolecule metabolic process 
GO:0006139 1,04E-06 2 3076 nucleobase-containing compound metabolic process 
GO:0005622 1,45E-06 24 8360 intracellular 
GO:0043227 2,87E-06 11 5449 membrane-bounded organelle 
GO:0065007 3,34E-06 17 6719 biological regulation 
GO:0043231 3,35E-06 10 5179 intracellular membrane-bounded organelle 
GO:0046483 4,93E-06 3 3153 heterocycle metabolic process 
GO:0016070 6,57E-06 1 2397 RNA metabolic process 
GO:0090304 9,45E-06 2 2700 nucleic acid metabolic process 
GO:0034641 1,41E-05 5 3597 cellular nitrogen compound metabolic process 
GO:0009059 1,76E-05 2 2624 macromolecule biosynthetic process 
GO:0034645 1,92E-05 2 2609 cellular macromolecule biosynthetic process 
GO:0019222 2,07E-05 2 2575 regulation of metabolic process 
GO:1901576 2,30E-05 4 3218 organic substance biosynthetic process 
GO:0006725 2,50E-05 4 3172 cellular aromatic compound metabolic process 
GO:0044271 2,84E-05 2 2545 cellular nitrogen compound biosynthetic process 
GO:0050789 3,07E-05 17 6269 regulation of biological process 
GO:0044249 3,13E-05 4 3160 cellular biosynthetic process 
GO:0010467 3,86E-05 3 2814 gene expression 
GO:0018130 4,40E-05 1 2080 heterocycle biosynthetic process 
GO:0019438 4,58E-05 1 2073 aromatic compound biosynthetic process 
GO:0060255 4,61E-05 2 2435 regulation of macromolecule metabolic process 
GO:0031323 5,13E-05 2 2421 regulation of cellular metabolic process 
GO:0034654 6,18E-05 1 2022 nucleobase-containing compound biosynthetic process 
GO:0080090 6,23E-05 2 2387 regulation of primary metabolic process 
GO:0044237 6,73E-05 18 6347 cellular metabolic process 
GO:0051171 7,71E-05 2 2348 regulation of nitrogen compound metabolic process 
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 without Mm infection. 




are indicated. The DGE 




 with the 
indicated GO category (described by GO ID and Term), while the Category column indicates the total number of 
genes in the GO category that were detected in our RNA sequencing. FDR indicates the false discovery rate. 
Supplementary table2: Zebrafish lines used in this study 




Siblings of dram1 carrying a transgenic GFP-Lc3 
reporter 




dram1 mutant line (∆19n indel) carrying a transgenic 
GFP-Lc3 reporter 










Supplementary figure 1: Mutation of dram1 leads to increased susceptibility to Mm infection 




















Chapter 4  
 
 
The selective autophagy receptors Optineurin and p62 are 
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Mycobacterial pathogens are the causative agents of chronic infectious diseases like 
tuberculosis and leprosy. Autophagy has recently emerged as an innate mechanism for defense 
against these intracellular pathogens. In vitro studies have shown that mycobacteria escaping 
from phagosomes into the cytosol are ubiquitinated and targeted by selective autophagy 
receptors. However, there is currently no in vivo evidence for the role of selective autophagy 
receptors in defense against mycobacteria, and the importance of autophagy in control of 
mycobacterial diseases remains controversial. Here we have used Mycobacterium marinum 
(Mm), which causes a tuberculosis-like disease in zebrafish, to investigate the function of two 
selective autophagy receptors, Optineurin (Optn) and SQSTM1 (p62), in host defense against a 
mycobacterial pathogen. To visualize the autophagy response to Mm in vivo, optn and p62 
zebrafish mutant lines were generated in the background of a GFP-Lc3 autophagy reporter line. 
We found that loss-of-function mutation of optn or p62 reduces autophagic targeting of Mm, 
and increases susceptibility of the zebrafish host to Mm infection. Transient knockdown studies 
confirmed the requirement of both selective autophagy receptors for host resistance against 
Mm infection. For gain-of-function analysis, we overexpressed optn or p62 by mRNA injection 
and found this to increase the levels of GFP-Lc3 puncta in association with Mm and to reduce 
the Mm infection burden. Taken together, our results demonstrate that both Optineurin and 
p62 are required for autophagic host defense against mycobacterial infection and support that 
protection against tuberculosis disease may be achieved by therapeutic strategies that enhance 
selective autophagy. 
Introduction     
Autophagy is a fundamental cellular pathway in eukaryotes that functions to maintain 
homeostasis by degradation of cytoplasmic contents in lysosomes 1. During autophagy, protein 
aggregates or defective organelles are sequestered by double-membrane structures, called 
isolation membranes or phagophores, which mature into autophagosomes capable of fusing 
with lysosomes. Autophagy was previously considered a strictly non-selective bulk degradation 
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pathway. However, recent comprehensive studies have highlighted its selective ability. Selective 
autophagy depends on receptors that interact simultaneously with the cytoplasmic material and 
with the autophagosome marker microtubule-associated protein 1 light chain 3 (Lc3), thereby 
physically linking the cargo with the autophagy compartment 2,3. Different selective autophagy 
pathways are classified according to their specific cargo; for example, mitophagy is the pathway 
that degrades mitochondria, aggrephagy targets misfolded proteins or damaged organelles, and 
xenophagy is directed against intracellular microorganisms. Recent studies have firmly 
established xenophagy as an effector arm of the innate immune system 4-6. The xenophagy 
pathway targets microbial invaders upon their escape from phagosomes into the cytosol, where 
they are coated by ubiquitin. These ubiquitinated microbes are then recognized by selective 
autophagy receptors of the Sequestosome (p62/SQSTM1)-like receptor (SLR) family, including 
p62, Optineurin, NDP52, NBRC1, and TAX1BP1 5. In addition to targeting microbes to autophagy, 
SLRs also deliver ubiquitinated proteins to the same compartments. It has been shown that the 
processing of these proteins into neo-antimicrobial peptides is important for elimination of the 
pathogen Mycobacterium tuberculosis in macrophages 7. 
M. tuberculosis (Mtb) is the causative agent of chronic and acute tuberculosis (Tb) infections 
that remain a formidable threat to global health, since approximately one-third of the human 
population carry latent infections and 9 million new cases of active disease manifest annually. 
Current therapeutic interventions are complicated by increased incidence of multi-antibiotic 
resistance of Mtb and co-infections with Human Immunodeficiency Virus (HIV). Despite decades 
of extensive research efforts, the mechanisms of how Mtb subverts the host’s innate immune 
defenses are incompletely understood, which poses a bottleneck for developing novel 
therapeutic strategies 8. Because of the discovery of autophagy as an innate host defense 
mechanism, the potential of autophagy-inducing drugs as adjunctive therapy for Tb is now being 
explored 9.  
Many studies have shown that induction of autophagy in macrophages by starvation, 
interferon-γ (IFN-γ) treatment, or by autophagy-inducing drugs, promotes maturation of 
mycobacteria-containing phagosomes and increases lysosome-mediated bacterial killing 7,10-12. 
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Furthermore, it has been shown that the ubiquitin ligase Parkin and the ubiquitin-recognizing 
SLRs p62 and NDP52 are activated by the escape of Mtb from phagosomes into the cytosol 13,14. 
Subsequently, the ubiquitin-mediated xenophagy pathway targets Mtb to autophagosomes 13,14. 
Parkin-deficient mice are extremely vulnerable to Mtb infection 14. However, a recent study has 
questioned the function of autophagy in the host immune response against Mtb, since 
mutations in several autophagy proteins, with the exception of ATG5, did not affect the 
susceptibility of mice to acute Mtb infection 15. The susceptibility of ATG5-deficient mice in this 
study was attributed to the ability of ATG5 to prevent a neutrophil-mediated 
immunopathological response rather than to direct autophagic elimination of Mtb. In the same 
study, loss of p62 did not affect the susceptibility of mice to Tb, despite that p62 has previously 
been shown to be required for autophagic control of Mtb in macrophages 7,15. These different 
reports suggest that Mtb employs virulence mechanisms to suppress autophagic defense 
mechanisms and that the host requires autophagy induction as a countermeasure 12. Taken 
together, the role that autophagy plays in Tb is complex and further studies are required to 
determine if pharmacological intervention in this process is useful for a more effective control 
of this disease. 
In this study, we utilized zebrafish embryos and larvae to investigate the role of selective 
autophagy during the early stages of mycobacterial infection, prior to the activation of adaptive 
immunity. Zebrafish is a well-established animal model for Tb that has generated important 
insights into host and bacterial factors determining the disease outcome 16,17. Infection of 
zebrafish embryos with Mycobacterium marinum (Mm), a pathogen that shares the majority of 
its virulence factors with Mtb, results in the formation of granulomatous aggregates of infected 
macrophages, considered as a pathological hallmark of Tb 17-19. Using a combination of confocal 
imaging in GFP-Lc3 transgenic zebrafish and transmission electron microscopy, we have 
previously shown that the autophagy machinery is activated during the early stages of 
granuloma formation in this model 20,21. Furthermore, we found that the DNA-damage regulated 
autophagy modulator Dram1 protects the zebrafish host against Mm infection by a p62-
dependent mechanism 21. However, the role of p62 and other SLRs in host defense against Mm 
remains to be further elucidated.  
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p62 is known to function cooperatively with Optineurin in xenophagy of Salmonella enterica 22-24. 
Both these SLRs are phosphorylated by Tank-binding kinase 1 (TBK1) and bind to different 
microdomains of ubiquitinated bacteria as well as interacting with Lc3 23,25. While several 
studies have implicated p62 in autophagic defense against Mtb, Optineurin has thus far not 
been linked to control of mycobacterial infection 7,13,24-26. We found gene expression of p62 and 
optn to be coordinately upregulated during granuloma formation in zebrafish larvae 27, and set 
out to study the function of these SLRs by CRISPR/Cas9-mediated mutagenesis. We found that 
either p62 or Optineurin deficiency increased the susceptibility of zebrafish embryos to Mm 
infection, while overexpression of p62 or optn mRNAs enhanced Lc3 association with Mm and 
had a host-protective effect. These results provide new in vivo evidence for the role of selective 
autophagy as an innate host defense mechanism against mycobacterial infection.  
Results 
Mycobacterium marinum bacteria are ubiquitinated during infection of zebrafish 
Phagosomal permeabilization and cytosolic escape of Mtb is known to induce the STING-
dependent DNA-sensing pathway, resulting in ubiquitination and targeting of bacteria to 
autophagy 13. We have previously shown that this pathway is also functional in zebrafish larvae 
infected with Mm and that a failure to induce autophagy reduces host resistance 21. However, it 
had not been formally demonstrated that Mm bacteria are ubiquitinated in this model. To 
examine whether ubiquitin interacts with Mm and Lc3 during infection of zebrafish, we infected 
embryos at 28 hours post fertilization (hpf) and performed immunostaining for ubiquitin at 1, 2, 
and 3 days post- infection (dpi), time points at which the early stages of tuberculous granuloma 
formation can be observed (Fig1 A). This process of granuloma formation is known to be 
induced by infected macrophages, which attract new macrophages that subsequently also 
become infected 28. Developing granulomas also attract neutrophils and usually contain 
extracellular bacteria released by dying cells 29. We observed that around 3% and 9% of Mm 
clusters are targeted by GFP-Lc3 at 1 and 2 dpi, respectively, which increases to uncountable 
levels at 3 dpi because of the increasing numbers and size of granulomas (Fig1 B and Fig1 C). 
These results were confirmed by Western blot, showing that LC3-II protein levels – indicative of 
120 
 
autophagosome formation – gradually increased during Mm infection compared to uninfected 
controls (Fig1 D). Using a FK2 ubiquitin antibody, which can recognize monoubiquitinated cell 
surface molecules as well as polyubiquitin chains, we observed that ubiquitin co-colocalized 
with approximately 4% and 10% of the Mm clusters at 1 and 2 dpi, respectively (Fig1 E and Fig1 
F). Furthermore, we observed by Western blot detection that Mm infection increased general 
levels of protein ubiquitination (Fig1 G). In addition, we found that ubiquitin and GFP-Lc3 co-
localized at Mm clusters (Fig1 H). Collectively, these data demonstrate that Mm is marked by 
ubiquitin and that overall ubiquitination levels are induced during infection in the zebrafish 
model, which coincides with autophagic targeting of bacteria.  
Figure 1: Ubiquitination and autophagy activity can be induced by Mm infection. (Figure on next page) 
A. Schematic diagram of the zebrafish Mm infection model for TB study. Mycobacterium marinum (Mm) strain 20 
fluorescently labelled with mCherry was microinjected into the blood island of embryos at 28 hpf. Red dots 
represent small clusters of Mm-infected cells visible from 1 dpi. At 3 dpi these Mm clusters have grown into early 
stage granulomas.  
B. Representative confocal micrographs of GFP-Lc3 co-localization with Mm clusters in infected embryos/larvae at 1, 
2 and 3 days post infection (dpi). Scale bars, 10 μm. 
 C. Quantification of the percentage of Mm clusters positive for GFP-Lc3 at 1 and 2 dpi. The results are 
representative for two individual repeats (≥ 20 embryo/group). ns, non-significant,*p<0.05,**p<0.01,***p<0.001.  
D. Western blot determination of Lc3 protein levels in infected and uninfected embryos/larvae at 1, 2 and 3 dpi. 
Protein samples were extracted from 1, 2 and 3 dpi infected and uninfected larvae (>10 larvae/sample). The blots 
were probed with antibodies against Lc3 and Actin as a loading control. Western blot was representative for three 
independent experimental repeats.  
E. Representative confocal micrographs of Ubiquitin co-localization with Mm clusters in infected embryos/larvae at 
1, 2 and 3 days post infection (dpi). Scale bars, 10 μm.  
F. Quantification of the percentage of Mm clusters positive for ubiquitin staining at 1 and 2 dpi (≥ 10 
embryo/group). The results are representative for two individual repeats.  ns, non-significant, *p<0.05, **p<0.01, 
***p<0.001. 
 G. Western blot analysis of ubiquitination levels in infected and uninfected embryos/larvae at 1, 2 and 3 dpi. 
Protein samples were extracted from 1, 2 and 3 dpi infected and uninfected larvae (>10 larvae/sample). The blots 
were probed with an antibody detecting both poly and mono ubiquitin and with anti-Actin antibody as a loading 
control. Western blot representative for three independent experimental repeats.  
H. Representative confocal micrographs of GFP-Lc3 and Ubiquitin co-localization with Mm clusters in infected 





































Deficiency in the ubiquitin receptors Optineurin or p62 does not impair zebrafish 
development 
Since ubiquitinated bacteria are targets for members of the sequestosome-like receptor family, 
we compared the protein sequences of its members p62, Optineurin, Calcoco2 (Ndp52), Nbrc1, 
and Tax1bp1 between human, zebrafish and other vertebrates, showing a high overall degree of 
conservation (S1B Fig and S1C Fig). We focused this study on two members of the family, p62 
and optn, which are transcriptionally induced during Mm infection of zebrafish based on 
published RNA sequencing data 27 and show strong similarity with their human orthologues in 
the ubiquitin-binding domains (UBA in p62 and UBAN in Optineurin) and Lc3 interaction regions 
(LIR) (S1D Fig).  With the aim to investigate the functions of Optineurin and p62 in anti-
mycobacterial autophagy, we utilized CRISPR/Cas9 genome editing technology to generate 
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mutant zebrafish lines. We designed short guide RNAs for target sites at the beginning of coding 
exons 2 of the optn and p62 genes, upstream of the exons encoding the ubiquitin and Lc3 
binding regions, such that the predicted effect of CRISPR mutation is a complete loss of protein 
function (Fig2 A). A mixture of  sgRNA and Cas9 mRNA was injected into zebrafish embryos at 
the one cell stage and founders carrying the desired mutations were outcrossed to the 
Tg(CMV:EGFP-map1lc3b) autophagy reporter line (hereafter referred to as GFP-Lc3) (Fig2 B) 30. 
The established optn mutant allele carried a 5 nucleotides deletion at the target site, which we 
named optn∆5n/∆5n (Fig2 C). The p62 mutant allele carried an indel resulting in the net loss of 37 
nucleotides, which we named p62∆37n/∆37n (Fig2 C). The homozygous mutants were fertile and 
produced embryos that did not exhibit detectable morphological differences compared with 
embryos produced by their wild-type (optn+/+ or p62+/+) siblings (S1A Fig). Furthermore, no 
significant deviation from the Mendelian 1:2:1 ratio for +/+, +/- and -/- genotypes was observed 
when the offspring of heterozygous incrosses were sequenced at 3 months of age (Fig2 E). 
Western blot analysis using anti-Optineurin and anti-p62 C-terminal antibodies confirmed the 
absence of the proteins in the respective mutant lines (Fig2 D). In addition, quantitative PCR (Q-
PCR) analysis revealed approximately 4.5-fold reduction of optn mRNA in the optn∆5n/∆5n larvae 
and 10-fold reduction of p62 mRNA in the p62∆37n/∆37n larvae, indicative of nonsense-mediated 
mRNA decay (Fig2 F). Collectively, the optn∆5n/∆5n and p62∆37n/∆37n mutant zebrafish produce no 
functional Optineurin or p62, respectively, and the loss of these ubiquitin receptors does not 
induce detectable developmental defects that could interfere with the use of the mutant lines 































Figure 2: Generation of Optineurin and p62 mutant lines  
A. Schematic representation of the Optn and p62 genetic and protein domain architecture and CRISPR target site. 
Optn (517 aa) and P62 (452 aa) both contain a Lc3 interaction region domain (LIR) and ubiquitin binding domains 
(UBAN in Optn and UBA in P62). Additionally, two coiled-coil motifs (CC) in Optineurin and the PHOX/Bem1p (PB) 
and Zinc Finger (ZZ) domains of P62 are indicated. The gene loci are shown with coding exons as grey boxes (14 in 
Optn and 8 in P62) and introns as solid black lines (large introns not drawn to scale). The position of the CRISPR 
target site sequences at the beginning of exon 2 in Optineurin and exon 3 in p62 are indicated and the predicted 
truncated proteins in the mutant lines are drawn above. 
B. Schematic diagram of the generation of Optn and P62 mutant lines. Target-specific sgRNA and Cas9 mRNAs were 
co-injected into one cell stage embryos (AB/TL WT line). Founders were outcrossed to Tg(CMV:EGFP-Lc3) fish and 
the F1 was incrossed to obtain homozygous mutant and wild type F2 siblings. 
C. Sanger sequencing of WT and mutant F2 fish. Red lines indicate CRISPR target sites. The Optn and p62 mutant 
sequences contain deletions of 5 and 37 nucleotides indel, respectively.  
D. Confirmation of CRISPR mutation effect by WB analysis. Protein samples were extracted from 4 dpf optn or 3dpf 
p62 mutant and WT larvae (>10 embryos/sample) and WBs were repeated at least three times with independent 
extracts. The blots were probed with antibodies against Optn or P62 and Actin as a loading control. Optn/Actin and 
P62/Actin ratios) are indicated below. kDa, kilodalton. 
E. Segregation from F1 heterozygous incross. Genotypes of adult fish (>3 months) combined from 4 (for optn) or 3 
(p62) independent breedings were confirmed by PCR and sequencing.  










 embryos (>10 embryos/sample) from three biological replicates. 
Optineurin or p62 deficiencies affect autophagy  
To analyze the effects of Optineurin or p62 deficiency on autophagy, we performed Lc3 Western 
blot detection on whole embryo extracts and imaged GFP-Lc3 signal in vivo (Fig3 A). Differences 
in the levels of the cytosolic (Lc3-I) and membrane-bound (Lc3-II) forms of Lc3 or effects on GFP-
Lc3 puncta accumulation can be due to altered basal autophagy levels, but can also be caused 
by differences in autophagosome degradation. Therefore, we also examined Lc3-I/Lc3-II levels 
and GFP-Lc3 accumulation in larvae following treatment with Bafilomycin A1 (Baf A1), which is 
an inhibitor of vacuolar H+ ATPase (V-ATPase) that prevents maturation of autophagic vacuoles 
by inhibiting fusion between autophagosomes and lysosomes 31,32. First, we performed a dose 
range assay to determine the effect of Baf A1 on Lc3-II accumulation in zebrafish embryos. 
Results showed that after 12 h of incubation, a dosage of 100nM resulted in Lc3-II accumulation 
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without affecting the Lc3-I level, whereas higher dosage additionally increased the Lc3-I level 
(S2A Fig). Thus, we utilized a dosage of 100nM to test Lc3-II accumulation in wildtype and 
mutant embryos not carrying the GFP-Lc3 reporter (Fig3 B). No differences in Lc3-II 
accumulation were observed between optn+/+ and optn∆5n/∆5n embryos or between p62+/+ and 
p62∆37n/∆37n embryos (Fig3 C). However, accumulation of Lc3-II in optn or p62 mutant embryos 
was significantly reduced in presence of Baf A1 (52% and 66%, respectively) compared to the 
wildtype controls (Fig3 C). In agreement, the number of GFP-Lc3 puncta in optn or p62 mutants 
were significantly lower than in the corresponding WT controls, showing 59% and 47% 
reductions, respectively (Fig3 D and Fig3 E).  
The function of Optineurin and p62 as ubiquitin receptors implies that these proteins are 
degraded themselves during the process of autophagy. Therefore, we asked if p62 protein levels 
are affected in optn mutants or, vice versa, if p62 mutation impacts Optineurin protein levels. 
Western blot analysis showed accumulation of p62 and Optineurin protein in wild type embryos 
in response to Baf A1 treatment, confirming that these ubiquitin receptors are substrates for 
autophagy under basal conditions (S2B Fig). Levels of p62 protein were reduced in optn∆5n/∆5n 
embryos compared with optn+/+, both in absence or presence of Baf A1 (Fig3 F). This difference 
was not due to a transcriptional effect, since p62 mRNA levels were not significantly different 
between optn+/+ and optn∆5n/∆5n embryos (Fig2 F). Similarly, levels of Optineurin protein were 
reduced in p62∆37n/∆37n embryos compared with p62+/+ in absence or presence of Baf A1 (Fig3 F), 
and again this was not associated with a difference in mRNA expression (Fig2 F). In conclusion, 
the absence of either of the ubiquitin receptors, Optineurin or p62, leads to increased use of the 
other ubiquitin receptor as a substrate for autophagic degradation. Furthermore, loss of either 
of the receptors leads to lower levels of Lc3-II and GFP-Lc3 accumulation when lysosomal 



































Figure 3: Optineurin or p62 deficiency affects autophagosome formation  
A. Workflow of the experiments shown in (B-G). 3.5 dpf larvae were treated with Bafilomycin A1 (Baf A1) (100 
nM) for 12h. The GPF-Lc3 negative larvae were selected to assay autophagy activity by WB, the GFP-Lc3 positive 
larvae were collected to monitor autophagic activity using confocal imaging. The red square indicates the region 
for confocal imaging. 
B. The level of basal autophagy in WT and mutant embryos in absence or presence of Baf A1. Protein samples 
were extracted from 4 dpf WT and mutant larvae (>10 embryos/sample). The blots were probed with 
antibodies against Lc3 and Actin as a loading control. WBs were repeated at least three times with independent 
extracts. 
C. Quantification of Lc3-II fold changes in WT and mutant embryos in absence or presence of Baf A1. WB band 
intensities were quantified by Lab Image. Data is combined from three independent experiments. 











 at 4 dpf
 
. Scale bars, 10 μm. 










 larvae with and 
without Baf A1 treatment. Each larva was imaged at a pre-defined region of the tail fin (as indicated by the red 
boxed area in Fig3 A)  (≥6 larvae/group). Results are representative of two independent experiments.  
Optineurin or p62 deficiencies increase the susceptibility of zebrafish embryos to Mm 
infection 
Next, we asked if optn or p62 mutations would affect the resistance of zebrafish embryos to 
mycobacterial infection. We injected Mm into embryos via the caudal vein at 28 hpf to measure 
infection burden at 3 dpi (Fig4 A). The infection data showed that optn or p62 mutant embryos 
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were hypersusceptible to Mm infection compared with their WT controls, culminating in an 
increase of the Mm fluorescent signal of 2.8 and 2.9 times, respectively (Fig4 B). In addition, we 
examined whether transient knockdown of optn or p62 would phenocopy the infection 
phenotype of the mutant lines. We injected optn or p62 antisense morpholino oligonucleotides 
into the one cell stage of embryos and collected injected individuals at 28h for confirmation of 
the knockdown effect by reverse transcription polymerase chain reaction (RT-PCR) and Western 
blot (S3A Fig , S3B Fig and S3C Fig). Subsequently, analysis of the Mm infection burden at 3 dpi 
showed that transient knockdown of optn or p62 led to similar increases of the Mm infection 
burden as had been observed in the mutant lines (Fig4 C). Since Optineurin and p62 are known 
to function cooperatively in xenophagy of Salmonella enterica 22-24, we asked if double 
deficiency of Optineurin and p62 resulted in an increased infection burden compared to single 
mutation of either optn or p62. No additive effect on the infection burden was observed when 
p62 morpholino was injected into optn mutant embryos or optn morpholino into p62 mutant 
embryos (Fig4 D). Taken together, our data demonstrate that both Optineurin and p62 are 
required for controlling Mm infection and that loss of either of these ubiquitin receptors cannot 





Figure 4: Optineurin or p62 deficiency leads to increased susceptibility to Mm infection (Figure on next page)  
A. Workflow of the experiments shown in (B-D). optn or p62 MO were injected into the one cell stage of embryos 
and infection was performed at 28 hpf with 200 CFU of Mm via blood island microinjection. Bacterial quantification 
was done at  3dpi. 
B-D. Mm infection burden in optn and p62 mutant larvae (B), under optn and p62 MO knockdown conditions (C), 
and following injection of p62 MO or optn MO in optn and p62 mutants, respectively (D). The data are accumulated 




























Optineurin or p62 deficiency reduces the autophagy response to Mm infection 
Having established that mutation of either optn or p62 results in increased Mm infection burden, 
we investigated if the inability of mutant embryos to control infection is due to a reduction in 
the targeting of mycobacteria to autophagy (Fig5 A). To this end, we first examined the 
association of GFP-Lc3 with Mm at 1 dpi. Mm has formed small infection foci at this time point, 
which could be manually scored as positive or negative for GFP-Lc3 association. In wild type 
embryos 5-6% of these infection foci were positive for GFP-Lc3 (S4A Fig and S4B Fig). The 
percentage of GFP-Lc3 positive Mm clusters was approximately 50% lower in the optn or p62 
mutant embryos compared with their wild type controls, but differences were not statistically 
significant due to the relatively low number of these GFP-Lc3 association events (S4A Fig and 
S4B Fig). We continued to examine GFP-Lc3 targeting to Mm at 2 dpi and found that mutation of 
optn or p62 resulted in significantly decreased GFP-Lc3 co-localization with Mm clusters (Fig5 A, 
B and C). In addition, we used GFP-Lc3-negative mutant and wild type larvae for Western blot 
analysis of Lc3-II protein levels in response to infection. We found that Mm infection increased 
Lc3-II protein levels approximately 3- to 5-fold in wild type (optn+/+ amd p62+/+) larvae at 3 dpi, 
whereas this induction level was approximately 50% lower in the optn and p62 mutant larvae 
(Fig5 D). Mm-infected mutant embryos also showed reduced Lc3-II accumulation in the 
presence of Baf A1 (S4B Fig). Taken together, these data support the hypothesis that Optineurin 












Figure 5: Optineurin or p62 deficiency inhibits targeting of Mm by GFP-Lc3 
A. Workflow of the experiment shown in B. 2 dpi fixed larvae were used for confocal imaging. The entire caudal 
hematopoietic tissue (CHT) was imaged, as indicated by the black box.  
B. Representative confocal micrographs of GFP-Lc3 co-localization with Mm clusters in infected larvae. The top 
image shows the entire CHT region in optn
+/+
 infected larvae. The bottom images show GFP-Lc3 co-localization of  










 infected larvae. The arrowheads indicate the overlap 
between GFP-Lc3 and Mm clusters. Scale bars, 10 μm. 
C. Quantification of the percentage of Mm clusters positive for GFP-Lc3 vesicles. The data is accumulated from two 
independent experiments; each dot represents an individual larva (≥12 larvae/group). ns, non-significant, 
*p<0.05,**p<0.01,***p<0.001. 
D. Lc3 protein levels were determined by WB in infected and uninfected larvae. Protein samples were extracted 
from 4 dpf larvae (>10 larvae/sample). The blots were probed with antibodies against Lc3 and Actin as a loading 
control. WBs were repeated two times with independent extracts.  
Overexpression of optn or p62 increases resistance of zebrafish embryos to Mm infection 
To further test the hypothesis that Optineurin and p62 mediate autophagic defense against Mm, 
we generated full-length optn and p62 mRNAs in vitro and injected these into embryos at the 
one cell stage, resulting in ubiquitous overexpression (Fig6 A). The increase in Optineurin or p62 
protein levels following mRNA injection was verified by Western blot analysis (Fig6 B) and no 
effects of overexpression on embryo survival or development were observed (data not shown). 
Overexpression of optn or p62 mRNAs significantly reduced Mm infection burden at 2 or 3 dpi 
compared to the control groups (Fig6 C and S5A Fig). Furthermore, injection of optn or p62 
mRNAs carrying deletions in the sequences encoding the ubiquitin binding domains or Lc3 
interaction regions did not lead to a reduction of the Mm infection burden compared with the 
control groups (Fig6 C). Thus, we conclude that optn or p62 overexpression protects against Mm 
infection in a manner dependent on the interaction of the Optn and p62 proteins with both 
































Figure 6: Transient overexpression optn or p62 mRNA  protects against Mm infection  
A. Workflow representing the experimental design in (B-C). optn or p62 mRNA was injected into the one cell stage 
of embryos (AB/TL) at a  dosage of 100 pg/embryo. Injected embryos were collected at 28 hpf for confirmation of 
the overexpression by WB analysis. Embryos were infected at 28hpf with 200 CFU Mm via the blood island by 
microinjection and bacterial burden was determined at 3 dpi. 
B. Western blot analysis to test the effect of transient overexpression of optn or p62 mRNA. Protein extracts were 
made from >20 mRNA-injected or control embryos per group. The blots were probed with antibodies against 
Optineurin or p62 and Actin as a loading control. Similar results were observed in two independent experiments. 
C. Quantification of Mm infection burden in embryos injected with full length or ΔLIR/ΔUBAN deletion mRNAs of 
optn and p62. Accumulated data from two independent infection experiments is shown. ns, non-
significant,*p<0.05,**P<0.01,***p<0.001. 
Overexpression of optn or p62 promotes GFP-Lc3 association with Mm 
Since overexpression of optn or p62 mRNAs resulted in decreased Mm infection burden, we 
postulated that elevation of the Optn or p62 protein levels would result in increased targeting 
of Mm to autophagy by these ubiquitin receptors, in a manner dependent on the functions of 
the Lc3 interaction (LIR) and ubiquitin binding domains (UBAN/UBA). To test this hypothesis, we 
injected the full-length mRNAs, or mRNAs generated from deletion constructs lacking these 
domains, and quantified GFP-Lc3-positive and GFP-negative Mm infection foci at 1 dpi and 2 dpi 
(S6A Fig and Fig7 A). The results showed that overexpression of full-length optn or p62 mRNAs 
significantly increased the percentage of GFP-Lc3-positive Mm clusters at 2 dpi, compared with 
the control groups (Fig7 B and Fig7 C). Conversely, injection of optn ∆UBAN, optn ∆LIR, p62 
∆UBA and p62 ∆LIR mRNAs did not increase the association of GFP-Lc3 with Mm clusters (Fig7 B 
and Fig7 C). Similar results could be observed as early as 1 day post infection (S6B Fig). In 
conclusion, our combined results demonstrate that Optineurin and p62 can target Lc3 to Mm 







Figure 7: Transient overexpression of optn or p62 mRNA promotes GFP-Lc3 recruitment to Mm clusters 
A. Workflow of the experiments in (B-C). optn or p62 mRNA was injected into the one cell stage of embryos at a 
dosage of 100 pg/embryo. 2 dpi fixed larvae were used for confocal imaging. The entire caudal hematopoietic 
tissue (CHT) was imaged, as indicated by the black box.  
B. Representative confocal micrographs of GFP-Lc3 co-localization with Mm clusters in larvae injected with full 
length or ΔLIR/ΔUBAN deletion mRNAs of optn and p62. The arrowheads indicate the overlap between GFP-Lc3 and 
Mm clusters. Scale bars, 10 μm. 
C. Quantification of the percentage of Mm clusters positive for GFP-Lc3 vesicles. Each dot represents an individual 
larva (≥7 larvae/group). ns, non-significant,*p<0.05,**P<0.01, *** p<0.001.    
Discussion  
Members of the family of sequestosome (p62/SQSTM1)-like receptors (SLRs) function in 
autophagic host defense mechanisms targeting a range of intracellular pathogens, including 
Salmonella, Shigella, Streptococci, Listeria, Mycobacteria, and Sindbis virus 5,13,14,33. These 
discoveries inspired investigations into autophagy modulators as host-directed therapeutics for 
treatment of infectious diseases, including Tb 9,34,35. However, the relevance of autophagic 
defense mechanisms for host resistance against Mtb infection has recently been questioned 15,36. 
This indicates that there are significant gaps in our understanding of the interaction between 
components of the autophagy pathway and mycobacterial pathogens, emphasizing the need for 
more research in animal models of Tb 12. Here, we have studied the function of two SLR family 
members in the zebrafish Tb model. We show that selective autophagy mediated by p62 and 
Optineurin provides resistance against mycobacterial infection in the context of our in vivo 
infection model that is representative of the early stages of Tb granuloma formation 17,19. Our 
findings support the host-protective role of p62 in Tb by autophagic targeting of Mycobacteria, 
in line with previous in vitro studies 13,14. Importantly, we also present the first evidence linking 
Optineurin to resistance against Mycobacteria, expanding our understanding of the function of 
SLRs in host defense against intracellular pathogens.   
The zebrafish embryo and larval Tb model provides the opportunity to image critical stages of 
the mycobacterial infection process, from the initial phagocytosis of Mm by macrophages up to 
the early stages of Tb granuloma formation 37. The model is representative of miliary Tb, where 
138 
 
the infection is disseminated to multiple organs of the host. The embryonic and larval stages of 
the zebrafish allow us to study the contribution of innate immunity to host defense, since they 
lack a matured adaptive immune response at this time point of development 17. We therefore 
used this model to study the importance of autophagic defense mechanisms during innate host 
defense against mycobacterial infections.  In this study, we successfully generated p62 and optn 
loss-of-function zebrafish mutant lines using CRISPR/Cas9 technology. Besides its role in host 
defense, p62 is a stress-inducible protein that functions as a signalling hub in diverse processes 
like amino acid sensing and the oxidative stress response 38. Defects in autophagy pathways 
caused by mutations in OPTN  have been associated with human disorders like glaucoma, Paget 
disease of bone, and amyotrophic lateral sclerosis 24,39. Despite the important functions 
reported for p62 and Optineurin in cellular homeostasis, the mutant fish lines we generated are 
viable and fertile. The absence of either p62 or Optineurin resulted in increased use of the other 
ubiquitin receptor to sequester autophagic cargo in zebrafish larvae. Nonetheless, loss of either 
of the receptors leads to lower levels of Lc3-II and GFP-Lc3 accumulation when lysosomal 
degradation is blocked, which indicates reduced activity of the autophagy pathway in these 
mutants. Therefore, we could use these mutant lines to gain a better understanding of the role 
of p62, Optineurin, and selective autophagy in host defense against mycobacterial infection. 
Genetic links between autophagy pathway genes and susceptibility to Tb in human populations 
support the function of autophagy in innate host defense against Mtb 40.  However, the 
contribution of autophagy as a direct anti-mycobacterial mechanism has recently been 
challenged, since macrophage-specific depletion of a number of autophagy genes, including p62, 
did not affect the outcome of disease in a mouse model of Tb  15,36. A possible explanation for 
these findings, as suggested by the authors of this study, is that Mtb, like other successful 
intracellular pathogens, could have evolved virulence mechanisms that subvert or exploit 
autophagic defense mechanisms employed by the host 41. In case of one of the autophagy genes, 
ATG5, macrophage-specific depletion increased Mtb infection in mice by over-activating 
inflammation rather than by impairing autophagic processes 15. It is therefore conceivable that 
modulating the activity of SLRs could also affect inflammation. Indeed, Optineurin has been 
implicated in inflammatory bowel disease and both p62 and Optineurin are involved in 
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regulation of inflammatory signaling downstream of NF-κB 42-46. Through a process that involves 
polyubiquitination of regulatory proteins, both p62 and Optineurin can modulate the activity of 
the IKK kinase complex that activates NFκB 42,43. It is therefore possible that altered 
inflammatory responses in p62 and optn mutants could explain (part of) the increase in 
mycobacterial burden observed in zebrafish hosts, while the beneficial role for autophagic 
defense mechanisms targeting the bacteria might be limited.  
To investigate the possible role of Optineurin and p62 in anti-mycobacterial autophagy, we 
quantified the association between GFP-Lc3 and Mm under loss-of-function and gain-of-
function conditions of both receptors. In wild type zebrafish embryos, only 3-5% of the bacteria 
co-localized with autophagic vesicles one day after a systemic infection with mycobacteria. 
Although the number of GFP-Lc3 positive bacterial clusters rises over the next two days, the 
percentage of bacteria targeted by autophagy at any distinct time point remains relatively low 
(e.g. ~10% at 2 days post infection). According to these results, the host only employs 
autophagic defense mechanisms against a small proportion of the invading mycobacteria during 
early stages of the infection, either because there is no greater need, or because the pathogens 
are indeed effectively suppressing this response. It is important to note though that GFP-Lc3 
association with Mm is a transient process 20, which means that the percentage of bacteria that 
encounter autophagic defenses throughout the early infection process might be much higher. 
Strikingly, the percentage of bacteria labeled by ubiquitin closely resembled the percentage of 
bacteria targeted by autophagy, and we were able to detect clear colocalization between 
ubiquitin and GFP-Lc3 at bacterial clusters. Upon loss-of-function of either p62 or Optineurin, 
the co-localization between bacteria and autophagic vesicles decreased and the bacterial 
burden increased. Conversely, overexpression of either ubiquitin binding receptor increased 
autophagic targeting of bacteria and resulted in lower bacterial burdens, both of which required 
the presence of functional Lc3 and ubiquitin binding domains. Taken together, we conclude that 
autophagic targeting of mycobacteria by p62 and Optineurin indeed provides protection against 
infection in our in vivo Tb model.  
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In summary, our findings confirm that p62 mediates ubiquitin-dependent autophagic targeting 
of mycobacteria in an in vivo model for Tb. We also provide the first evidence that the SLR 
family member Optineurin is involved in autophagic targeting of ubiquitinated mycobacteria. 
While we cannot exclude a role for p62 and Optineurin in regulating inflammatory processes 
during Tb disease progression, we have shown that the autophagic targeting of mycobacteria by 
these ubiquitin-binding receptors forms an important aspect of innate host defense against Tb. 
Our results are therefore especially important for the development of new treatment strategies 
for Tb patients with a compromised adaptive immune system – such as in HIV-coinfection. 
Based on these results, selective autophagy stimulation remains a promising strategy for 
development of novel anti-Tb therapeutics. 
Materials and methods  
Zebrafish culture and lines  
Zebrafish lines in this study (S1 Table) were handled in compliance with local animal welfare 
regulations as overseen by the Animal Welfare Body of Leiden University (License 
number:10612) and maintained according to standard protocols (zfin.org). All protocols adhered 
to the international guidelines specified by the EU Animal Protection Directive 2010/63/EU. 
Embryos were grown at 28.5°C and kept under anesthesia with egg water containing 0.02% 
buffered 3-aminobenzoic acid ethyl ester (Tricaine, Sigma) during bacterial injections, imaging 
and fixation. 
CRISPR/Cas9 mediated mutagenesis of zebrafish optn and p62 
Single guide RNAs (sgRNAs) targeting the second coding exon of zebrafish optn 
(ENSDART00000014036.10) and the third coding exon of p62 (ENSDART00000140061.2) were 
designed using the chop-chop website 47. To make sgRNAs, the template single strand DNA 
(ssDNA) (122 bases) was obtained by PCR complementation and amplification of full length 
ssDNA oligonucleotides. Oligonucleotides up to 81 nucleotides were purchased from Sigma-
Aldrich using standard synthesis procedures (25 nmol concentration, purification with desalting 
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method) (S2 Table and S3 Table). The pairs of semi-complimentary oligos were annealed 
together by a short PCR program (50 µL reaction, 200uM dTNPs, 1 unit of Dream Taq 
polymerase (EP0703, ThermoFisher); PCR program: initial denaturation 95°C/3 minute (min), 5 
amplification cycles 95°C/30 Second (s), 55°C/60 s, 72°C/30 s, final extension step 72°C/15 min) 
and subsequently the products were amplified using the primers in S2 Table with a standard 
PCR program (initial denaturation 95°C/3 min, 35 amplification cycles 95°C/30 s,55°C/60 s, 
72°C/30 s, final extension step 72°C/15 min). The final PCR products were purified with Quick 
gel extraction and PCR purification combo kit (00505495, ThermoFisher). The purified PCR 
products were confirmed by gel electrophoresis and Sanger sequencing (Base Clear, 
Netherlands). For in vitro transcription of sgRNAs, 0.2 µg template DNA was used to generate 
sgRNAs using the MEGA short script ®T7 kit (AM1354, ThermoFisher) and purified by RNeasy 
Mini Elute Clean up kit (74204, QIAGEN Benelux B.V., Venlo, Netherlands). The Cas9 mRNA was 
transcribed using mMACHINE® SP6 Transcription Kit (AM1340, Thermo Fisher) from a Cas9 
plasmid (39312, Addgene) (Hrucha et al 2013) and purified with RNeasy Mini Elute Clean up kit 
(74204,QIAGEN Benelux B.V., Venlo, Netherlands). A mixture of sgRNA and Cas9 mRNA was 
injected into one cell stage AB/TL embryos (sgRNA 150 pg/embryo and Cas9 mRNA 300 
pg/embryo). The effect of CRISPR injection was confirmed by PCR and Sanger sequencing. 
Genomic DNA isolation and genotyping  
Genomic DNA was isolated from an individual embryo (2 dpf) or small pieces of the tail fin tissue 
of adults (>3 months) by fin clipping. Embryos or tissue samples were incubated in 200 µL 100% 
Methanol at -20°C overnight (O/N), then methanol was removed, and remaining methanol was 
evaporated at 70°C for 20 min. Next, samples were incubated in 25 µL of TE buffer containing 
1.7 µg/µL proteinase K at 55°C for more than 5 h. Proteinase K was heat inactivated at 80°C for 
30 min, after which samples were diluted with 100 µL of Milli-Q water. Genotyping was 
performed by PCR-amplification of the region of interest using the primers in S5 Table followed 
by Sanger sequencing to identify mutations (Base Clear, Netherlands). 
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Western blot analysis  
Embryos (28hpf/2dpf/4dpf/3dpi) were anaesthetised with Tricaine (Lot#MKBG4400V, SIGMA-
ALDRICH) and homogenised with a Bullet-blender (Next-Advance) in RIPA buffer (#9806, Cell 
Signalling) containing a protein inhibitor cocktail (000000011836153001, cOmplete, Roche). The 
extracts were then spun down at 4°C for 10 min at 12000 rpm/min and the supernatants were 
frozen for storage at −80°C. Western blot was performed using Mini-PROTEAN-TGX (456-9036, 
Bio-Rad) or 18% Tris—Hcl 18% polyacrylamide gels, and protein transfer to commercial PVDF 
membranes (Trans-Blot Turbo-Transfer pack, 1704156, Bio-Rad). Membranes were blocked with 
5% dry milk (ELK, Campina) in Tris buffered saline (TBS) solution with Tween 20 (TBST, 1XTBS 
contains 0.1% Tween 20) buffer and incubated with primary and secondary antibodies. Digital 
images were acquired using Bio-Rad Universal Hood II imaging system (720BR/01565 UAS). 
Band intensities were quantified by densitometric analysis using Image Lab Software (Bio-Rad, 
USA) and values were normalised to actin as a loading control. Antibodies used were as follows: 
polyclonal rabbit anti-Optineurin (C-terminal) (1:200, lot#100000; Cayman Chemical), polyclonal 
rabbit anti-p62 (C-terminal) (PM045, lot#019, MBL), polyclonal rabbit anti Lc3 (1:1000, NB100-
2331, lot#AB-3, Novus Biologicals), Anti mono-and polyubiquitinated conjugates mouse 
monoclonal antibody (1:200; BML-PW8810-0100, lot#01031445, Enzo life Sciences), Polyclonal 
actin antibody (1:1000, 4968S, lot#3, Cell Signaling), Anti-rabbit IgG, HRP-Linked Antibody 
(1:1000, 7074S, Lot#0026, Cell Signaling), Anti-mouse IgG, HRP-linked Antibody (1:3000, 7076S, 
Lot#029, Cell Signaling).  
Morpholino design and validation  
optn and p62 splice blocking morpholinos were purchased from Gene Tools. For morpholino 
sequences see S4 Table. Morpholinos were diluted in Milli Q water with 0.05% phenol red and 1 
nL of 0.1 mM optn or 0.5 mM p62 Morpholino was injected into the one cell stage of embryos as 
previously described 21. The knockdown effect was validated by RT-PCR and Western blot. 
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Infection conditions and bacterial burden quantification 
Mycobacterium marinum strain 20 bacteria, fluorescently labelled with mCherry, were 
microinjected into the blood island of embryos at 28 hpf as previously described 48. The 
injection dose was 200 CFU for all experiments. Before the injection, embryos were manually 
dechorionated around 24hpf. Approximately 5 min before bacterial injections, zebrafish 
embryos were brought under anaesthesia with tricaine. Infected embryos were imaged using a 
Leica MZ16FA stereo fluorescence microscopy with DFC420C camera, total fluorescent bacterial 
pixels per infected fish were determined on whole-embryo stereo fluorescent micrographs 
using previously described software 49 .  
Confocal laser scanning microscopy and image quantification 
Fixed or live embryos were mounted with 1.5% low melting agarose (140727, SERVA) and 
imaged using a Leica TCS SPE confocal microscope. For quantification of basal autophagy, fixed 
uninfected 4dpf larvae were imaged by confocal microscopy with a 63x water immersion 
objective (NA 1.2) in a pre-defined region of the tail fin to detect GFP-LC3-positive vesicles (Fig3 
D and Fig3 E). The number of GFP-Lc3 vesicles per condition was quantified using Fiji/ImageJ 
software (Fig3 D and Fig3 E). For quantification of the autophagic response targeted to Mm 
clusters (Fig1 B and C, S4A Fig and B, S6A Fig and B), live or fixed infected embryos were viewed 
by confocal microscopy with a 63x water immersion objective (NA 1.2) and the number of Mm 
clusters that were targeted by GFP-Lc3 puncta in the tail region were counted manually. The 
same approach was used to quantify Ubiquitin targeting to Mm clusters (Fig1 E and F). To 
quantify the percentage of GFP-Lc3+ Mm clusters, we imaged the entire caudal hematopoietic 
tissue (CHT) region of 2 dpi larvae (confocal microscopy; 40X water immersion objective with NA 
1.0) and stitched multiple images together to manually count the number of Mm clusters 




Embryos (1,2,3 dpi) were fixed with 4% PFA in PBS and incubated overnight with shaking at 4ᵒC. 
After washing the embryos three times briefly in (PBS with triton-100) PBSTx, the 
embryos/larvae were digested in 10 µg/ml proteinase K (000000003115879001, SIGMA-
ALDRICH) for 10 minutes at 37ᵒC. Subsequently, the embryos were quickly washed, blocked with 
PBSTx containing 1% Bovine serum albumins (BSA) (A4503-100g, SIGMA-ALDRICH) for 2h at 
room temperature and incubated overnight at 4ᵒC in mono-and polyubiquitinated conjugates 
mouse monoclonal antibody (1:200; BML-PW8810-0100; Enzo lifes Siences), diluted in the 
blocking buffer. Next, embryos were washed three times in PBSTx, incubated for 1 h in blocking 
buffer at room temperature, incubated for 2 h at room temperature in 1:200 dilution of Alexa 
Fluor 488 or 633 goat anti-mouse (Invitrogen) in blocking buffer, followed with three times 
washes in PBSTx for imaging.  
mRNA preparation and injection 
optn (ENSDART00000014036.10, Ensembl) and p62 (ENSDART00000140061.2, Ensembl) cDNAs 
were amplified from 3dpf AB/TL embryos by PCR (primers in S5 Table) and ligated into a vector 
using the Zero-blunt cloning PCR kit (450245, Invitrogen). The sequence was confirmed by 
Sanger sequencing (BaseClear, Netherlands), after which optn and p62 cDNAs were subcloned 
into a pCS2+ expression vector. 
optn ΔUBAN cDNA was produced by in vitro transcription of optn–pCS2+ constructs digested by 
Sca1(R3122, NEB), which excludes the region encoding the UBAN protein domain. 
optn ΔLIR cDNA was amplified from optn-pCS2+ constructs by designed primers (S5 Table), 
excluding the LIR protein domain. The PCR products were gel purified by Quick gel Extraction 
PCR Purification Combo Kit (K220001,Invitrogen) and the two fragments and pCS2+ plasmid 
were digested by BamH1(R0136S,NEB) and EcoR1(R0101S,NEB), after which the two fragments 
were ligated into pCS2+ plasmid by T4 DNA ligase.  
p62 ∆UBA cDNA was obtained from a p62-pCS2+ construct by Nco1(R0193S, NEB) digestion and 
religation, which excludes the region encoding the UBA protein domain. 
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p62 ∆LIR cDNA was obtained from a p62-pCS2+ construct by NcoN1 digestion and religation. 
Optn mRNA,optn ΔUBAN, and optn ΔLIR mRNA was generated using SP6 mMessage mMachine 
kit (Life Technologies) from Kpn1 or Sac1(R0156S, NEB) digested optn–pCS2+ constructs. RNA 
purification was performed using the RNeasy Mini Elute Clean up kit (QIAGEN Benelux B.V., 
Venlo, Netherlands).  
In vitro transcription of p62, p62 ΔUBA, and p62 ΔLIR was performed using mMESSAGE 
mMACHINE® T3 Transcription Kit (AM1348, Thermo Fisher) and purified using the RNeasy 
MiniElute Cleanup kit (QIAGEN Benelux B.V., Venlo, Netherlands). All mRNAs were injected into 
one cell stage embryos, and the overexpression effects of optn or p62 were validated by Q-PCR 
and Western blot. 
Gene Expression Analysis 
Total RNA was extracted using Trizol reagent (15596026, Invitrogen) according to the 
manufacturer’s instructions and purified with RNeasy Min Elute Clean up kit (Lot:154015861, 
QIAGEN). RNAs were quantified using a NanoDrop 2000c instrument (Thermo Scientific, U.S). 
Reverse transcription reaction was performed using 0.5 µg of total RNA with iScript cDNA 
synthesis kit (Cat:#170-8891, Bio-Rad). The mRNA expression level was determined by 
quantitative real-time PCR using iQSYBR Green Supermix (Cat:170-8882, Rio-Rad) and Single 
color Real-Time PCR Detection System (Bio-Rad, U.S) as previously described 50. All primers are 
listed in S5 Table. 
Statistical analyses 
Statistical analyses were performed using GraphPad Prism software (Version 5.01; GraphPad). 
All experimental data (mean ± SEM) was analyzed using unpaired, two-tailed t-tests for 
comparisons between two groups and one-way ANOVA with Tukey’s multiple comparison 
methods as a posthoc test for comparisons between more than two groups. (ns, no significant 
difference; *p < 0.05; **p < 0.01; ***p < 0.001). To determine whether the offspring of F1 
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heterozygous mutants follows Mendelian segregation, the obtained data was analysed with a 
Chi-square test (ns, no significant difference). 
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Supplementary figure 1: Optineurin and p62 are highly conserved between zebrafish and human 
A. Representative images of WT and mutant F2 embryos at 4dpf. Scale bars, 250 µm. 
B. Phylogenetic tree of SLR amino acid sequences. Optineurin, p62, NDP52(Calcoco2), NBRC1 and TAX1BP1 
sequences were searched from the NCBI Ensembl database and the accession number listed in TableS6. MUSCLE 
online server was used to generate the protein alignment. The best-fitting amino acid replacement model to the 
alignment (JTT) was determined using ProtTest 3.2 based on the Akaike Information Criterion (AIC). Finally, the 
maximum likelihood gene tree was estimated with PhyML 3.0 and represented in FigTree v1.3.1 
(http://tree.bio.ed.ac.uk/software/figtree/). Nodal confidence was calculated with non-parametric bootstrap 
of 100 replicates. 
C. Protein sequence identity of SLRs between zebrafish and human. The percentage identity and similarity was 
calculated using a Clustal Omega alignment.  
D. Alignment of LIR, UBAN and UBA motifs from the Optn and p62 sequences of different vertebrates. Amino acid 
sequences of the LIR motif of Optn and p62 from the indicated species were aligned using Mega7 software (DNASTAR, 
Madison, WI) and aligned  Clustal W2 method{EMBL,Cambridge,UK}. The Ubiquitin binding domains of Optineurin or 




















Supplementary figure 2: Characterization of Optineurin and p62 mutant lines 
A. Validation of Baf A1 effect on zebrafish by WB. Baf A1 treatment at dosages of 20, 100 and 400 nM was 
performed by incubation for 12h in egg water. The protein samples were extracted from 4 dpf AB/TL larvae (>10 
embryos/sample). The blots were probed with antibodies against Lc3 and Actin 











 larvae at 4 dpf(>10 embryos/sample). The blots were 
probed with antibodies against Optineurin, p62 and Actin as a loading control. Optineurin/Actin and p62/Actin 






















Supplementary figure 3:  Injection of optn or p62 MO transiently knocks down the corresponding mRNA and 
protein. 
A. Workflow representing the experimental design in (B-E). optn or p62 MO were injected into one cell stage 
embryos (AB/TL), and injected embryos were collected for confirmation of the knockdown effect by RT-PCR and 
Western blot analysis (>20 embryos /Sample). 
155 
 
B. Validation of the effect of optn splice-blocking MO e2i2 (targeting the splice event between exon 2 and intron 2) 
by RT-PCR on (a) the wild type control group, (b) embryos injected with 0.1mM MO, or (c) embryos injected with 
0.15 mM MO. The wild type PCR product is expected to be  400 bp in length. 
C. Validation of the effect of p62 splice-blocking MO  i1 e2 (targeting the splice event between intron 1 and exon 2) 
by RT-PCR on (a) the wild type control group, (b) embryos injected with 0.5mM MO. The wild type PCR products is 
expected to be  200 bp in length. 
D and E. Validation of MO knockdown effect by WB analysis. The protein samples were exacted from 2 dpf AB/TL 
embryos injected with 0.1mM optn or 0.5 mM p62 MO (>20 embryos/sample). The blots were probed with 


















Supplementary figure 4: Optineurin or p62 mutation reduces autophagosome formation during Mm infection 











 infected embryos at 1 dpi. The arrowheads indicate the overlap between GFP-Lc3 and Mm clusters. 
Scale bars, 10 μm. 
B. Quantification of the percentage of Mm co-localizing with GFP-Lc3 in infected embryos at 1dpi (>6 
embryo/group). ns, non-significant, *p<0.05,**P<0.01,***p<0.001.  











 infected larvae with Baf A1 12 h treatment (>10 larvae/sample). The blots were probed with 










Supplementary figure 5: Transient overexpression of optn or p62 mRNA reduces the susceptibility to Mm 
A. Quantification of Mm infection burden in mRNA-injected embryos at 2 dpi. Data are accumulated data from two 







Supplementary figure 6: Transient overexpression of optn or p62 mRNA results in increased recruitment of GFP-
Lc3 to Mm clusters at 1 dpi. 
A. Representative confocal micrographs of GFP-Lc3 co-localization with Mm clusters in mRNA-injected larvae at 1 
dpi. The arrowheads indicate the overlap between GFP-Lc3 and Mm clusters. Scale bars, 10 μm. 
C. Quantification of the percentage of Mm clusters positive for GFP-Lc3 vesicles. ns, non-
significant,*p<0.05,**P<0.01, *** p<0.001. Data are accumulated from two independent experiments 






Supplementary table 1: Zebrafish lines used 
Name Description Reference 
AB/TL Wild type strain 21 










carrying a transgenic GFP-Lc3 reporter 
In this study 
optn
∆5n/∆5n
/GFP-Lc3 optn mutant line carrying a transgenic 
GFP-Lc3 reporter 
In this study 
p62
+/+
/GFP-Lc3 Siblings of carrying a transgenic GFP-
Lc3 reporter 
In this study 
p62
∆37n/∆37n
/GFP-Lc3 p62 mutant line carrying a transgenic 
GFP-Lc3 reporter 
In this study 
optn
∆5n/∆5n
 optineurin mutant line In this study 
p62
∆37n/∆37n
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Supplementary table 2:Target sites for CRISPR/Cas 9 systems  
Gene Name Target location Sequence(5’-3’) 
optn optn target site Exon 2 GCTGGAAAAAAGTGGAGCTG 
p62 p62 target site Exon 3 GGACCAGGAGGGCTAAAGTG 
 
Supplementary table 3: Primers for complementation and amplification of sgRNA  
Name Forward (5’-3’) Reverse (5’-3’) 
 


















sg RNA amplify GCGTAATACGACTCACTATAG GATCCGCACCGACTCGGT 
 
T7 promoter: TAATACGACTCACTATAG. The underlined sequence indicates the target sites for gRNAs designed to 




Supplementary table 4: Morpholino sequences  
 
Supplementary table 5: Primers used in this study  
Gene Type Species Accession  Forward (5’-3’) Reverse (5’-3’) 
optn PCR-cDNA ZF ENSDART00000014036.10 ATCAGGAAGAGCAGCATTTCCC TTAATCTGAAACCCTCCAGACT 
p62 PCR-cDNA ZF ENSDART00000140061.2 GTCGGCTGAAGTAGGAAACG ACCCTCCAGGTTTATGCTTG 
optn RT-PCR ZF ENSDART00000014036.10 GGACATTAGTCACCCACGT TTGGAGTTCAGAGTTCATCGCA 
p62 RT-PCR ZF ENSDART00000140061.2 ATTTGCAGCGAAAAGTGCTC AGTGAACGGAAACCCAGGAA 
optn Q-PCR ZF ENSDART00000014036.10 GACTGAACACTATGGCGTGGA GAATGCGAATCTGACCTCT 











PCR ZF ENSDART00000014036.10 GGAATTCGGATCAGGAAGAGC
AGCATTTC    
GGAGTTGCTAGGTGAACC TTGA  
optn ∆LIR 
2 
PCR ZF ENSDART00000014036.10 AGAATAGCTGATGATGACTTA 
AAAGTG 
AAGGCCTTTTAATCTGAAACCCTC





















Gene Name Target location Sequence(5’-3’) 
optn optn MO Intron2>Exon 2 AGAGCCTCTGTGGGATGCATATAAT 
p62 p62  MO Intron1>Exon 2 CTTCATCTAGAGACAAAGTTCAGGA 
160 
 















Optineurin P62 Calcoco2 TAXBP1 NBR1 
Homo sapiens 
(H.s) 
ENSG00000123240 ENSG00000161011 ENSG00000136436 ENSG00000106052 ENSG00000188554 
Pan troglodytes 
(P.t) 
ENSPTRG00000002298 ENSPTRG00000017626 ENSPTRG00000009363 ENSPTRG00000019025 ENSPTRG00000009241 
Mus musculus 
(M.m) 
ENSMUSG00000026672 ENSMUSG00000015837 ENSMUSG00000006056 ENSMUSG00000004535 ENSMUSG00000017119 
Xenopus tropicalis 
(X.t) 
ENSGALG00000013738 ENSGALG00000035804 ENSGALG00000001525 ENSGALG00000042822 ENSPTRG00000009241 
Gallus gallus 
(G.g) 
ENSXETG00000009111 ENSXETG00000015913 ENSXETG00000022806 ENSXETG00000000752 ENSXETG00000014883 
Danio rerio 
(D.r) 
































The effective treatment of tuberculosis (TB) remains a significant challenge. Drug-resistant 
Mycobacterium tuberculosis (Mtb) strains and co-infection with HIV increase the problem of 
controlling TB. Thus, under the current situation, it is essential to develop effective treatment 
strategies for Mtb infections. A bottleneck in TB treatment is the long-term residence of 
bacteria inside organized structures of immune cells, called granulomas 1. The traditional 
antibiotics cannot sufficiently penetrate into granulomas and therefore lengthly antibiotic 
treatment regimes are required to eradicate the infection. Poor patient compliance with such 
antibiotic therapy results in a rise of multidrug-resistant Mtb strains. Host-directed therapies 
can help to overcome the limitations of direct anti-bacterial therapies. However, the 
development of host-directed therapies requires a complete understanding of the interaction 
between the host and invading pathogens to identify host processes that can be targeted. A 
useful tool for such studies is the zebrafish model for TB. Zebrafish can be infected with 
Mycobacterium marinum (Mm), which is closely related to Mtb and causes similar disease 
characteristics. Importantly, the early life stages of the zebrafish (embryos and larvae) provide 
access to the earliest steps in the host-pathogen interaction that lead to the initiation of 
granulomas 2, 3. 
Mtb is an intracellular pathogen which mainly resides inside immune cells, predominantly 
macrophages. Thus, increasing the cell’s capability to kill Mtb is a valid approach to restrict TB 
disease progression. Autophagy is a lysosomal degradation process and substantial 
experimental evidence has demonstrated that autophagy is an important host immune defense 
mechanism against mycobacterial infection 4-6. Work in our laboratory has shown that the 
autophagy modulator Dram1 is activated downstream of mycobacterial recognition by the 
TLR/MyD88/NFkB pathway to activate autophagy and restrict mycobacterial infection 5. 
Overexpression of zebrafish dram1 increased autophagic targeting of mycobacteria and resulted 
in lower bacterial burdens. The autophagic control of infection by Dram1 required the selective 
autophagy receptor p62 and the cytosolic DNA sensor STING. In this thesis, we further explore 
the function of Dram1 in zebrafish host defense against mycobacterial infection. Furthermore, 




DRAM1 has been identified and characterized as a lysosomal membrane protein by Crighton et 
al. in 2006. Expression of DRAM1 is induced by DNA damage and its expression is regulated by 
tumour suppressor factor p53 7.  It has been reported that DRAM1 functions as a regulator of 
autophagy and apoptosis in the context of diverse cellular processes, such as immunity, and 
cellular differentiation 8. In addition to its link with TB 5, DRAM 1 has also been implicated in 
several other diseases, including HIV and several forms of cancer 9-11. Until now, 5 DRAM family 
members have been identified and partially characterized. They are DRAM1, DRAM2/TMEM77, 
DRAM3/TMEM150B, DRAM4/TMEM150C and DRAM5/TMEM150A. DRAM2 is most closely 
related to DRAM1 among the DRAM family members. Like DRAM1, DRAM2 is also involved in 
cell death and autophagy in response to cellular stress factors. Furthermore, DRAM2 has also 
been implicated in TB and cancer 12, 13. The expression of DRAM3 has been detected in a broad 
range of normal tissues and tumour cells. It has been demonstrated that DRAM3 regulates 
autophagic flux and cell survival in response to starvation 14. DRAM4 and DRAM5 have been 
identified as DRAM family members in an in silico study. DRAM4 could be detected at the 
plasma membrane but is primarily localized at lysosomes 15. DRAM5 can form a complex with PI 
4-kinase type IIIα (PI4KIIIα) at the plasma membrane to control the  production of 
phosphatidylinositol 4,5-biphosphate PI(4,5)P2 
15. A potential role for DRAM4 and DRAM5 in 
regulation of autophagy or cell death has not been investigated yet. Thus, the function of these 
two DRAM family members requires further elucidation. In summary, DRAM family members 
play an important role in regulating cellular process in response to diverse stress factors and 
they are highly conserved from zebrafish, to mouse to human. We speculate that other DRAM 
family members, besides DRAM1 and DRAM2, could also be involved in host defense 
mechanisms (Chapter 1). Among all Dram family members in zebrafish, dram1 is one that is 
most abundantly expressed in the immune cells of larvae and its expression is strongly induced 
by infection. Furthermore, our previous work had shown that increasing Dram1 activity can 
protect zebrafish larvae against Mm infection, based on which we proposed DRAM1 as a 
potential target for host-directed TB therapy 5. Therefore, the studies in this thesis were focused 
on further elucidating the role of dram1 in the zebrafish model for TB. 
164 
 
Dram1 is required to restrict mycobacterial infection in lysosomal 
compartments and to prevent lytic cell death of infected macrophages  
Using CRISPR/Cas9 technology we generated loss-of-function mutant alleles of zebrafish dram1 
to study its function during host defense against mycobacterial infection. Based on confocal 
image analysis we concluded that macrophages in dram1 mutants fail to restrict Mm inside 
lysosomal compartments, which eventually results in cell death of the infected macrophages 
and excessive growth of extracellular mycobacteria. Furthermore, we demonstrated that the 
macrophage cell death in dram1 mutants occurs in a Caspase 1 dependent manner (Chapter 2).  
The lysosomal protein Dram1 promotes the maturation of autophagosomes by facilitating their 
fusion with lysosomes 5, 16. In absence of Dram1, this process is affected, which can explain the 
reduced acidification of Mm-containing vesicles (Chapter 2). On a molecular level, DRAM2 has 
been reported to interact with the Beclin1-VPS34-UVRAG complex to facilitate the displacement 
of Rubicon in order to promote the maturation of autophagosomes 12. Given the large degree of 
similarity in protein structure between DRAM1 and DRAM2 17, 18, we speculate that Dram1 
might utilize a similar mechanism as DRAM2 in mediating autophagosome maturation.  
Mycobacteria-infected macrophages can undergo at least three general types of cell death: 
apoptosis, necrosis/necroptosis and pyroptosis 19. Apoptosis is a non-lytic form of cell death, 
which avoids activation of an inflammatory response. This means that intracellular 
mycobacteria are encapsulated within the apoptotic envelope until the remains of the 
apoptotic cell are phagocytIosed by newly recruited macrophages 20-22. Since uncontrolled 
extracellular growth of the bacteria is avoided during apoptosis of infected macrophages, this 
type of cell death is generally considered as host beneficial. Necrosis and pyroptosis, on the 
other hand, are lytic forms of cell death, meaning that the bacterial content of dying infected 
macrophages ends up in the extracellular environment. While necrosis is an ‘accidental’ form 
of cell death, this type of cell death can also occur as a regulated process, referred to as 
necroptosis. Pyroptosis is another regulated form of lytic cell death that is characterized by 
the formation of gasdermin pores in the cell membrane 23. Pyroptosis is usually dependent 
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on caspase 1 activation and triggers an inflammatory response 24. In this study, we found that 
Dram1 deficiency leads to impaired maturation of mycobacteria-containing vesicles, ultimately 
resulting in caspase 1 dependent cell death and extracellular overgrowth of bacteria. An 
important remaining question is how the reduced acidification of mycobacteria-containing 
vesicles in dram1 mutants is related to the initiation of pyroptotic cell death in mycobacteria-
containing macrophages. This question will need to be addressed in future studies. Other follow 
up studies regarding the molecular function of Dram1 in host defense should focus on 
identifying the interaction partners of Dram1/DRAM1 during homeostasis and infection. 
Collectively, with the analysis of dram1 mutants presented in this thesis we have provided new 
evidence for the function for Dram1 in maturation  of mycobacteria-containing vesicles, and 
have uncovered a link between this process and the control of cell survival versus the initiation 
of programmed cell death (Fig1). 
 
Figure 1: Schematic representation of a macrophage restricting mycobacterial infection via autophagic defense in 
Wild type and Dram1 deficient larvae (Figure on next page)  
1. The invading mycobacteria are phagocytosed by macrophages and detected by pattern recognition receptors, 
such as Toll-like receptors (TLRs). During phagocytosis, mycobacteria are captured in phagosomes. 
2. Whether the mycobacteria-containing phagosome matures into a bactericidal phagolysosome is a crucial factor 
in the outcome of infection. a) The phagosome fuses with a lysosome to degrade mycobacteria. b) However, 
mycobacteria have evolved diverse mechanisms to prevent fusion between phagosomes and lysosomes, such as 
the ESX-1 secretion system that facilitates mycobacterial escape from phagosomes. In the absence of the lysosomal 
protein Dram1, fusion between phagosomes and lysosomes is impaired, which contributes to mycobacterial escape 
from phagosomes 
3. A proportion of mycobacteria have escaped from the phagosome into the cytosol. Their presence in the cytosol 
can be sensed and results in ubiquitination of mycobacteria. The DNA damage regulated autophagy modulator 1 
(Dram1) activates selective autophagy against ubiquitinated mycobacteria. During this process, the ubiquitin 
receptors p62 and Optineurin are involved in the delivery of ubiquitinated mycobacteria to autophagosomes. The 
sequestered mycobacteria will be degraded in autophagolysosomes. However, the targeting of mycobacteria by 
autophagy is affected in the absence of Dram1 and the formation of autophagolysosomes is impaired. 
4. Mycobacterial infection is temporarily restricted inside macrophages to avoid the dissemination of the infection. 
However, the mycobacteria are not effectively restricted by macrophages in Dram1-deficient larvae, which leads to 






















Dram1 deficiency affects gene expression of metabolic signaling pathways  
In chapter 2 of this thesis, we described that Dram1 deficiency did not significantly affect 
autophagy activity and cell death under basal, uninfected  conditions. To better understand the 
function of Dram1 during homeostasis and mycobacterial infection, we performed RNA deep 
sequencing to analyse the transcriptomes of infected and uninfected dram1 mutants and wild 
type sibling (Chapter 3). Under uninfected conditions, we found that the proteasome, ribosome, 
mitochondria, and polymerase pathways were affected to a relatively minor extent due to the 
absence of Dram1. This suggests that dram1 mutants have deficiencies or alterations in these 
metabolic pathways. However, these metabolic alterations did not have a detectable impact on 
embryo and larval development. Furthermore, we found that Dram1 deficiency does not affect 
survival or fertility in adult zebrafish (Chapter 2). Taken together, we propose that the main 
function of Dram1/DRAM1 lies in facilitating an appropriate response to certain cellular stress 
factors, while its functions are somewhat redundant under homeostatic conditions (Chapter 2 
and Chapter 3).  
Indeed, during mycobacterial infection various gene expression pathways were significantly 
changed in Dram1-deficient larvae compared with wild type individuals. Specifically, we found 
that gene expression of regulators of necroptotic and pyroptotic cell death (hsp90 and caspa) 
was significantly altered in dram1 mutants compared to wild type larvae infected with the same 
dose of mycobacteria. In contrast, while expression of caspase 8 and caspase 9 was slightly 
altered, we detected no differences in regulation of apoptosis effector genes in response to 
infection between infected dram1+/+ and dram1∆19n/∆19n larvae. The analysis of the 
transcriptomics data confirmed our previous results that macrophages of Dram1-deficient 
larvae are more likely to undergo pyroptotic cell death when infected with mycobacteria 
(Chapter 2). While we have not addressed this experimentally yet, the results suggest that 
Dram1-deficient macrophages are more likely to undergo necroptosis in response to 
mycobacterial infection as well. Previously, it has been shown that DRAM1 mediates cell death 
of HIV-infected T-cells via lysosomal membrane permeabilization 9, and it would be interesting 
to investigate whether this is also the case in mycobacteria-infected macrophages. This could 
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potentially present a direct link between the reduced acidification of mycobacteria-containing 
vesicles and initiation of lytic cell death in infected Dram1-deficient macrophages.  
We found that the gene expression of TLRs was also significantly altered in infected dram1 
mutant larvae compared to infected wild types. The expression of the plasma membrane 
receptor tlr2 was reduced in the absence of Dram1, while the expression of the endosomal 
receptors tlr3 and tlr9 was significantly increased in Dram1 deficient larvae during 
mycobacterial infection 25, 26. This differential expression of pattern recognition receptors might 
reflect the increased extracellular localization of mycobacteria in the absence of Dram1, which 
potentially results in adjustments in the expression of plasma membrane and endosomal TLRs. 
For instance, we speculate that Tlr2 molecules on the plasma membrane are continuously 
recognizing extracellular mycobacteria, which can result in down regulation of tlr2 itself as a 
negative feedback loop. Collectively, we have demonstrated that Dram1 affects transcriptional 
regulation of metabolic processes; promotes maturation of mycobacteriacontaining vesicles; is 
required to prevent lytic cell death of macrophages in response to mycobacterial infection; and 
affects Toll-like receptor recognition of mycobacteria (Chapters 2 and 3). 
The selective autophagy receptors Optineurin and p62 are required for 
autophagic targeting of mycobacteria 
Recently, the relevance of autophagic defense mechanisms in host immune responses against 
Mtb infection has been challenged 27, 28. These reports propose that Mtb utilises virulence 
mechanisms to suppress autophagic defense mechanisms and that a potential host beneficial 
function of autophagy factors depends on their role in other processes. Furthermore, mutation 
of the selective autophagy receptor p62 in mice did not affect the outcome of Mtb infection in 
this work 27. In contrast, other studies in mice and zebrafish demonstrated that p62 is required 
for autophagic targeting of mycobacteria in vitro and in vivo 4, 5. Here, we made zebrafish 
CRISPR/Cas9 loss-of-function mutants of p62 and another selective autophagy receptor, 
Optineurin, which, like p62, shows induced gene expression during Mm infection in our model. 
We found that both p62 and Optineurin restrict mycobacterial growth by sequestering 
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ubiquitinated bacteria to Lc3-positive vesicles (Chapter 4). Our findings provide in vivo 
confirmation of the importance of selective autophagy as an innate immune defense 
mechanism against intracellular mycobacterial pathogens. To the best of our knowledge, this is 
also the first time that a host protective function for Optineurin has been shown in defense 
against mycobacterial infection (Chapter 4).  
Since a combined silencing of p62 and Optineurin did not have an additive effect on the 
mycobacterial burden compared to single mutation of p62 or Optineurin, we suspect that these 
receptors are part of the same defense pathway and are mutually dependent in promoting 
autophagic targeting of ubiquitinated cytosolic mycobacteria. Overexpression of either p62 or 
Optineurin increased host resistance to mycobacterial infection. To further investigate a 
potential mutual dependent relationship for these ubiquitin-binding receptors, it will be 
interesting to overexpress p62 in the Optineurin knock out situation and vice versa. If the two 
receptors truly depend on each other for their host protective effect, overexpression of one of 
the two will not have a beneficial effect in the absence of the other.   
Optineurin and p62 have also been linked to the regulation of cell death 29, 30. Another 
important question stemming from our studies is whether Optineurin or p62 are involved in cell 
death processes during mycobacterial infection. And if so, is this part of the same process of cell 
death modulation as Dram1? Collectively, this study provided in vivo evidence that p62 is 
involved in autophagic defense against mycobacteria during the critical early steps in the 
infection process when macrophages are parasitized and granuloma formation is initiated. 
During this phase, host defense relies on the function of the innate immune system. A similar 
situation occurs in patients with a compromised adaptive immune system and therefore these 
patients might benefit from stimulating the autophagic host defense mechanisms. In addition to 
consolidating the function of p62 in anti-mycobacterial host defense, our study provides the 






The proper control of cell death during mycobacterial infection is a critical factor in the battle 
between the host immune system and these pathogens 32. Despite recent controversies, the 
current view remains that autophagy is an important host defense mechanism to restrict 
replication of mycobacteria inside immune cells 4, 6, 27. Dying infected macrophages release a 
large number of mycobacteria which are disseminated into other tissues by newly recruited 
macrophages 3. Since mycobacterial proliferation predominantly occurs inside immune cells, 
modulation of the cell-mediated immune response is a promosing potential target for host- 
directed therapy to control TB or other mycobacterial infections 33. Based on our studies we 
propose that the defense pathway mediated by Dram1 is a promising target for host-directed 
therapy against TB by stimulating autophagic defense and preventing lytic cell death of infected 
immune macrophages (Chapter 2 and Chapter 3). The current bottleneck is to figure out how to 
pharmacologically stimulate Dram1/DRAM1 in animal models or human patients. A possible 
approach would be to directly inject DRAM1 recombinant protein into TB patients to artificially 
elevate DRAM1 protein levels. DRAM1 protein might directly participate in defense against Mtb. 
However, it remains unsure whether DRAM1 can be delivered to the appropriate membrane 
location in infected cells to exert its function. Thus, the more practical approach is to study 
mechanisms of DRAM1 activation in in vivo and in vitro models for TB (and other members of 
the DRAM family), to screen for endogenous modulators or upstream partners that can be used 
as drugable  targets to activate the host defense pathway mediated by DRAM1.  
The zebrafish dram1 knockout mutants generated and characterized here (Chapter 2) revealed 
that deficiency  in Dram1 results in uncontrolled mycobacterial infection not only due to 
impaired maturation of mycobacteria containing vesicles and defects in autophagic targeting, 
but also due to increased pyroptotic cell death of infected macrophages. In Chapter 3, we 
provide a fundamental characterization of the effect of Dram1 deficiency on the  gene 
expression profiles in health and during mycobacterial infection, which revealed effects on 
metabolic pathways, lytic cell death, and Toll-like receptor signaling. Finally, in Chapter 4 we 
demonstrate that the selective autophagy receptors Optineurin and p62 function in innate host 
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defense against mycobacterial infection by targeting ubiquitinated bacteria to autophagic 
compartments. Overall, this thesis presents new in vivo evidence for the important function of 
selective autophagy to inhibit mycobacterial proliferation inside macrophages. Furthermore, the 
results support that stimulating the innate host defense processes that are dependent on 
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Een effectieve behandeling van tuberculose (tbc) blijft een grote uitdaging. Een toename van 
antibioticumresistente stammen van Mycobacterium tuberculosis (Mtb) en co-infecties met hiv 
dragen sterk bij aan dit probleem. Het is daarom van essentieel belang om effectieve 
behandelstrategieën te ontwikkelen voor tbc. Een knelpunt bij de behandeling van tbc is dat de 
bacteriën gedurende lange tijd in compacte conglomeraten van immuuncellen verblijven, 
zogenaamde granulomen. De traditionele antibiotica kunnen slechts met moeite doordringen in 
deze granulomen, waardoor langdurige behandeling noodzakelijk is om de bacteriën volledig uit 
te schakelen. Deze langdurige behandelingen met een cocktail van antibiotica worden niet altijd 
volledig afgerond door patiënten, met een sterke toename in het aantal antibioticumresistente 
Mtb-stammen als gevolg. Medicatie gericht op de gastheer, bijvoorbeeld om de immuunreactie 
te versterken, kan mogelijk oplossingen bieden voor de beperkingen van de huidige therapieën 
met antibiotica. Echter, de ontwikkeling van zulke gastheergerichte therapieën vereist een 
verregaand begrip van de interacties tussen de gastheer en de ziekteverwekker. Door meer 
inzicht in die interacties te verkrijgen hopen wij aanknopingspunten te vinden voor de 
ontdekking van medicijnen die aangrijpen op gastheerprocessen die belangrijk zijn voor de 
afweer tegen tbc. De zebravis is een veelgebruikt onderzoeksmodel voor tbc en is uitermate 
geschikt voor onderzoek naar interacties tussen gastheer en ziekteverwekker. Zebravisembryo’s 
en -larven kunnen geïnfecteerd worden met Mycobacterium marinum (Mm), een bacterie die 
nauw verwant is aan Mtb en die een infectie met tbc-gerelateerde symptomen veroorzaakt in 
vissen. Met behulp van zebravisembryo’s en -larven is het mogelijk om interacties tussen 
immuuncellen en Mm-bacteriën te bestuderen tijdens de vroegste stadia van de ontwikkeling 
van de karakteristieke tbc-granulomen. 
Mycobacteriële ziekteverwekkers kunnen overleven en zich vermeerderen in cellen van het 
immuunsysteem, de macrofagen. Als reactie hierop initiëren macrofagen diverse 
afweermechanismen in een poging om de intracellulaire bacteriën op te ruimen en verdere 
verspreiding van de infectie te voorkomen. Er zijn veel factoren – zowel aan de gastheerkant als 
aan de bacteriële kant – die samen het lot van een geïnfecteerde macrofaag bepalen: ruimt de 
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macrofaag de bacteriën op, of gaat de cel ten onder aan de infectie? DRAM1, een regulator van 
autofagie en celdood, is in tijdens eerder onderzoek in verband gebracht met anti-
mycobacteriële afweermechanismen die gebruik maken van de autofagiemachinerie. In dit 
proefschrift hebben we een mutatie in het dram1-gen van de zebravis geïntroduceerd met 
behulp van de CRISPR/Cas9-methode. In deze mutant zagen wij geen verlaging van de activiteit 
van autofagie in de afwezigheid van infectie. Echter, tijdens Mm-infectie zorgt mutatie van 
dram1 voor een verminderde co-lokalisatie tussen bacteriën en autofagiestructuren en voor een 
verminderde afweer tegen mycobacteriële infecties. Bovendien hebben we aangetoond dat 
Dram1, een voornamelijk lysosomaal eiwit, noodzakelijk is voor de verzuring van de organellen 
waarin Mm verblijft. Door middel van intravitale microscopie konden we observeren dat 
macrofagen zonder Dram1 niet in staat zijn om een mycobacteriële infectie te beteugelen 
tijdens de vroege stadia van tbc. Uitschakelen van de functionele zebravishomoloog van 
Caspase 1 zorgde ervoor dat infectieniveaus in dram1-mutanten verlaagd werden. 
Voortbordurend op de eerder beschreven rol van Dram1 bij verzuring van Mm-bevattende 
organellen, wijzen deze nieuwe resultaten erop dat de aanwezigheid van Dram1 pyroptotische 
celdood van geïnfecteerde macrofagen voorkomt en op die manier bijdraagt aan de weerstand 
van de gastheer tegen een mycobacteriële infectie.                       
Om de functie van Dram1 nader te onderzoeken hebben we door middel van sequentieanalyse 
van het RNA de volledige genexpressiepatronen in kaart gebracht van ongeïnfecteerde en Mm-
geïnfecteerde zebravislarven van de dram1-mutant en van wild-type zebravislarven als 
controlegroep. Deze zogenoemde transcriptoomanalyse liet zien dat in de gezonde situatie het 
netwerk van genexpressie slechts in geringe mate werd beïnvloed door afwezigheid van Dram1, 
met detecteerbare verschillen in proteolytische en metabole processen. De 
transcriptoomreactie op mycobacteriële infectie was echter sterk afwijkend in dram1-mutanten, 
wat suggereert dat de afweerreactie van de gastheer veranderd is in afwezigheid van Dram1. 
Bovendien vonden we dat de metabole reactie op mycobacteriële infectie die plaatsvindt in 
wild-type larven afwezig was in dram1-mutanten, wat nogmaals wijst op een rol voor Dram1 in 
metabole processen. Tenslotte is het noemenswaardig dat het verlies van Dram1 
celdoodprocessen en herkenning van bacteriën via zogenaamde Toll-receptoren beïnvloedde. 
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Onze analyse suggereert dat Dram1 betrokken is bij de regulatie van celdoodprocessen die 
geactiveerd worden tijdens een mycobacteriële infectie, terwijl de herkenning van Mm op een 
andere manier plaats lijkt te vinden in afwezigheid van Dram1. Samenvattend onthult onze 
transcriptoomanalyse een rol voor Dram1 in metabole processen onder zowel gezonde 
omstandigheden als tijdens de cellulaire stress die veroorzaakt wordt door infectie. Bovendien 
benadrukt onze analyse het belang van autofagiemechanismen in de verdediging van de 
gastheer tegen mycobacteriële infecties.  
In vitro studies hebben aangetoond dat mycobacteriën die ontsnappen vanuit fagosomen naar 
het cytosol gemarkeerd worden met een afbraaksignaal, ubiquitine, en vervolgens herkend 
worden door selectieve autofagiereceptoren. Daarentegen is er tot op heden geen in vivo 
bewijs voor een rol van selectieve autofagiereceptoren in de verdediging van de gastheer tegen 
mycobacteriële infecties en het belang van dit proces is controversieel. In dit proefschrift 
hebben we het zebravismodel voor tbc gebruikt om de rol van twee selectieve 
autofagiereceptoren, Optineurin (optn) en SQSTM1 (p62), in de verdediging van de gastheer 
tegen mycobacteriële ziekteverwekkers. Hiertoe zijn mutanten van optn en p62 gegenereerd 
met de CRISPR/Cas9-methode in een transgene GFP-Lc3-zebravislijn die gebruikt kan worden 
om de autofagiereactie tegen Mm te visualiseren. We vonden dat mutaties in optn of p62 
resulteerde in een verminderde autofagiereactie tegen Mm en een verhoogde vatbaarheid voor 
Mm-infectie. We konden deze resultaten reproduceren door de genen tijdelijk uit te schakelen. 
Bovendien resulteerde verhoogde genexpressie van optn of p62 door middel van mRNA-injectie 
in een verhoogde associatie tussen GFP-Lc3 en Mm en een verlaagde infectiegraad. 
Samenvattend kunnen we op grond van de resultaten van deze in vivo studie naar de rol van 
selectieve autofagiereceptoren concluderen dat zowel Optineurin als p62 noodzakelijk zijn voor 
autofagie-gerelateerde verdedigingsmechanismen tegen mycobacteriële infecties in de zebravis.  
De zebravis dram1-mutanten beschreven en gekarakteriseerd in hoofdstuk 2 van dit 
proefschrift laten zien dat afwezigheid van Dram1 resulteert in ongecontroleerde Mm-infecties 
door gebrekkige maturatie van organellen die Mm bevatten, verminderde 
verdedigingsmechanismen gebaseerd op autofagie en een verhoging van het aantal cellen dat 
pyroptotische celdood ondergaat. In hoofdstuk 3 hebben we laten zien dat de afwezigheid van 
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Dram1 invloed heeft op genexpressienetwerken in zowel ongeïnfecteerde als Mm-
geïnfecteerde zebravislarven, met name metabole processen, lytische celdood en signaalroutes 
van Toll-receptoren. Tenslotte hebben we in hoofdstuk 4 van dit proefschrift laten zien dat de 
selectieve autofagiereceptoren Optineurin en p62 een belangrijke rol spelen in de 
immuunverdediging van de gastheer tijdens mycobacteriële infecties door geubiquitineerde 
bacteriën te herkennen en aan te vallen door middel van autofagie. Samenvattend levert dit 
proefschrift nieuw bewijs voor de belangrijke rol van selectieve autofagie in het verhinderen van 
mycobacteriële proliferatie binnen macrofagen van de gastheer. Bovendien levert dit 
proefschrift verdere ondersteuning voor de notie dat het stimuleren van de aangeboren 
immuunprocessen die gebaseerd zijn op de functies van Dram1, p62 en Optineurin, een 
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